identifier,alternative_identifiers,country,continent,region,culture,epoch,group,comment,latitude,longitude,sex,site,site_detail,mt_hg,ychr_hg,year_from,year_to,date_detail,bp,c14_lab_code,reference_name,c14_sample_tag,ychr_snps,avg_coverage,sequence_source,mitopatho_alleles,mitopatho_positions,mitopatho_locus,mitopatho_diseases,mitopatho_statuses,mitopatho_homoplasms,mitopatho_heteroplasms
I1072,I1072_enhanced_d,Israel,,,Israel_Natufian_d,,Israel_Natufian_d,,32.65,35.067,M,Raqefet Cave,,N1b,..,,,12000-9500 BCE,,Unknown,Lazaridis et al. 2022,0,..,8.193132,fasta,12705T;16390A;8836G,12705;16390;8836,MT-CO1;MT-CR;MT-ATP6,Possible protective factor for normal tension glaucoma;POAG - potential for association;LHON,Reported,<NA>;+,<NA>;-
I1072,I1072_d,Israel,,,Israel_Natufian,,Israel_Natufian,,32.65,35.067,M,Raqefet Cave,,n/a (<2x),..,,,12000-9500 BCE,,Unknown,Lazaridis et al. 2016,0,..,1.897519,fasta,12705T;16390A;8836G,12705;16390;8836,MT-CO1;MT-CR;MT-ATP6,Possible protective factor for normal tension glaucoma;POAG - potential for association;LHON,Reported,<NA>;+,<NA>;-
I1072,I1072,Israel,,,Israel_Natufian_contam,,Israel_Natufian_contam,,32.65,35.067,M,Raqefet Cave,,N1b,..,,,12000-9500 BCE,,Unknown,Lazaridis et al. 2016,0,..,12.656105,fasta,12705T;16390A;8836G,12705;16390;8836,MT-CO1;MT-CR;MT-ATP6,Possible protective factor for normal tension glaucoma;POAG - potential for association;LHON,Reported,<NA>;+,<NA>;-
I1415,I1415_enhanced,Jordan,,,Jordan_PPNB,,Jordan_PPNB,,31.988,35.976,M,'Ain Ghazal,,T1a2,..,-8790.0,-8690.0,"8176-7608 calBCE (8790±50 BP, Poz-81101)",8790,Unknown,Lazaridis et al. 2022,0,..,23.444746,fasta,11251G;15928A;16189C;4216C;4917G,11251;15928;16189;4216;4917,MT-ND4;MT-TT;MT-CR;MT-ND1;MT-ND2,Reduced risk of PD;Multiple Sclerosis / idiopathic repeat miscarriage / AD protection;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;LHON / Insulin Resistance / AMD / NRTI-PN,Reported;Conflicting reports,nr;+,nr;-
I1701,I1701_enhanced,Jordan,,,Jordan_PPNB,,Jordan_PPNB,,31.988,35.976,F,'Ain Ghazal,,K1a18,n/a (female),-8620.0,-8520.0,"7752-7543 calBCE (8620±50 BP, Poz-81094)",8620,Unknown,Lazaridis et al. 2022,0,n/a (female),14.818215,fasta,10398G;11467G;12308G;12372A;16093C;9055A,10398;11467;12308;12372;16093;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-CR;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Cyclic Vomiting Syndrome;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+;-,-;+
I1707,I1707,Jordan,,,Jordan_PPNB,,Jordan_PPNB,,31.988,35.976,M,'Ain Ghazal,,R0a,..,-8590.0,-8490.0,"7732-7537 calBCE (8590±50 BP, Poz-81097)",8590,Unknown,Lazaridis et al. 2016,0,..,20.3,fasta,,,,,,,
I1709,I1709_enhanced,Jordan,,,Jordan_PPNB,,Jordan_PPNB,,31.988,35.976,M,'Ain Ghazal,,n/a (<2x),..,,,8300-7900 BCE,,Unknown,Lazaridis et al. 2022,0,..,0.9162,fasta,195C;14831A,195;14831,MT-CR;MT-CYB,BD-associated / melanoma pts;LHON,Reported,+,+;-
I1710,I1710,Jordan,,,Jordan_PPNB,,Jordan_PPNB,,31.988,35.976,M,'Ain Ghazal,,T1a2,..,-8580.0,-8460.0,"7741-7522 calBCE (8580±60 BP, Poz-81098)",8580,Unknown,Lazaridis et al. 2016,0,..,48.5,fasta,11251G;15928A;16189C;4216C;4917G,11251;15928;16189;4216;4917,MT-ND4;MT-TT;MT-CR;MT-ND1;MT-ND2,Reduced risk of PD;Multiple Sclerosis / idiopathic repeat miscarriage / AD protection;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;LHON / Insulin Resistance / AMD / NRTI-PN,Reported;Conflicting reports,nr;+,nr;-
I1704,I1704,Jordan,,,Jordan_PPNB_contam,,Jordan_PPNB_contam,,31.988,35.976,F,'Ain Ghazal,,T,n/a (female),-8190.0,-8070.0,"7451-7056 calBCE (8190±60 BP, Poz-81095)",8190,Unknown,Lazaridis et al. 2016,0,n/a (female),21.7,fasta,11251G;15928A;16189C;4216C;4917G,11251;15928;16189;4216;4917,MT-ND4;MT-TT;MT-CR;MT-ND1;MT-ND2,Reduced risk of PD;Multiple Sclerosis / idiopathic repeat miscarriage / AD protection;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;LHON / Insulin Resistance / AMD / NRTI-PN,Reported;Conflicting reports,nr;+,nr;-
I1727,I1727,Jordan,,,Jordan_PPNB_contam,,Jordan_PPNB_contam,,31.988,35.976,M,'Ain Ghazal,,T1a2,..,,,8300-7900 BCE,,Unknown,Lazaridis et al. 2016,0,..,8.89,fasta,11251G;15928A;16189C;4216C;4917G,11251;15928;16189;4216;4917,MT-ND4;MT-TT;MT-CR;MT-ND1;MT-ND2,Reduced risk of PD;Multiple Sclerosis / idiopathic repeat miscarriage / AD protection;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;LHON / Insulin Resistance / AMD / NRTI-PN,Reported;Conflicting reports,nr;+,nr;-
I1415,I1415,Jordan,,,Jordan_PPNB,,Jordan_PPNB,,31.988,35.976,M,'Ain Ghazal,,T1a2,..,-8790.0,-8690.0,"8176-7608 calBCE (8790±50 BP, Poz-81101)",8790,Unknown,Lazaridis et al. 2016,0,..,10.035307,fasta,11251G;15928A;16189C;4216C;4917G,11251;15928;16189;4216;4917,MT-ND4;MT-TT;MT-CR;MT-ND1;MT-ND2,Reduced risk of PD;Multiple Sclerosis / idiopathic repeat miscarriage / AD protection;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;LHON / Insulin Resistance / AMD / NRTI-PN,Reported;Conflicting reports,nr;+,nr;-
I1701,I1701,Jordan,,,Jordan_PPNB,,Jordan_PPNB,,31.988,35.976,F,'Ain Ghazal,,K,n/a (female),-8620.0,-8520.0,"7752-7543 calBCE (8620±50 BP, Poz-81094)",8620,Unknown,Lazaridis et al. 2016,0,n/a (female),7.87718,fasta,10398G;11467G;12308G;12372A;16093C;9055A,10398;11467;12308;12372;16093;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-CR;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Cyclic Vomiting Syndrome;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+;-,-;+
I1709,I1709,Jordan,,,Jordan_PPNB_lc,,Jordan_PPNB_lc,,31.988,35.976,M,'Ain Ghazal,,n/a (<2x),..,,,8300-7900 BCE,,Unknown,Lazaridis et al. 2016,0,..,1.62,fasta,195C;14831A,195;14831,MT-CR;MT-CYB,BD-associated / melanoma pts;LHON,Reported,+,+;-
I1679,I1679_enhanced,Jordan,,,Jordan_PPNC,,Jordan_PPNC,,31.988,35.976,F,'Ain Ghazal,,n/a (<2x),n/a (female),,,6900-6800 BCE,,Unknown,Lazaridis et al. 2022,0,n/a (female),1.76,fasta,10398G;15043A;15924G;12705T,10398;15043;15924;12705,MT-ND3;MT-CYB;MT-TT;MT-CO1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;MDD-associated;LIMM;Possible protective factor for normal tension glaucoma,Reported / lineage L & M marker / also hg IJK;Reported,+;nr;<NA>,-;nr;<NA>
I1699,I1699,Jordan,,,Jordan_PPNC,,Jordan_PPNC,,31.988,35.976,F,'Ain Ghazal,,R0a2,n/a (female),,,6800-6700 BCE,,Unknown,Lazaridis et al. 2016,0,n/a (female),32.4,fasta,15674C,15674,MT-CYB,LHON,Reported,+,-
I1679,I1679,Jordan,,,Jordan_PPNC,,Jordan_PPNC,,31.988,35.976,F,'Ain Ghazal,,R,n/a (female),,,6900-6800 BCE,,Unknown,Lazaridis et al. 2016,0,n/a (female),2.18,fasta,10398G;15043A;15924G;12705T,10398;15043;15924;12705,MT-ND3;MT-CYB;MT-TT;MT-CO1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;MDD-associated;LIMM;Possible protective factor for normal tension glaucoma,Reported / lineage L & M marker / also hg IJK;Reported,+;nr;<NA>,-;nr;<NA>
I1407,I1407,Armenia,,,Armenia_C,,Armenia_C,,39.73,45.2,M,Areni 1,,H,L1a,,,4350-3500 BCE,,Unknown,Lazaridis et al. 2016,0,..,554,fasta,,,,,,,
I1409,I1409,Armenia,,,Armenia_C,,Armenia_C,,39.73,45.2,F,Areni 1,,U4a,n/a (female),-5260.0,-5200.0,"4230-3984 calBCE (5260±30 BP, Poz-81110)",5260,Unknown,Lazaridis et al. 2016,0,n/a (female),22.2,fasta,11467G;12308G;12372A;15693C;195C;499A,11467;12308;12372;15693;195;499,MT-ND4;MT-TL2;MT-ND5;MT-CYB;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Possibly LVNC cardiomyopathy-associated;BD-associated / melanoma pts;Endometriosis,Reported,+,-;+
I1631,I1631,Armenia,,,Armenia_C,,Armenia_C,,39.73,45.2,F,Areni 1,,K1a8,n/a (female),-5323.0,-5263.0,"4311-4049 calBCE (5323±30 BP, OxA-19332)",5323,Unknown,Lazaridis et al. 2016,0,n/a (female),468,fasta,10398G;11467G;12308G;12372A;9055A,10398;11467;12308;12372;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+,-;+
I1632,I1632,Armenia,,,Armenia_C,,Armenia_C,,39.73,45.2,M,Areni 1,,K,..,-5285.0,-5227.0,"4236-3994 calBCE (5285±29 BP, OxA-18599)",5285,Unknown,Lazaridis et al. 2016,0,..,267,fasta,10398G;11467G;12308G;12372A;9055A,10398;11467;12308;12372;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+,-;+
I1634,I1634,Armenia,,,Armenia_C,,Armenia_C,,39.73,45.2,M,Areni 1,,H2a1,..,-5366.0,-5304.0,"4330-4056 calBCE (5366±31 BP, OxA-19331)",5366,Unknown,Lazaridis et al. 2016,0,..,482,fasta,,,,,,,
I1633,I1633,Armenia,,,Armenia_EBA,,Armenia_EBA,,40.65,45.1167,F,Kalavan,,H1u,n/a (female),-3990.0,-3920.0,"2621-2354 calBCE (3990±35 BP, Poz-22234)",3990,Unknown,Lazaridis et al. 2016,0,n/a (female),429,fasta,3010A,3010,MT-RNR2,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor,Reported,+,-
I1635,I1635,Armenia,,,Armenia_EBA,,Armenia_EBA,,40.65,45.1167,M,Kalavan,,X2f,"R1b1x(R1b1a1, R1b1a2, R1b1c2, R1b1c3) ",-4005.0,-3935.0,"2623-2461 calBCE (4005±35 BP, Poz-81102)",4005,Unknown,Lazaridis et al. 2016,0,..,483,fasta,12705T;16189C;195C,12705;16189;195,MT-CO1;MT-CR,Possible protective factor for normal tension glaucoma;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;BD-associated / melanoma pts,Reported,<NA>;+,<NA>;-;+
I1658,I1658,Armenia,,,Armenia_EBA,,Armenia_EBA,,40.382958,43.873663,F,Talin,,U3a2a,n/a (female),-4492.0,-4434.0,"3350-3041 calBCE (4492±29 BP, OxA-31874)",4492,Unknown,Lazaridis et al. 2016,0,n/a (female),596,fasta,11467G;12308G;12372A;150T;16390A,11467;12308;12372;150;16390,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Longevity / Cervical Carcinoma / HPV infection risk;POAG - potential for association,Reported;Conflicting reports,+,-;+
I1656,I1656,Armenia,,,Armenia_MBA,,Armenia_MBA,,40.377222,43.938333,F,Katnaghbiur 1,,T1a2,n/a (female),-3168.0,-3114.0,"1502-1402 calBCE (3168±27 BP, OxA-31674)",3168,Unknown,Lazaridis et al. 2016,0,n/a (female),404,fasta,11251G;15928A;16189C;4216C;4917G,11251;15928;16189;4216;4917,MT-ND4;MT-TT;MT-CR;MT-ND1;MT-ND2,Reduced risk of PD;Multiple Sclerosis / idiopathic repeat miscarriage / AD protection;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;LHON / Insulin Resistance / AMD / NRTI-PN,Reported;Conflicting reports,nr;+,nr;-
Bul6,Bul6,Bulgaria,,,Bulgaria_BeliBreyag_EBA,,Bulgaria_BeliBreyag_EBA,,42.429624,25.898354,M,"Nova Zagora, Beli Breyag",,..,..,,,3400-1600 BCE,,Unknown,Mathieson et al. 2018,0,..,..,fasta,,,,,,,
Bul8,Bul8,Bulgaria,,,Bulgaria_BeliBreyag_EBA,,Bulgaria_BeliBreyag_EBA,,42.429624,25.898354,M,"Nova Zagora, Beli Breyag",,..,..,,,3400-1600 BCE,,Unknown,Mathieson et al. 2018,0,..,..,fasta,,,,,,,
Bul4,Bul4,Bulgaria,,,Bulgaria_EBA_Yamnaya_o,,Bulgaria_EBA_Yamnaya_o,,42.4296241,25.8983541,M,"Nova Zagora, Mednikarovo",,..,..,-4333.0,-4293.0,"3011-2898 calBCE (4333±20 BP, MAMS-26834)",4333,Unknown,Mathieson et al. 2018,0,..,..,fasta,,,,,,,
RISE21,RISE21_noUDG.SG,Denmark,,,Denmark_BA.SG,,Denmark_BA.SG,,55.55,12.209,M,Karlstrup,,N1a1a1a2,..,-3092.0,-3034.0,"1426-1272 calBCE (3092±29 BP, OxA-28047)",3092,Unknown,Allentoft et al. 2015,0,..,..,fasta,,,,,,,
RISE47,RISE47_noUDG.SG,Denmark,,,Denmark_BA.SG,,Denmark_BA.SG,,56.97,9.552,M,Sebber skole,,I,..,-3153.0,-3101.0,"1499-1322 calBCE (3153±26 BP, OxA-28258)",3153,Unknown,Allentoft et al. 2015,0,..,..,fasta,,,,,,,
RISE276,RISE276_noUDG.SG,Denmark,,,Denmark_LBA.SG,,Denmark_LBA.SG,,55.914,11.565,M,Trundholm II,,T2b,..,-2525.0,-2475.0,"789-546 calBCE (2525±25 BP, OxA-30485)",2525,Unknown,Allentoft et al. 2015,0,..,..,fasta,,,,,,,
RISE42,RISE42_noUDG.SG,Denmark,,,Denmark_LN_o.SG,,Denmark_LN_o.SG,,55.657,12.148,M,Marbjerg,,H3v+16093,..,-3681.0,-3625.0,"2193-1971 calBCE (3681±28 BP, OxA-28225)",3681,Unknown,Allentoft et al. 2015,0,..,..,fasta,,,,,,,
RISE71,RISE71_noUDG.SG,Denmark,,,Denmark_LN.SG,,Denmark_LN.SG,,56.676,10.034,F,Falshöj,,H3b,n/a (female),-3701.0,-3649.0,"2197-1983 calBCE (3701±26 BP, OxA-28269)",3701,Unknown,Allentoft et al. 2015,0,n/a (female),..,fasta,,,,,,,
RISE61,RISE61_noUDG.SG,Denmark,,,Denmark_MN_B.SG,,Denmark_MN_B.SG,,55.703,11.855,M,Kyndelöse,,J1c4,..,-4071.0,-4017.0,"2848-2492 calBCE (4071±27 BP, OxA-28296)",4071,Unknown,Allentoft et al. 2015,0,..,..,fasta,,,,,,,
JK2888,JK2888,Egypt,,,Egypt_Ptolemaic_contam,,Egypt_Ptolemaic_contam,,29.9,31.2,M,Abusir-el Meleq,,U6a2,..,-2050.0,-2002.0,"151 calBCE - 23 calCE (2050±24 BP, MAMS-23575)",2050,Unknown,Scheunemann et al. 2017,0,..,..,fasta,,,,,,,
JK2134,JK2134,Egypt,,,Egypt_ThirdIntermediatePeriod,,Egypt_ThirdIntermediatePeriod,,29.9,31.2,M,Abusir-el Meleq,,J1d,..,-2522.0,-2474.0,"787-546 calBCE (2522±24 BP, MAMS-23047)",2522,Unknown,Scheunemann et al. 2017,0,..,..,fasta,,,,,,,
JK2911,JK2911,Egypt,,,Egypt_ThirdIntermediatePeriod,,Egypt_ThirdIntermediatePeriod,,29.9,31.2,M,Abusir-el Meleq,,M1a1,..,-2513.0,-2465.0,"779-544 calBCE (2513±24 BP, MAMS-23617)",2513,Unknown,Scheunemann et al. 2017,0,..,..,fasta,,,,,,,
Chaudardes1,Chaudardes1_noUDG,France,,,France_Chaudardes,,France_Chaudardes,,49.24,3.46,M,Chaudardes,,U5b1b,I,-7400.0,-7280.0,"6400-6086 calBCE (7400±60 BP, GrA-28268)",7400,Unknown,Fu et al. 2016,0,..,..,fasta,,,,,,,
SATP,SATP_noUDG.SG,Georgia,,,Georgia_Satsurblia.SG,,Georgia_Satsurblia.SG,,42.38,42.59,M,Satsurblia,,K3,..,-1415.0,-1315.0,"11461-11225 calBCE (11415±50 BP, OxA-34632)",1415,Unknown,Jones et al. 2015,0,..,..,fasta,,,,,,,
I0108,I0108,Germany,,,Germany_BellBeaker,,Germany_BellBeaker,,51.45,11.54,F,Rothenschirmbach,,H5a3,n/a (female),-3953.0,-3859.0,"2575-2297 calBCE (3953±47 BP, Erl-8710)",3953,Unknown,Mathieson et al. 2015,0,n/a (female),271.808981,fasta,4336C,4336,MT-TQ,ADPD / Hearing Loss & Migraine / autism spectrum / intellectual disability,Unclear,+,+
I0111,I0111,Germany,,,Germany_BellBeaker,,Germany_BellBeaker,,51.45,11.54,F,Rothenschirmbach,,H3ao,n/a (female),-3881.0,-3781.0,"2474-2201 calBCE (3881±50 BP, Erl-8712)",3881,Unknown,Mathieson et al. 2015,0,n/a (female),188.260668,fasta,,,,,,,
I0112,I0112,Germany,,,Germany_BellBeaker,,Germany_BellBeaker,,51.791,11.141,F,Quedlinburg Site XII,,H13a1a2,n/a (female),-3820.0,-3736.0,"2455-2141 calBCE (3820±42 BP, Erl-7038)",3820,Unknown,Mathieson et al. 2015,0,n/a (female),227.673245,fasta,,,,,,,
I0113,I0113,Germany,,,Germany_BellBeaker,,Germany_BellBeaker,,51.791,11.141,F,Quedlinburg Site XII,,J1c5,n/a (female),-3773.0,-3679.0,"2396-2034 calBCE (3773±47 BP, Erl-7283)",3773,Unknown,Mathieson et al. 2015,0,n/a (female),8.427183,fasta,462T;13708A;489C;3010A;10398G;295T;4216C;11251G;185A;228A,462;13708;489;3010;10398;295;4216;11251;185;228,MT-CR;MT-ND5;MT-RNR2;MT-ND3;MT-ND1;MT-ND4,Low VO2max response;LHON / Increased MS risk / higher freq in PD-ADS;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;Reduced risk of PD,Reported;Conflicting reports;Reported / lineage L & M marker / also hg IJK,+;nr,-;+;nr
I0806,I0806,Germany,,,Germany_BellBeaker,,Germany_BellBeaker,,51.79,11.14,M,Quedlinburg Site VII,,H1,R1b1a2a1a2,-3824.0,-3774.0,"2433-2147 calBCE (3824±25 BP, MAMS-22820)",3824,Unknown,Mathieson et al. 2015,0,..,268,fasta,3010A,3010,MT-RNR2,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor,Reported,+,-
I1546,I1546,Germany,,,Germany_BellBeaker,,Germany_BellBeaker,,51.82,10.91,F,Benzingerode-Heimburg,,U5a1b1,n/a (female),,,2500-2050 BCE,,Unknown,Mathieson et al. 2015,0,n/a (female),195.599734,fasta,11467G;12308G;12372A;16192T;16270T,11467;12308;12372;16192;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Melanoma patients,Reported,+;nr,-;+;nr
I1549,I1549,Germany,,,Germany_BellBeaker,,Germany_BellBeaker,,51.82,10.91,F,Benzingerode-Heimburg,,W1c1,n/a (female),,,2500-2050 BCE,,Unknown,Mathieson et al. 2015,0,n/a (female),163,fasta,12705T;195C;5460A,12705;195;5460,MT-CO1;MT-CR;MT-ND2,Possible protective factor for normal tension glaucoma;BD-associated / melanoma pts;AD / PD / LHON,Reported;Conflicting reports,<NA>;+,<NA>;+
I1530,I1530,Germany,,,Germany_BellBeaker_1d.rel.I0111,,Germany_BellBeaker_1d.rel.I0111,,51.45,11.54,M,Rothenschirmbach,,H3ao,R1,-3818.0,-3722.0,"2456-2140 calBCE (3818±48 BP, Erl-8715)",3818,Unknown,Mathieson et al. 2015,0,..,148.841994,fasta,,,,,,,
I0805,I0805,Germany,,,Germany_BellBeaker_contam,,Germany_BellBeaker_contam,,51.79,11.14,M,Quedlinburg Site VII,,H1,R1b1a2,-3839.0,-3729.0,"2465-2142 calBCE (3839±55 BP, Erl-8558)",3839,Unknown,Mathieson et al. 2015,0,..,199,fasta,3010A,3010,MT-RNR2,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor,Reported,+,-
I0060,I0060,Germany,,,Germany_BellBeaker,,Germany_BellBeaker,,51.45,11.54,F,Rothenschirmbach,,K1a2c,n/a (female),-3822.0,-3772.0,"2404-2146 calBCE (3822±25 BP, MAMS-22819)",3822,Unknown,Mathieson et al. 2015,0,n/a (female),..,fasta,,,,,,,
I0171,I0171,Germany,,,Germany_BenzigerodeHeimburg_LN,,Germany_BenzigerodeHeimburg_LN,,51.82,10.91,F,Benzingerode-Heimburg,,U5a1a2a,n/a (female),-3758.0,-3692.0,"2288-2039 calBCE (3758±33 BP, KIA-27952)",3758,Unknown,Mathieson et al. 2015,0,n/a (female),160.013399,fasta,11467G;12308G;12372A;16270T,11467;12308;12372;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Melanoma patients,Reported,+;nr,-;+;nr
I1536,I1536,Germany,,,Germany_CordedWare,,Germany_CordedWare,,51.42,11.68,M,Esperstedt,,U5a1g2,..,,,2500-2050 BCE,,Unknown,Mathieson et al. 2015,0,..,112.040437,fasta,11467G;12308G;12372A;16270T,11467;12308;12372;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Melanoma patients,Reported,+;nr,-;+;nr
I0803,I0803,Germany,,,Germany_EBA_Unetice,,Germany_EBA_Unetice,,51.167663,11.847527,F,Eulau,,H4a1a1a,n/a (female),-3650.0,-3598.0,"2135-1941 calBCE (3650±26 BP, MAMS-22822)",3650,Unknown,Mathieson et al. 2015,0,n/a (female),200,fasta,10044G;14582G,10044;14582,MT-TG;MT-ND6,SIDS;LHON synergistic combo 14258A + 14582G,Unclear;Reported: individually neutral variants causing LHON in combination,-;+,+;-
I0804,I0804,Germany,,,Germany_EBA_Unetice,,Germany_EBA_Unetice,,51.167663,11.847527,M,Eulau,,H3,I2,-3671.0,-3619.0,"2139-1959 calBCE (3671±26 BP, MAMS-22821)",3671,Unknown,Mathieson et al. 2015,0,..,131,fasta,,,,,,,
I2022,I2022,Germany,,,Germany_EN_LBK,,Germany_EN_LBK,,51.89583333,11.04666667,F,Halberstadt-Sonntagsfeld,,T2b,n/a (female),,,5500-4850 BCE,,Unknown,Lipson et al. 2017,0,n/a (female),168,fasta,11251G;15928A;4216C;4917G,11251;15928;4216;4917,MT-ND4;MT-TT;MT-ND1;MT-ND2,Reduced risk of PD;Multiple Sclerosis / idiopathic repeat miscarriage / AD protection;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;LHON / Insulin Resistance / AMD / NRTI-PN,Reported;Conflicting reports,nr;+,nr;-
I2020,I2020,Germany,,,Germany_EN_LBK_1d.or.2d.rel.I1550,,Germany_EN_LBK_1d.or.2d.rel.I1550,,51.89583333,11.04666667,M,Halberstadt-Sonntagsfeld,,K1a2,..,,,5500-4850 BCE,,Unknown,Lipson et al. 2017,0,..,855,fasta,10398G;11467G;12308G;12372A;16093C;9055A,10398;11467;12308;12372;16093;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-CR;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Cyclic Vomiting Syndrome;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+;-,-;+
I2008,I2008,Germany,,,Germany_EN_LBK,,Germany_EN_LBK,,51.89583333,11.04666667,F,Halberstadt-Sonntagsfeld,,N1a1a1,n/a (female),-6137.0,-6067.0,"5211-4957 calBCE (6137±35 BP, KIA-40342)",6137,Unknown,Lipson et al. 2017,0,n/a (female),..,fasta,10398G;12705T;15043A;3336C;669C,10398;12705;15043;3336;669,MT-ND3;MT-CO1;MT-CYB;MT-ND1;MT-RNR1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Possible protective factor for normal tension glaucoma;MDD-associated;Carotid atherosclerosis risk;DEAF,Reported / lineage L & M marker / also hg IJK;Reported,+;<NA>;-,-;<NA>;+
I2017,I2017,Germany,,,Germany_EN_LBK,,Germany_EN_LBK,,51.89583333,11.04666667,F,Halberstadt-Sonntagsfeld,,K2a,n/a (female),,,5500-4850 BCE,,Unknown,Lipson et al. 2017,0,n/a (female),..,fasta,11467G;12308G;12372A;146C;9055A,11467;12308;12372;146;9055,MT-ND4;MT-TL2;MT-ND5;MT-CR;MT-ATP6,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Absence of Endometriosis;PD protective factor,Reported,+,-;+
I2026,I2026,Germany,,,Germany_EN_LBK,,Germany_EN_LBK,,51.89583333,11.04666667,M,Halberstadt-Sonntagsfeld,,N1a1a1a3,..,,,5500-4850 BCE,,Unknown,Lipson et al. 2017,0,..,..,fasta,10398G;12705T;15043A;3336C;669C,10398;12705;15043;3336;669,MT-ND3;MT-CO1;MT-CYB;MT-ND1;MT-RNR1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Possible protective factor for normal tension glaucoma;MDD-associated;Carotid atherosclerosis risk;DEAF,Reported / lineage L & M marker / also hg IJK;Reported,+;<NA>;-,-;<NA>;+
I2029,I2029,Germany,,,Germany_EN_LBK,,Germany_EN_LBK,,51.89583333,11.04666667,F,Halberstadt-Sonntagsfeld,,K1,n/a (female),-6211.0,-6147.0,"5299-5049 calBCE (6211±32 BP, KIA-40349)",6211,Unknown,Lipson et al. 2017,0,n/a (female),..,fasta,10398G;11467G;12308G;12372A;9055A,10398;11467;12308;12372;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+,-;+
I2032,I2032,Germany,,,Germany_EN_LBK,,Germany_EN_LBK,,51.89583333,11.04666667,F,Halberstadt-Sonntagsfeld,,J1c,n/a (female),,,5500-4850 BCE,,Unknown,Lipson et al. 2017,0,n/a (female),..,fasta,10398G;11251G;13708A;185A;228A;295T;3010A;4216C;462T;489C,10398;11251;13708;185;228;295;3010;4216;462;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-RNR2;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Low VO2max response;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports,+;nr,-;nr;+
I2036,I2036,Germany,,,Germany_EN_LBK,,Germany_EN_LBK,,51.89583333,11.04666667,F,Halberstadt-Sonntagsfeld,,V1,n/a (female),,,5500-4850 BCE,,Unknown,Lipson et al. 2017,0,n/a (female),..,fasta,,,,,,,
I2038,I2038,Germany,,,Germany_EN_LBK,,Germany_EN_LBK,,51.89583333,11.04666667,F,Halberstadt-Sonntagsfeld,,T2b,n/a (female),,,5350-5000 BCE,,Unknown,Lipson et al. 2017,0,n/a (female),..,fasta,11251G;15928A;4216C;4917G,11251;15928;4216;4917,MT-ND4;MT-TT;MT-ND1;MT-ND2,Reduced risk of PD;Multiple Sclerosis / idiopathic repeat miscarriage / AD protection;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;LHON / Insulin Resistance / AMD / NRTI-PN,Reported;Conflicting reports,nr;+,nr;-
I2016,I2016,Germany,,,Germany_EN_LBK_1d.or.2d.rel.I2036,,Germany_EN_LBK_1d.or.2d.rel.I2036,,51.89583333,11.04666667,F,Halberstadt-Sonntagsfeld,,V1,n/a (female),,,5500-4850 BCE,,Unknown,Lipson et al. 2017,0,n/a (female),..,fasta,,,,,,,
I2021,I2021,Germany,,,Germany_EN_LBK_lc,,Germany_EN_LBK_lc,,51.89583333,11.04666667,M,Halberstadt-Sonntagsfeld,,T2b,..,,,5500-4850 BCE,,Unknown,Lipson et al. 2017,0,..,..,fasta,11251G;15928A;4216C;4917G,11251;15928;4216;4917,MT-ND4;MT-TT;MT-ND1;MT-ND2,Reduced risk of PD;Multiple Sclerosis / idiopathic repeat miscarriage / AD protection;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;LHON / Insulin Resistance / AMD / NRTI-PN,Reported;Conflicting reports,nr;+,nr;-
POST_2,POST_2,Germany,,,Germany_Lech_EBA,,Germany_Lech_EBA,,48.29573,10.89103,F,Haunstetten - Postillionstraße,,,n/a (female),-3648.0,-3610.0,"2131-1946 calBCE (3648±19 BP, MAMS-18953)",3648,Unknown,Mittnik et al. 2019,0,n/a (female),..,fasta,,,,,,,
POST_99,POST_99_d,Germany,,,Germany_Lech_EBA,,Germany_Lech_EBA,,48.29573,10.89103,F,Haunstetten - Postillionstraße,,K1a4a1,n/a (female),-3641.0,-3591.0,"2133-1931 calBCE (3641±25 BP, MAMS-18969)",3641,Unknown,Mittnik et al. 2019,0,n/a (female),..,fasta,,,,,,,
UNTA85_1412,UNTA85_1412,Germany,,,Germany_Lech_EBA,,Germany_Lech_EBA,,48.31966,10.89153,M,Haunstetten - Unterer Talweg 85,,H,R1b1a2,-3602.0,-3552.0,"2028-1891 calBCE (3602±25 BP, MAMS-18951)",3602,Unknown,Mittnik et al. 2019,0,..,..,fasta,,,,,,,
POST_99,POST_99,Germany,,,Germany_Lech_EBA_possible.contam,,Germany_Lech_EBA_possible.contam,,48.29573,10.89103,F,Haunstetten - Postillionstraße,,K1a4a1,n/a (female),-3641.0,-3591.0,"2133-1931 calBCE (3641±25 BP, MAMS-18969)",3641,Unknown,Mittnik et al. 2019,0,n/a (female),..,fasta,,,,,,,
I0118,I0118,Germany,,,Germany_LN_Alberstedt,,Germany_LN_Alberstedt,,51.45,11.63,F,Alberstedt,,H+16311,n/a (female),-3892.0,-3828.0,"2469-2238 calBCE (3892±32 BP, MAMS-21492)",3892,Unknown,Mathieson et al. 2015,0,n/a (female),231.954312,fasta,,,,,,,
I0550,I0550,Germany,,,Germany_LN_Karsdorf,,Germany_LN_Karsdorf,,51.28305556,11.65,F,Karsdorf,,T1a1,n/a (female),-3993.0,-3951.0,"2572-2467 calBCE (3993±21 BP, MAMS-23344)",3993,Unknown,Mathieson et al. 2015,0,n/a (female),201.003199,fasta,11251G;15928A;16189C;195C;4216C;4917G,11251;15928;16189;195;4216;4917,MT-ND4;MT-TT;MT-CR;MT-ND1;MT-ND2,Reduced risk of PD;Multiple Sclerosis / idiopathic repeat miscarriage / AD protection;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;BD-associated / melanoma pts;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;LHON / Insulin Resistance / AMD / NRTI-PN,Reported;Conflicting reports,nr;+,nr;-;+
I0560,I0560,Germany,,,Germany_MN_Baalberge,,Germany_MN_Baalberge,,51.792,11.142,F,Quedlinburg Site IX,,T2e1,n/a (female),-4745.0,-4641.0,"3637-3376 calBCE (4745±52 BP, Erl-7856)",4745,Unknown,Mathieson et al. 2015,0,n/a (female),231.918945,fasta,11251G;150T;15928A;4216C;4917G,11251;150;15928;4216;4917,MT-ND4;MT-CR;MT-TT;MT-ND1;MT-ND2,Reduced risk of PD;Longevity / Cervical Carcinoma / HPV infection risk;Multiple Sclerosis / idiopathic repeat miscarriage / AD protection;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;LHON / Insulin Resistance / AMD / NRTI-PN,Reported;Conflicting reports,nr;+,nr;+;-
I0807,I0807,Germany,,,Germany_MN_Baalberge,,Germany_MN_Baalberge,,51.42,11.68,M,Esperstedt,,H1e1a,..,-5061.0,-4937.0,"3977-3659 calBCE (5061±62 BP, Erl-7784)",5061,Unknown,Mathieson et al. 2015,0,..,48.9,fasta,3010A;5460A,3010;5460,MT-RNR2;MT-ND2,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;AD / PD / LHON,Reported;Conflicting reports,+,-;+
I0172,I0172,Germany,,,Germany_MN_Esperstedt,,Germany_MN_Esperstedt,,51.42,11.68,M,Esperstedt,,T2b,..,-4502.0,-4406.0,"3363-3029 calBCE (4502±48 BP, Erl-8699)",4502,Unknown,Mathieson et al. 2015,0,..,1182.455489,fasta,11251G;15928A;4216C;4917G,11251;15928;4216;4917,MT-ND4;MT-TT;MT-ND1;MT-ND2,Reduced risk of PD;Multiple Sclerosis / idiopathic repeat miscarriage / AD protection;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;LHON / Insulin Resistance / AMD / NRTI-PN,Reported;Conflicting reports,nr;+,nr;-
MX280,MX280,Germany,,,Germany_SouthernGermany_Singen_EBA,,Germany_SouthernGermany_Singen_EBA,,47.767097,8.872239,F,"Southern Germany, Singen",,U5a1,n/a (female),-3620.0,-3576.0,"2111-1897 calBCE (3620±22 BP, MAMS-21975)",3620,Unknown,Furtwangler et al. 2020,0,n/a (female),..,fasta,,,,,,,
I10939,I10939,Gibraltar,,,Gibraltar_EBA,,Gibraltar_EBA,,36.132004,-5.343773,M,Bray Cave,,K1a3a,..,,,1900-1400 BCE,,Unknown,Olalde et al. 2019,0,..,..,fasta,10398G;11467G;12308G;12372A;16093C;9055A,10398;11467;12308;12372;16093;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-CR;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Cyclic Vomiting Syndrome;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+;-,-;+
I10940,I10940,Gibraltar,,,Gibraltar_EBA,,Gibraltar_EBA,,36.132004,-5.343773,M,Bray Cave,,H1e1a,..,,,1900-1400 BCE,,Unknown,Olalde et al. 2019,0,..,..,fasta,3010A;5460A,3010;5460,MT-RNR2;MT-ND2,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;AD / PD / LHON,Reported;Conflicting reports,+,-;+
I10941,I10941,Gibraltar,,,Gibraltar_EBA,,Gibraltar_EBA,,36.132004,-5.343773,M,Bray Cave,,T2e1,..,,,1900-1400 BCE,,Unknown,Olalde et al. 2019,0,..,..,fasta,11251G;150T;15928A;4216C;4917G,11251;150;15928;4216;4917,MT-ND4;MT-CR;MT-TT;MT-ND1;MT-ND2,Reduced risk of PD;Longevity / Cervical Carcinoma / HPV infection risk;Multiple Sclerosis / idiopathic repeat miscarriage / AD protection;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;LHON / Insulin Resistance / AMD / NRTI-PN,Reported;Conflicting reports,nr;+,nr;+;-
I10942,I10942,Gibraltar,,,Gibraltar_EN,,Gibraltar_EN,,36.132004,-5.343773,F,"Gibraltar, Europa 1",,N1a1a1,n/a (female),,,5500-4500 BCE,,Unknown,Olalde et al. 2019,0,n/a (female),..,fasta,10398G;12705T;15043A;3336C;669C,10398;12705;15043;3336;669,MT-ND3;MT-CO1;MT-CYB;MT-ND1;MT-RNR1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Possible protective factor for normal tension glaucoma;MDD-associated;Carotid atherosclerosis risk;DEAF,Reported / lineage L & M marker / also hg IJK;Reported,+;<NA>;-,-;<NA>;+
I0070,I0070,Greece,,,Greece_Minoan_Lassithi,,Greece_Minoan_Lassithi,,35.08,25.83,M,"Crete, Lassithi",,H13a1a,..,,,2400-1700 BCE,,Unknown,Lazaridis et al. 2017,0,..,962.750317,fasta,,,,,,,
I0071,I0071,Greece,,,Greece_Minoan_Lassithi,,Greece_Minoan_Lassithi,,35.08,25.83,F,"Crete, Lassithi",,U5a1,n/a (female),,,2400-1700 BCE,,Unknown,Lazaridis et al. 2017,0,n/a (female),552,fasta,11467G;12308G;12372A;16192T;16270T,11467;12308;12372;16192;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Melanoma patients,Reported,+;nr,-;+;nr
I0073,I0073,Greece,,,Greece_Minoan_Lassithi,,Greece_Minoan_Lassithi,,35.08,25.83,M,"Crete, Lassithi",,H,..,,,2400-1700 BCE,,Unknown,Lazaridis et al. 2017,0,..,563.156799,fasta,,,,,,,
I0074,I0074,Greece,,,Greece_Minoan_Lassithi,,Greece_Minoan_Lassithi,,35.08,25.83,F,"Crete, Lassithi",,H5,n/a (female),,,2400-1700 BCE,,Unknown,Lazaridis et al. 2017,0,n/a (female),933.503289,fasta,,,,,,,
I9005,I9005,Greece,,,Greece_Minoan_Lassithi,,Greece_Minoan_Lassithi,,35.08,25.83,F,"Crete, Lassithi",,H,n/a (female),,,2400-1700 BCE,,Unknown,Lazaridis et al. 2017,0,n/a (female),..,fasta,,,,,,,
I9127,I9127,Greece,,,Greece_Minoan_Odigitria,,Greece_Minoan_Odigitria,,35.05138889,24.81361111,F,"Crete, Heraklion, Moni Odigitria",,J2b1a1,n/a (female),,,2210-1680 BCE,,Unknown,Lazaridis et al. 2017,0,n/a (female),..,fasta,10398G;11251G;13708A;150T;15257A;15812A;295T;4216C;489C,10398;11251;13708;150;15257;15812;295;4216;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-CYB;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Longevity / Cervical Carcinoma / HPV infection risk;LHON;Low VO2max response;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports;Reported / Secondary,+;nr,-;nr;+
I9128,I9128,Greece,,,Greece_Minoan_Odigitria,,Greece_Minoan_Odigitria,,35.05138889,24.81361111,F,"Crete, Heraklion, Moni Odigitria",,I5,n/a (female),,,2210-1680 BCE,,Unknown,Lazaridis et al. 2017,0,n/a (female),..,fasta,10398G;12705T;15043A;15924G;16129A,10398;12705;15043;15924;16129,MT-ND3;MT-CO1;MT-CYB;MT-TT;MT-CR,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Possible protective factor for normal tension glaucoma;MDD-associated;LIMM;Cyclic Vomiting Syndrome with Migraine,Reported / lineage L & M marker / also hg IJK;Reported,+;<NA>;nr;-,-;<NA>;nr;+
I9129,I9129,Greece,,,Greece_Minoan_Odigitria,,Greece_Minoan_Odigitria,,35.05138889,24.81361111,F,"Crete, Heraklion, Moni Odigitria",,H+163,n/a (female),,,2210-1680 BCE,,Unknown,Lazaridis et al. 2017,0,n/a (female),..,fasta,,,,,,,
I9130,I9130,Greece,,,Greece_Minoan_Odigitria,,Greece_Minoan_Odigitria,,35.05138889,24.81361111,M,"Crete, Heraklion, Moni Odigitria",,U3b3,..,,,2210-1680 BCE,,Unknown,Lazaridis et al. 2017,0,..,..,fasta,11467G;12308G;12372A;150T;4640A,11467;12308;12372;150;4640,MT-ND4;MT-TL2;MT-ND5;MT-CR;MT-ND2,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Longevity / Cervical Carcinoma / HPV infection risk;LHON / Epilepsy,Reported;Conflicting reports,+,-;+
I9131,I9131,Greece,,,Greece_Minoan_Odigitria,,Greece_Minoan_Odigitria,,35.05138889,24.81361111,F,"Crete, Heraklion, Moni Odigitria",,K1a2,n/a (female),,,2210-1680 BCE,,Unknown,Lazaridis et al. 2017,0,n/a (female),..,fasta,10398G;11467G;12308G;12372A;9055A,10398;11467;12308;12372;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+,-;+
I2937,I2937,Greece,,,Greece_Peloponnese_N,,Greece_Peloponnese_N,,36.63833333,22.3825,F,"Diros, Alepotrypa Cave",,K1a+195,n/a (female),-6441.0,-6365.0,"5477-5331 calBCE (6441±38 BP, OxA-22012)",6441,Unknown,Lazaridis et al. 2017,0,n/a (female),62.143521,fasta,10398G;11467G;12308G;12372A;16093C;195C;9055A,10398;11467;12308;12372;16093;195;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-CR;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Cyclic Vomiting Syndrome;BD-associated / melanoma pts;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+;-,-;+
I2937,I2937_noUDG,Greece,,,Greece_Peloponnese_N_noUDG,,Greece_Peloponnese_N_noUDG,,36.63833333,22.3825,F,"Diros, Alepotrypa Cave",,K1a+195,n/a (female),-6441.0,-6365.0,"5477-5331 calBCE (6441±38 BP, OxA-22012)",6441,Unknown,Lazaridis et al. 2017,0,n/a (female),62.143521,fasta,10398G;11467G;12308G;12372A;16093C;195C;9055A,10398;11467;12308;12372;16093;195;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-CR;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Cyclic Vomiting Syndrome;BD-associated / melanoma pts;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+;-,-;+
I1497,CO1_noUDG.SG,Hungary,,,Hungary_Baden_LateCA.SG,,Hungary_Baden_LateCA.SG,,47.167,19.833,F,Apc-Berekalya I,,H,n/a (female),-4421.0,-4367.0,"3320-2922 calBCE (4421±27 BP, MAMS-14825)",4421,Unknown,Gamba et al. 2014,0,n/a (female),..,fasta,,,,,,,
SZ41,SZ41_noUDG,Hungary,,,Hungary_Langobard,,Hungary_Langobard,,46.28333333,17.85,F,Szólád,,n/a (<2x),n/a (female),,,412-604 CE,,Unknown,Amorim et al. 2018,0,n/a (female),0.94,fasta,,,,,,,
SZ44,SZ44,Hungary,,,Hungary_Langobard_lc,,Hungary_Langobard_lc,,46.28333333,17.85,U,Szólád,,..,n/a  (sex unknown),,,412-604 CE,,Unknown,Amorim et al. 2018,0,n/a  (sex unknown),..,fasta,,,,,,,
SZ43,SZ43.SG,Hungary,,,Hungary_Langobard_o1.SG,,Hungary_Langobard_o1.SG,,46.28333333,17.85,M,Szólád,,H1e,..,-1521.0,-1471.0,438-605 calCE (1521±25 BP),1521,Unknown,Amorim et al. 2018,0,..,140.37,fasta,,,,,,,
SZ6,SZ6,Hungary,,,Hungary_Langobard_o2_brother.SZ14_brother.SZ8,,Hungary_Langobard_o2_brother.SZ14_brother.SZ8,,46.28333333,17.85,M,Szólád,,n/a (<2x),..,,,412-604 CE,,Unknown,Amorim et al. 2018,0,..,0.14,fasta,,,,,,,
SZ45,SZ45.SG,Hungary,,,Hungary_Langobard_o2.SG,,Hungary_Langobard_o2.SG,,46.28333333,17.85,M,Szólád,,J1c,..,,,412-604 CE,,Unknown,Amorim et al. 2018,0,..,144.5,fasta,,,,,,,
SZ8,SZ8,Hungary,,,Hungary_Langobard_sister.SZ14_sister.SZ6,,Hungary_Langobard_sister.SZ14_sister.SZ6,,46.28333333,17.85,F,Szólád,,n/a (<2x),n/a (female),,,412-604 CE,,Unknown,Amorim et al. 2018,0,n/a (female),1.41,fasta,,,,,,,
I1497,I1497,Hungary,,,Hungary_LateC_Baden,,Hungary_LateC_Baden,,47.167,19.833,F,Apc-Berekalya I,,H,n/a (female),-4421.0,-4367.0,"3320-2922 calBCE (4421±27 BP, MAMS-14825)",4421,Unknown,Mathieson et al. 2015,0,n/a (female),445,fasta,,,,,,,
I2369,I2369,Hungary,,,Hungary_LateC_Baden,,Hungary_LateC_Baden,,47.62094,19.04494,M,Budakalász-Luppa csárda,,J2a1a1,..,-4545.0,-4475.0,"3370-3101 calBCE (4545±35 BP, Poz-83634)",4545,Unknown,Lipson et al. 2017,0,..,125,fasta,10398G;11251G;13708A;150T;15257A;195C;295T;4216C;489C,10398;11251;13708;150;15257;195;295;4216;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-CYB;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Longevity / Cervical Carcinoma / HPV infection risk;LHON;BD-associated / melanoma pts;Low VO2max response;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports,+;nr,-;nr;+
I2371,I2371,Hungary,,,Hungary_LateC_Baden,,Hungary_LateC_Baden,,47.31875,19.16692,M,Alsónémedi,,U5b,..,-4520.0,-4450.0,"3361-3099 calBCE (4520±35 BP, Poz-83635)",4520,Unknown,Lipson et al. 2017,0,..,42,fasta,11467G;12308G;12372A;150T;16129A;16270T,11467;12308;12372;150;16129;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Longevity / Cervical Carcinoma / HPV infection risk;Cyclic Vomiting Syndrome with Migraine;Melanoma patients,Reported;Conflicting reports,+;-;nr,-;+;nr
I2752,I2752,Hungary,,,Hungary_LateC_Baden,,Hungary_LateC_Baden,,46.78469,17.731714,M,Balatonlelle-Felső-Gamász,,K1a,I2a1,,,3600-2850 BCE,,Unknown,Lipson et al. 2017,0,..,56.6,fasta,10398G;11467G;12308G;12372A;16093C;9055A,10398;11467;12308;12372;16093;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-CR;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Cyclic Vomiting Syndrome;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+;-,-;+
I2753,I2753,Hungary,,,Hungary_LateC_Baden,,Hungary_LateC_Baden,,46.78469,17.731714,M,Balatonlelle-Felső-Gamász,,U5a1,..,-4440.0,-4370.0,"3333-2928 calBCE (4440±35 BP, Poz-88231)",4440,Unknown,Lipson et al. 2017,0,..,315,fasta,11467G;12308G;12372A;16192T;16270T,11467;12308;12372;16192;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Melanoma patients,Reported,+;nr,-;+;nr
I2754,I2754,Hungary,,,Hungary_LateC_Baden,,Hungary_LateC_Baden,,46.78469,17.731714,M,Balatonlelle-Felső-Gamász,,J1c+16261+189,..,-4465.0,-4405.0,"3338-3024 calBCE (4465±30 BP, Poz-83637)",4465,Unknown,Lipson et al. 2017,0,..,71.9,fasta,10398G;11251G;13708A;185A;228A;295T;3010A;4216C;462T;489C,10398;11251;13708;185;228;295;3010;4216;462;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-RNR2;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Low VO2max response;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports,+;nr,-;nr;+
I2755,I2755,Hungary,,,Hungary_LateC_Baden,,Hungary_LateC_Baden,,46.78469,17.731714,M,Balatonlelle-Felső-Gamász,,U8b1a1,..,,,3600-2850 BCE,,Unknown,Lipson et al. 2017,0,..,29.7,fasta,11467G;12308G;12372A;16129A;195C;9055A,11467;12308;12372;16129;195;9055,MT-ND4;MT-TL2;MT-ND5;MT-CR;MT-ATP6,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Cyclic Vomiting Syndrome with Migraine;BD-associated / melanoma pts;PD protective factor,Reported,+;-,-;+
I2763,I2763,Hungary,,,Hungary_LateC_Baden,,Hungary_LateC_Baden,,46.665765,17.270774,F,Vörs,,T2,n/a (female),-4528.0,-4466.0,"3363-3101 calBCE (4528±31 BP, DeA-14662)",4528,Unknown,Lipson et al. 2017,0,n/a (female),555,fasta,11251G;15928A;16189C;4216C;4917G,11251;15928;16189;4216;4917,MT-ND4;MT-TT;MT-CR;MT-ND1;MT-ND2,Reduced risk of PD;Multiple Sclerosis / idiopathic repeat miscarriage / AD protection;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;LHON / Insulin Resistance / AMD / NRTI-PN,Reported;Conflicting reports,nr;+,nr;-
I2785,I2785,Hungary,,,Hungary_LateC_Baden,,Hungary_LateC_Baden,,47.684976,19.918434,F,Vámosgyörk MHAT telep,,T2c1d1,n/a (female),,,3600-2850 BCE,,Unknown,Lipson et al. 2017,0,n/a (female),115,fasta,11251G;146C;15928A;4216C;4917G;6261A,11251;146;15928;4216;4917;6261,MT-ND4;MT-CR;MT-TT;MT-ND1;MT-ND2;MT-CO1,Reduced risk of PD;Absence of Endometriosis;Multiple Sclerosis / idiopathic repeat miscarriage / AD protection;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;LHON / Insulin Resistance / AMD / NRTI-PN;Prostate Cancer / LHON,Reported;Conflicting reports,nr;+,nr;-
I2366,I2366,Hungary,,,Hungary_LateC_Baden,,Hungary_LateC_Baden,,47.62094,19.04494,M,"Budakalász, Luppa csárda",,H26a,..,-4455.0,-4385.0,"3340-2937 calBCE (4455±35 BP, Poz-88227)",4455,Unknown,Lipson et al. 2017,0,..,..,fasta,,,,,,,
I2367,I2367,Hungary,,,Hungary_LateC_Baden,,Hungary_LateC_Baden,,47.62094,19.04494,M,"Budakalász, Luppa csárda",,HV,..,-4440.0,-4370.0,"3333-2928 calBCE (4440±35 BP, Poz-88228)",4440,Unknown,Lipson et al. 2017,0,..,..,fasta,,,,,,,
I2788,I2788,Hungary,,,Hungary_LateC_Protoboleraz,,Hungary_LateC_Protoboleraz,,47.189141,20.004795,M,"Abony, Turjányos-dűlő",,H,..,-4960.0,-4880.0,"3910-3644 calBCE (4960±40 BP, VERA-5402)",4960,Unknown,Lipson et al. 2017,0,..,334,fasta,,,,,,,
I2789,I2789,Hungary,,,Hungary_LateC_Protoboleraz,,Hungary_LateC_Protoboleraz,,47.189141,20.004795,M,"Abony, Turjányos-dűlő",,J1c3b,..,,,3800-3600 BCE,,Unknown,Lipson et al. 2017,0,..,137,fasta,10398G;11251G;13708A;185A;295T;3010A;4216C;462T;489C,10398;11251;13708;185;295;3010;4216;462;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-RNR2;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Low VO2max response;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports,+;nr,-;nr;+
I2790,I2790,Hungary,,,Hungary_LateC_Protoboleraz,,Hungary_LateC_Protoboleraz,,47.189141,20.004795,F,"Abony, Turjános-dülö",,N1a1a3,n/a (female),-4890.0,-4820.0,"3768-3543 calBCE (4890±35 BP, Poz-82205)",4890,Unknown,Lipson et al. 2017,0,n/a (female),..,fasta,10398G;12705T;15043A;3336C;669C,10398;12705;15043;3336;669,MT-ND3;MT-CO1;MT-CYB;MT-ND1;MT-RNR1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Possible protective factor for normal tension glaucoma;MDD-associated;Carotid atherosclerosis risk;DEAF,Reported / lineage L & M marker / also hg IJK;Reported,+;<NA>;-,-;<NA>;+
I2791,I2791,Hungary,,,Hungary_LateC_Protoboleraz,,Hungary_LateC_Protoboleraz,,47.189141,20.004795,M,"Abony, Turjános-dülö",,U5a1c1,..,-4800.0,-4720.0,"3649-3516 calBCE (4800±40 BP, Poz-82206)",4800,Unknown,Lipson et al. 2017,0,..,..,fasta,11467G;12308G;12372A;16192T;16270T;195C,11467;12308;12372;16192;16270;195,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Melanoma patients;BD-associated / melanoma pts,Reported,+;nr,-;+;nr
I1498,I1498,Hungary,,,Hungary_MN_ALPc,,Hungary_MN_ALPc,,47.524728,21.58557,F,Debrecen Tocopart Erdoalja,,H,n/a (female),-6207.0,-6147.0,"5297-5048 calBCE (6207±30 BP, OxA-27858)",6207,Unknown,Mathieson et al. 2015,0,n/a (female),465,fasta,,,,,,,
I1500,I1500,Hungary,,,Hungary_MN_ALPc,,Hungary_MN_ALPc,,47.167,20.833,M,Kompolt-Kigyoser,,J1c1,..,-6164.0,-6036.0,"5301-4940 calBCE (6164±64 BP, OxA-23763)",6164,Unknown,Mathieson et al. 2015,0,..,528,fasta,10398G;11251G;13708A;185A;228A;295T;3010A;3394C;4216C;462T;489C,10398;11251;13708;185;228;295;3010;3394;4216;462;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-RNR2;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Low VO2max response;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;LHON / Diabetes / CPTdeficiency / high altitude adaptation;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports;Reported / Population-dependent,+;nr,-;nr;+
I1505,I1505,Hungary,,,Hungary_MN_ALPc,,Hungary_MN_ALPc,,47.846464,21.149429,F,"Polgár-Ferenci hát, M3-31",,J1c5,n/a (female),-6153.0,-6087.0,"5210-5003 calBCE (6153±33 BP, OxA-28020)",6153,Unknown,Mathieson et al. 2015,0,n/a (female),142,fasta,10398G;11251G;13708A;185A;228A;295T;3010A;4216C;462T;489C,10398;11251;13708;185;228;295;3010;4216;462;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-RNR2;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Low VO2max response;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports,+;nr,-;nr;+
I1506,I1506,Hungary,,,Hungary_MN_ALPc,,Hungary_MN_ALPc,,47.846464,21.149429,F,"Polgár-Ferenci hát, M3-31",,U5b2c,n/a (female),-6237.0,-6173.0,"5306-5064 calBCE (6237±32 BP, OxA-27861)",6237,Unknown,Mathieson et al. 2015,0,n/a (female),220,fasta,11467G;12308G;12372A;13637G;150T;16270T,11467;12308;12372;13637;150;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Possible LHON factor;Longevity / Cervical Carcinoma / HPV infection risk;Melanoma patients,Reported;Conflicting reports,+;nr,-;+;nr
I1499,I1499,Hungary,,,Hungary_MN_ALPc_Bukk,,Hungary_MN_ALPc_Bukk,,48.52,21.168,F,Garadna,,X2b+226,n/a (female),-6185.0,-6117.0,"5286-5015 calBCE (6185±34 BP, OxA-27732)",6185,Unknown,Mathieson et al. 2015,0,n/a (female),320,fasta,12705T;13708A;15927A;16189C;195C;8393T,12705;13708;15927;16189;195;8393,MT-CO1;MT-ND5;MT-TT;MT-CR;MT-ATP8,Possible protective factor for normal tension glaucoma;LHON / Increased MS risk / higher freq in PD-ADS;LHON / Multiple Sclerosis / DEAF1555 increased penetrance / CHD;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;BD-associated / melanoma pts;Reversible brain pseudoatrophy,Reported;Conflicting reports,<NA>;+;-,<NA>;+;-
I1499,NE3_noUDG.SG,Hungary,,,Hungary_MN_ALPc_Bukk.SG,,Hungary_MN_ALPc_Bukk.SG,,48.52,21.168,F,Garadna,,X2b-T226C,n/a (female),-6185.0,-6117.0,"5286-5015 calBCE (6185±34 BP, OxA-27732)",6185,Unknown,Gamba et al. 2014,0,n/a (female),..,fasta,12705T;13708A;15927A;16189C;195C;8393T,12705;13708;15927;16189;195;8393,MT-CO1;MT-ND5;MT-TT;MT-CR;MT-ATP8,Possible protective factor for normal tension glaucoma;LHON / Increased MS risk / higher freq in PD-ADS;LHON / Multiple Sclerosis / DEAF1555 increased penetrance / CHD;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;BD-associated / melanoma pts;Reversible brain pseudoatrophy,Reported;Conflicting reports,<NA>;+;-,<NA>;+;-
I1498,NE2_noUDG.SG,Hungary,,,Hungary_MN_ALPc.SG,,Hungary_MN_ALPc.SG,,47.524728,21.58557,F,Debrecen Tocopart Erdoalja,,H,n/a (female),-6207.0,-6147.0,"5297-5048 calBCE (6207±30 BP, OxA-27858)",6207,Unknown,Gamba et al. 2014,0,n/a (female),..,fasta,,,,,,,
I1500,NE5_noUDG.SG,Hungary,,,Hungary_MN_ALPc.SG,,Hungary_MN_ALPc.SG,,47.167,20.833,M,Kompolt-Kigyoser,,J1c1,C1a2,-6164.0,-6036.0,"5301-4940 calBCE (6164±64 BP, OxA-23763)",6164,Unknown,Gamba et al. 2014,0,..,..,fasta,10398G;11251G;13708A;185A;228A;295T;3010A;3394C;4216C;462T;489C,10398;11251;13708;185;228;295;3010;3394;4216;462;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-RNR2;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Low VO2max response;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;LHON / Diabetes / CPTdeficiency / high altitude adaptation;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports;Reported / Population-dependent,+;nr,-;nr;+
I1505,NE4_noUDG.SG,Hungary,,,Hungary_MN_ALPc.SG,,Hungary_MN_ALPc.SG,,47.846464,21.149429,F,"Polgár-Ferenci hát, M3-31",,J1c5,n/a (female),-6153.0,-6087.0,"5210-5003 calBCE (6153±33 BP, OxA-28020)",6153,Unknown,Gamba et al. 2014,0,n/a (female),..,fasta,10398G;11251G;13708A;185A;228A;295T;3010A;4216C;462T;489C,10398;11251;13708;185;228;295;3010;4216;462;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-RNR2;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Low VO2max response;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports,+;nr,-;nr;+
I1506,NE1_noUDG.SG,Hungary,,,Hungary_MN_LBK.SG,,Hungary_MN_LBK.SG,,47.846464,21.149429,F,"Polgár-Ferenci hát, M3-31",,U5b2c,n/a (female),-6237.0,-6173.0,"5306-5064 calBCE (6237±32 BP, OxA-27861)",6237,Unknown,Gamba et al. 2014,0,n/a (female),..,fasta,11467G;12308G;12372A;13637G;150T;16270T,11467;12308;12372;13637;150;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Possible LHON factor;Longevity / Cervical Carcinoma / HPV infection risk;Melanoma patients,Reported;Conflicting reports,+;nr,-;+;nr
I1661,I1661,Iran,,,Iran_C_SehGabi,,Iran_C_SehGabi,,34.5,47.96,F,Seh Gabi,,H29,n/a (female),-5740.0,-5660.0,"4700-4461 calBCE (5740±40 BP, Poz-81104)",5740,Unknown,Lazaridis et al. 2016,0,n/a (female),510.913453,fasta,,,,,,,
I1662,I1662,Iran,,,Iran_C_SehGabi,,Iran_C_SehGabi,,34.5,47.96,M,Seh Gabi,,K1a12a,..,-5860.0,-5780.0,"4836-4610 calBCE (5860±40 BP, Poz-81105)",5860,Unknown,Lazaridis et al. 2016,0,..,432,fasta,10398G;11467G;12308G;12372A;16093C;5460A;9055A,10398;11467;12308;12372;16093;5460;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-CR;MT-ND2;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Cyclic Vomiting Syndrome;AD / PD / LHON;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports,+;-,-;+
I1665,I1665,Iran,,,Iran_C_SehGabi,,Iran_C_SehGabi,,34.5,47.96,F,Seh Gabi,,U7a,n/a (female),-5070.0,-5010.0,"3957-3792 calBCE (5070±30 BP, Poz-81106)",5070,Unknown,Lazaridis et al. 2016,0,n/a (female),595,fasta,10142T;11467G;12308G;12372A,10142;11467;12308;12372,MT-ND3;MT-ND4;MT-TL2;MT-ND5,Recurrent pregnancy loss;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD,Reported,nr;+,nr;-;+
I1670,I1670,Iran,,,Iran_C_SehGabi,,Iran_C_SehGabi,,34.5,47.96,F,Seh Gabi,,U3a'c,n/a (female),-5870.0,-5790.0,"4840-4615 calBCE (5870±40 BP, Poz-81107)",5870,Unknown,Lazaridis et al. 2016,0,n/a (female),19.313236,fasta,11467G;12308G;12372A;150T,11467;12308;12372;150,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Longevity / Cervical Carcinoma / HPV infection risk,Reported;Conflicting reports,+,-;+
I1674,I1674,Iran,,,Iran_C_SehGabi,,Iran_C_SehGabi,,34.5,47.96,M,Seh Gabi,,I1c,..,-5105.0,-5035.0,"3978-3798 calBCE (5105±35 BP, Poz-81108)",5105,Unknown,Lazaridis et al. 2016,0,..,334,fasta,10398G;12705T;15043A;15924G;16129A;8573A;9966A,10398;12705;15043;15924;16129;8573;9966,MT-ND3;MT-CO1;MT-CYB;MT-TT;MT-CR;MT-ATP6;MT-CO3,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Possible protective factor for normal tension glaucoma;MDD-associated;LIMM;Cyclic Vomiting Syndrome with Migraine;Patient with suspected mitochondrial disease;LHON possible helper variant,Reported / lineage L & M marker / also hg IJK;Reported;Reported as Benign,+;<NA>;nr;-,-;<NA>;nr;+
I1290,I1290,Iran,,,Iran_GanjDareh_N,,Iran_GanjDareh_N,,34.45,48.116,F,Ganj Dareh,,X1'2'3,n/a (female),-8780.0,-8680.0,"8170-7606 calBCE (8780±50 BP, Poz-81100)",8780,Unknown,Lazaridis et al. 2016,0,n/a (female),112.02565,fasta,12705T;16189C,12705;16189,MT-CO1;MT-CR,Possible protective factor for normal tension glaucoma;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients,Reported,<NA>;+,<NA>;-
I1944,I1944,Iran,,,Iran_GanjDareh_N,,Iran_GanjDareh_N,,34.45,48.116,F,Ganj Dareh,,R2+13500,n/a (female),,,8000-7700 BCE,,Unknown,Narasimhan et al. 2019,0,n/a (female),4.453256,fasta,4216C,4216,MT-ND1,LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Conflicting reports,+,-
I1945,I1945,Iran,,,Iran_GanjDareh_N,,Iran_GanjDareh_N,,34.45,48.116,M,Ganj Dareh,,J1,"P1(xQ,R1b1a2,R1a1a1b1a1b,R1a1a1b1a3a,R1a1a1b2a2a) ",,,8000-7700 BCE,,Unknown,Narasimhan et al. 2019,0,..,14.20985,fasta,10398G;11251G;13708A;295T;3010A;4216C;462T;489C,10398;11251;13708;295;3010;4216;462;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-RNR2;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Low VO2max response;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports,+;nr,-;nr;+
I1949,I1949,Iran,,,Iran_GanjDareh_N,,Iran_GanjDareh_N,,34.45,48.116,M,Ganj Dareh,,R2b,CT,-8915.0,-8835.0,"8242-7954 calBCE (8915±40 BP, PSUAMS-2261)",8915,Unknown,Narasimhan et al. 2019,0,..,13.450057,fasta,4216C,4216,MT-ND1,LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Conflicting reports,+,-
I1951,I1951,Iran,,,Iran_GanjDareh_N,,Iran_GanjDareh_N,,34.45,48.116,F,Ganj Dareh,,HV,n/a (female),-8800.0,-8700.0,"8198-7613 calBCE (8800±50 BP, Poz-81109)",8800,Unknown,Narasimhan et al. 2019,0,n/a (female),13.102963,fasta,,,,,,,
I1293,I1293_noUDG_d,Iran,,,Iran_Mesolithic_HotuIIIb,,Iran_Mesolithic_HotuIIIb,,35.591,53.501,M,"Alborz Mountains, near Behshahr, Hotu Cave",,n/a (<2x),..,,,9100-8600 BCE,,Unknown,Narasimhan et al. 2019,0,..,1.313356,fasta,,,,,,,
rath1,rath1_noUDG.SG,Ireland,,,Ireland_EBA.SG,,Ireland_EBA.SG,,55.292132,-6.191685,M,"Rathlin Island,  County Antrim",,U5a1b1e,R1b1a1b1a1a2c1a5,-3591.0,-3533.0,"2031-1830 calBCE (3591±29 BP, UBA-8707)",3591,Unknown,Cassidy et al. 2016,0,R-DF21,..,fasta,,,,,,,
rath2,rath2_noUDG.SG,Ireland,,,Ireland_EBA.SG,,Ireland_EBA.SG,,55.292132,-6.191685,M,"Rathlin Island,  County Antrim",,U5b2a2,R1b1a1b1a1a2c1a5c,-3539.0,-3431.0,"2026-1700 calBCE (3539±54 BP, UBA-8705)",3539,Unknown,Cassidy et al. 2016,0,R-S5488,..,fasta,,,,,,,
rath3,rath3_noUDG.SG,Ireland,,,Ireland_EBA.SG,,Ireland_EBA.SG,,55.292132,-6.191685,M,"Rathlin Island,  County Antrim",,J2b1a,R1b1a1b1a1a2c1,-3354.0,-3298.0,"1736-1539 calBCE (3354±28 BP, UBA-8706)",3354,Unknown,Cassidy et al. 2016,0,R-L21,..,fasta,,,,,,,
bally,bally_noUDG.SG,Ireland,,,Ireland_N.SG,,Ireland_N.SG,,54.54222222,-5.956666667,F,"Ballynahatty,  County Down",,HV0+195,n/a (female),-4465.0,-4389.0,"3346-3014 calBCE (4465±38 BP, UBA-7059)",4465,Unknown,Cassidy et al. 2016,0,n/a (female),..,fasta,,,,,,,
I0861,I0861_d,Israel,,,Israel_Natufian,,Israel_Natufian,,32.65,35.067,M,Raqefet Cave,,n/a (<2x),..,,,12000-9500 BCE,,Unknown,Lazaridis et al. 2022,0,..,1.616392,fasta,150T;13708A;489C;10398G;15257A;295T;11251G,150;13708;489;10398;15257;295;11251,MT-CR;MT-ND5;MT-ND3;MT-CYB;MT-ND4,Longevity / Cervical Carcinoma / HPV infection risk;LHON / Increased MS risk / higher freq in PD-ADS;Low VO2max response;PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;LHON;Reduced risk of PD,Conflicting reports;Reported;Reported / lineage L & M marker / also hg IJK,+;nr,+;-;nr
I1685,I1685,Israel,,,Israel_Natufian_contam,,Israel_Natufian_contam,,32.65,35.067,M,Raqefet Cave,,J2a2,..,,,12000-9500 BCE,,Unknown,Lazaridis et al. 2016,0,..,5.251373,fasta,150T;13708A;195C;489C;10398G;295T;4216C;11251G,150;13708;195;489;10398;295;4216;11251,MT-CR;MT-ND5;MT-ND3;MT-ND1;MT-ND4,Longevity / Cervical Carcinoma / HPV infection risk;LHON / Increased MS risk / higher freq in PD-ADS;BD-associated / melanoma pts;Low VO2max response;PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;Reduced risk of PD,Conflicting reports;Reported;Reported / lineage L & M marker / also hg IJK,+;nr,+;-;nr
I1685,I1685_d,Israel,,,Israel_Natufian_d_lc,,Israel_Natufian_d_lc,,32.65,35.067,M,Raqefet Cave,,n/a (<2x),..,,,12000-9500 BCE,,Unknown,Lazaridis et al. 2022,0,..,1.151427,fasta,150T;13708A;195C;489C;10398G;295T;4216C;11251G,150;13708;195;489;10398;295;4216;11251,MT-CR;MT-ND5;MT-ND3;MT-ND1;MT-ND4,Longevity / Cervical Carcinoma / HPV infection risk;LHON / Increased MS risk / higher freq in PD-ADS;BD-associated / melanoma pts;Low VO2max response;PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;Reduced risk of PD,Conflicting reports;Reported;Reported / lineage L & M marker / also hg IJK,+;nr,+;-;nr
I1687,I1687_d,Israel,,,Israel_Natufian_lc,,Israel_Natufian_lc,,32.65,35.067,F,Raqefet Cave,,n/a (<2x),n/a (female),-1405.0,-1381.0,"11541-11150 calBCE (11405±120 BP, RTK-6607)",1405,Unknown,Lazaridis et al. 2022,0,n/a (female),0.608787,fasta,,,,,,,
I0861,I0861,Israel,,,Israel_Natufian,,Israel_Natufian,,32.65,35.067,M,Raqefet Cave,,JT,..,,,12000-9500 BCE,,Unknown,Lazaridis et al. 2016,0,..,5.384151,fasta,150T;13708A;489C;10398G;15257A;295T;11251G,150;13708;489;10398;15257;295;11251,MT-CR;MT-ND5;MT-ND3;MT-CYB;MT-ND4,Longevity / Cervical Carcinoma / HPV infection risk;LHON / Increased MS risk / higher freq in PD-ADS;Low VO2max response;PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;LHON;Reduced risk of PD,Conflicting reports;Reported;Reported / lineage L & M marker / also hg IJK,+;nr,+;-;nr
I1069,I1069,Israel,,,Israel_Natufian,,Israel_Natufian,,32.65,35.067,M,Raqefet Cave,,HV,..,,,12000-9500 BCE,,Unknown,Lazaridis et al. 2016,0,..,4.628946,fasta,,,,,,,
I1690,I1690,Israel,,,Israel_Natufian,,Israel_Natufian,,32.65,35.067,M,Raqefet Cave,,n/a (<2x),..,,,12000-9500 BCE,,Unknown,Lazaridis et al. 2016,0,..,1.943086,fasta,,,,,,,
I1687,I1687,Israel,,,Israel_Natufian_contam,,Israel_Natufian_contam,,32.65,35.067,F,Raqefet Cave,,H2a,n/a (female),-1405.0,-1381.0,"11541-11150 calBCE (11405±120 BP, RTK-6607)",1405,Unknown,Lazaridis et al. 2016,0,n/a (female),2.536363,fasta,,,,,,,
I0867,I0867,Israel,,,Israel_PPNB,,Israel_PPNB,,31.79,35.168,M,Motza,,K1a4b,..,,,7300-6200 BCE,,Unknown,Lazaridis et al. 2016,0,..,126.826302,fasta,10398G;11467G;12308G;12372A;9055A,10398;11467;12308;12372;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+,-;+
CL97,CL97,Italy,,,Italy_North_EarlyMedieval_Langobards_1,,Italy_North_EarlyMedieval_Langobards_1,,45.0792,7.5783,M,"Piedmont, Collegno",,n/a (<2x),..,,,580-630 CE,,Unknown,Amorim et al. 2018,0,..,0.39,fasta,,,,,,,
CL49,CL49_noUDG,Italy,,,Italy_North_EarlyMedieval_Langobards_2,,Italy_North_EarlyMedieval_Langobards_2,,45.0792,7.5783,M,"Piedmont, Collegno",,n/a (<2x),R1b1a1a2a1a2b1a,,,580-630 CE,,Unknown,Amorim et al. 2018,0,..,1.13,fasta,,,,,,,
CL110,CL110_noUDG,Italy,,,Italy_North_EarlyMedieval_Langobards_4,,Italy_North_EarlyMedieval_Langobards_4,,45.0792,7.5783,M,"Piedmont, Collegno",,n/a (<2x),R1b1a2a,,,580-630 CE,,Unknown,Amorim et al. 2018,0,..,0.03,fasta,,,,,,,
RISE487,RISE487_noUDG.SG,Italy,,,Italy_North_Remedello_C.SG,,Italy_North_Remedello_C.SG,,45.26,10.379,M,"Lombardy, Remedello di Sotto",,H2a,..,-4557.0,-4501.0,"3485-3103 calBCE (4557±28 BP, OxA-X-2621)",4557,Unknown,Allentoft et al. 2015,0,..,..,fasta,,,,,,,
RISE489,RISE489_noUDG.SG,Italy,,,Italy_North_Remedello_C.SG,,Italy_North_Remedello_C.SG,,45.26,10.379,M,"Lombardy, Remedello di Sotto",,X2c1,..,-4185.0,-4045.0,"2909-2576 calBCE (4185±70 BP, ETH-12188)",4185,Unknown,Allentoft et al. 2015,0,..,..,fasta,,,,,,,
RISE486,RISE486_noUDG.SG,Italy,,,Italy_North_Remedello_EBA.SG,,Italy_North_Remedello_EBA.SG,,45.26,10.379,M,"Lombardy, Remedello di Sotto",,J1c1b,..,-3595.0,-3485.0,"2136-1771 calBCE (3595±55 BP, ETH-12913)",3595,Unknown,Allentoft et al. 2015,0,..,..,fasta,,,,,,,
I1705,I1705,Jordan,,,Jordan_EBA,,Jordan_EBA,,31.988,35.976,M,'Ain Ghazal,,H14a,J1(xJ1a) ,-3690.0,-3620.0,"2198-1961 calBCE (3690±35 BP, Poz-81096)",3690,Unknown,Lazaridis et al. 2016,0,..,671,fasta,,,,,,,
I1706,I1706,Jordan,,,Jordan_EBA,,Jordan_EBA,,31.988,35.976,F,'Ain Ghazal,,X2n,n/a (female),,,2490-2300 BCE,,Unknown,Lazaridis et al. 2016,0,n/a (female),986,fasta,12705T;16189C;195C;4659A,12705;16189;195;4659,MT-CO1;MT-CR;MT-ND2,Possible protective factor for normal tension glaucoma;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;BD-associated / melanoma pts;possible PD risk factor / LHON,Reported,<NA>;+,<NA>;-;+
I1730,I1730,Jordan,,,Jordan_EBA,,Jordan_EBA,,31.988,35.976,M,'Ain Ghazal,,R0a1a,"J(xJ1,J2a,J2b2a) ",-3925.0,-3863.0,"2557-2296 calBCE (3925±31 BP, OxA-32775)",3925,Unknown,Lazaridis et al. 2016,0,..,470,fasta,146C;827G,146;827,MT-CR;MT-RNR1,Absence of Endometriosis;DEAF,Reported;Conflicting reports,+,-
I1414,I1414_enhanced,Jordan,,,Jordan_PPNB,,Jordan_PPNB,,31.988,35.976,M,'Ain Ghazal,,K1a18,..,,,8300-7900 BCE,,Unknown,Lazaridis et al. 2022,0,..,20.331281,fasta,12308G;10398G;16093C;12372A;9055A;11467G,12308;10398;16093;12372;9055;11467,MT-TL2;MT-ND3;MT-CR;MT-ND5;MT-ATP6;MT-ND4,CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Cyclic Vomiting Syndrome;Altered brain pH / sCJD patients;PD protective factor,Reported;Reported / lineage L & M marker / also hg IJK,+;-,+;-
I1700,I1700_enhanced,Jordan,,,Jordan_PPNB,,Jordan_PPNB,,31.988,35.976,M,'Ain Ghazal,,T1a2,..,,,8300-7900 BCE,,Unknown,Lazaridis et al. 2022,0,..,14.949424,fasta,15928A;4917G;4216C;11251G;16189C,15928;4917;4216;11251;16189,MT-TT;MT-ND2;MT-ND1;MT-ND4;MT-CR,Multiple Sclerosis / idiopathic repeat miscarriage / AD protection;LHON / Insulin Resistance / AMD / NRTI-PN;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;Reduced risk of PD;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients,Reported;Conflicting reports,+;nr,-;nr
I1414,I1414,Jordan,,,Jordan_PPNB,,Jordan_PPNB,,31.988,35.976,M,'Ain Ghazal,,K1a18,"E(xE2,E1a,E1b1a1a1c2c3b1,E1b1b1b1a1,E1b1b1b2b)",,,8300-7900 BCE,,Unknown,Lazaridis et al. 2016,0,..,7.175448,fasta,12308G;10398G;16093C;12372A;9055A;11467G,12308;10398;16093;12372;9055;11467,MT-TL2;MT-ND3;MT-CR;MT-ND5;MT-ATP6;MT-ND4,CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Cyclic Vomiting Syndrome;Altered brain pH / sCJD patients;PD protective factor,Reported;Reported / lineage L & M marker / also hg IJK,+;-,+;-
I1700,I1700,Jordan,,,Jordan_PPNB,,Jordan_PPNB,,31.988,35.976,M,'Ain Ghazal,,T1a2,..,,,8300-7900 BCE,,Unknown,Lazaridis et al. 2016,0,..,5.612107,fasta,15928A;4917G;4216C;11251G;16189C,15928;4917;4216;11251;16189,MT-TT;MT-ND2;MT-ND1;MT-ND4;MT-CR,Multiple Sclerosis / idiopathic repeat miscarriage / AD protection;LHON / Insulin Resistance / AMD / NRTI-PN;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;Reduced risk of PD;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients,Reported;Conflicting reports,+;nr,-;nr
ERS1790729,ERS1790729_noUDG.SG,Lebanon,,,Lebanon_MBA.SG,,Lebanon_MBA.SG,,33.561623,35.371184,F,"Sidon, College Site",,H1bc,n/a (female),,,1900-1700 BCE,,Unknown,Haber et al. 2017,0,n/a (female),..,fasta,,,,,,,
ERS1790730,ERS1790730_noUDG.SG,Lebanon,,,Lebanon_MBA.SG,,Lebanon_MBA.SG,,33.561623,35.371184,F,"Sidon, College Site",,K1a2,n/a (female),,,1800-1600 BCE,,Unknown,Haber et al. 2017,0,n/a (female),..,fasta,,,,,,,
ERS1790731,ERS1790731_noUDG.SG,Lebanon,,,Lebanon_MBA.SG,,Lebanon_MBA.SG,,33.561623,35.371184,F,"Sidon, College Site",,R2,n/a (female),,,1900-1700 BCE,,Unknown,Haber et al. 2017,0,n/a (female),..,fasta,,,,,,,
ERS1790732,ERS1790732_noUDG.SG,Lebanon,,,Lebanon_MBA.SG,,Lebanon_MBA.SG,,33.561623,35.371184,M,"Sidon, College Site",,HV1b1,..,,,1800-1600 BCE,,Unknown,Haber et al. 2017,0,..,..,fasta,,,,,,,
ERS1790733,ERS1790733_noUDG.SG,Lebanon,,,Lebanon_MBA.SG,,Lebanon_MBA.SG,,33.561623,35.371184,M,"Sidon, College Site",,N1a3a,..,-3505.0,-3415.0,"1950-1692 calBCE (3505±45 BP, VERA-3890)",3505,Unknown,Haber et al. 2017,0,..,..,fasta,,,,,,,
RISE598,RISE598_noUDG.SG,Lithuania,,,Lithuania_LBA.SG,,Lithuania_LBA.SG,,54.358,23.302,M,Turlojiske,,H2a2,..,-2590.0,-2440.0,"906-477 calBCE (2590±75 BP, Ua-16681)",2590,16681,Allentoft et al. 2015,0,..,..,fasta,,,,,,,
ARS001,ARS001.A0101,Mongolia,,,Mongolia_LBA_Khovsgol_6,,Mongolia_LBA_Khovsgol_6,,49.656833,99.726694,M,"Khovsgol aimag, Arbulag sorum",,D4,..,-2779.0,-2679.0,"1048-816 calBCE (2779±50 BP, A-)",2779,Unknown,Jeong et al. 2018,0,..,..,fasta,,,,,,,
ARS002,ARS002.B0101,Mongolia,,,Mongolia_LBA_Khovsgol_6,,Mongolia_LBA_Khovsgol_6,,49.659472,99.72775,F,"Khovsgol aimag, Arbulag sorum",,D4j5,n/a (female),-2910.0,-2806.0,"1261-932 calBCE (2910±52 BP, A-)",2910,Unknown,Jeong et al. 2018,0,n/a (female),..,fasta,,,,,,,
ARS003,ARS003.B0101,Mongolia,,,Mongolia_LBA_Khovsgol_6,,Mongolia_LBA_Khovsgol_6,,49.506111,99.69325,M,"Khovsgol aimag, Arbulag sorum",,U5a2d1,..,-3044.0,-2944.0,"1423-1127 calBCE (3044±50 BP, A-)",3044,Unknown,Jeong et al. 2018,0,..,..,fasta,,,,,,,
ARS004,ARS004.A0101,Mongolia,,,Mongolia_LBA_Khovsgol_6,,Mongolia_LBA_Khovsgol_6,,49.692222,99.766361,M,"Khovsgol aimag, Arbulag sorum",,F2a,..,-2857.0,-2749.0,"1211-901 calBCE (2857±54 BP, A-)",2857,Unknown,Jeong et al. 2018,0,..,..,fasta,,,,,,,
ARS005,ARS005.A0101,Mongolia,,,Mongolia_LBA_Khovsgol_6,,Mongolia_LBA_Khovsgol_6,,49.692583,99.76675,M,"Khovsgol aimag, Arbulag sorum",,D4e1,..,-2897.0,-2787.0,"1257-926 calBCE (2897±55 BP, A-)",2897,Unknown,Jeong et al. 2018,0,..,..,fasta,,,,,,,
ARS006,ARS006.A0101,Mongolia,,,Mongolia_LBA_Khovsgol_6,,Mongolia_LBA_Khovsgol_6,,49.690139,99.760694,F,"Khovsgol aimag, Arbulag sorum",,C4a1a+195 ,n/a (female),-2872.0,-2776.0,"1207-920 calBCE (2872±48 BP, A-)",2872,Unknown,Jeong et al. 2018,0,n/a (female),..,fasta,,,,,,,
ARS007,ARS007.B0101,Mongolia,,,Mongolia_LBA_Khovsgol_6,,Mongolia_LBA_Khovsgol_6,,49.689639,99.773611,M,"Khovsgol aimag, Arbulag sorum",,A+152+16362 ,..,-2991.0,-2895.0,"1389-1054 calBCE (2991±48 BP, A-)",2991,Unknown,Jeong et al. 2018,0,..,..,fasta,,,,,,,
ARS008,ARS008.A0101,Mongolia,,,Mongolia_LBA_Khovsgol_6,,Mongolia_LBA_Khovsgol_6,,49.690444,99.773917,M,"Khovsgol aimag, Arbulag sorum",,C4a2c ,..,-2992.0,-2896.0,"1390-1055 calBCE (2992±48 BP, A-)",2992,Unknown,Jeong et al. 2018,0,..,..,fasta,,,,,,,
ARS011,ARS011.A0101,Mongolia,,,Mongolia_LBA_Khovsgol_6,,Mongolia_LBA_Khovsgol_6,,49.657333,99.725944,M,"Khovsgol aimag, Arbulag sorum",,..,..,-2930.0,-2830.0,"1283-940 calBCE (2930±50 BP, A-)",2930,Unknown,Jeong et al. 2018,0,..,..,fasta,,,,,,,
ARS012,ARS012.A0101,Mongolia,,,Mongolia_LBA_Khovsgol_6,,Mongolia_LBA_Khovsgol_6,,49.657361,99.726389,F,"Khovsgol aimag, Arbulag sorum",,C4a2a1 ,n/a (female),-3029.0,-2931.0,"1412-1126 calBCE (3029±49 BP, A-)",3029,Unknown,Jeong et al. 2018,0,n/a (female),..,fasta,,,,,,,
ARS013,ARS013.A0101,Mongolia,,,Mongolia_LBA_Khovsgol_6,,Mongolia_LBA_Khovsgol_6,,49.6575,99.727556,F,"Khovsgol aimag, Arbulag sorum",,C,n/a (female),-3074.0,-2976.0,"1446-1204 calBCE (3074±49 BP, A-)",3074,Unknown,Jeong et al. 2018,0,n/a (female),..,fasta,,,,,,,
ARS014,ARS014.B0101,Mongolia,,,Mongolia_LBA_Khovsgol_6,,Mongolia_LBA_Khovsgol_6,,49.6575,99.723667,F,"Khovsgol aimag, Arbulag sorum",,C4a2c1,n/a (female),-3033.0,-2935.0,"1415-1127 calBCE (3033±49 BP, A-)",3033,Unknown,Jeong et al. 2018,0,n/a (female),..,fasta,,,,,,,
ARS015,ARS015.A0101,Mongolia,,,Mongolia_LBA_Khovsgol_6,,Mongolia_LBA_Khovsgol_6,,49.65725,99.725833,M,"Khovsgol aimag, Arbulag sorum",,G3a ,..,-3052.0,-2948.0,"1431-1128 calBCE (3052±52 BP, A-)",3052,Unknown,Jeong et al. 2018,0,..,..,fasta,,,,,,,
ARS016,ARS016.A0101,Mongolia,,,Mongolia_LBA_Khovsgol_6,,Mongolia_LBA_Khovsgol_6,,49.657222,99.726,M,"Khovsgol aimag, Arbulag sorum",,A+152+16362+16189 ,..,-3174.0,-3068.0,"1539-1291 calBCE (3174±53 BP, A-)",3174,Unknown,Jeong et al. 2018,0,..,..,fasta,,,,,,,
ARS017,ARS017.A0101,Mongolia,,,Mongolia_LBA_Khovsgol_6,,Mongolia_LBA_Khovsgol_6,,49.657194,99.725778,F,"Khovsgol aimag, Arbulag sorum",,G2a,n/a (female),-3052.0,-2952.0,"1428-1130 calBCE (3052±50 BP, A-)",3052,Unknown,Jeong et al. 2018,0,n/a (female),..,fasta,,,,,,,
ARS018,ARS018.A0101,Mongolia,,,Mongolia_LBA_Khovsgol_6,,Mongolia_LBA_Khovsgol_6,,49.657167,99.725944,M,"Khovsgol aimag, Arbulag sorum",,B5b1,..,-2835.0,-2735.0,"1191-839 calBCE (2835±50 BP, A-)",2835,Unknown,Jeong et al. 2018,0,..,..,fasta,,,,,,,
ARS024,ARS024.A0101,Mongolia,,,Mongolia_LBA_Khovsgol_6,,Mongolia_LBA_Khovsgol_6,,49.695556,99.778667,F,"Khovsgol aimag, Arbulag sorum",,C4a1a1 ,n/a (female),-2990.0,-2914.0,"1385-1057 calBCE (2990±38 BP, A-)",2990,Unknown,Jeong et al. 2018,0,n/a (female),..,fasta,,,,,,,
ARS025,ARS025.A0101,Mongolia,,,Mongolia_LBA_Khovsgol_6,,Mongolia_LBA_Khovsgol_6,,49.683889,99.806333,M,"Khovsgol aimag, Arbulag sorum",,D4b1a2a ,..,-3056.0,-2964.0,"1427-1134 calBCE (3056±46 BP, A-)",3056,Unknown,Jeong et al. 2018,0,..,..,fasta,,,,,,,
ARS026,ARS026.A0101,Mongolia,,,Mongolia_LBA_Khovsgol_6,,Mongolia_LBA_Khovsgol_6,,49.694333,99.780417,M,"Khovsgol aimag, Arbulag sorum",,C4a1a+195 ,..,-2842.0,-2758.0,"1189-899 calBCE (2842±42 BP, A-)",2842,Unknown,Jeong et al. 2018,0,..,..,fasta,,,,,,,
C1,C1_noUDG.SG,Nepal,,,Nepal_Chokhopani_2800BP.SG,,Nepal_Chokhopani_2800BP.SG,,..,..,M,"Chokhopani Tomb, Nepal",,D4j1b,O-M117,,,1200-450 BCE,,Unknown,Jeong et al. 2016,0,..,..,fasta,,,,,,,
M240,M240_noUDG.SG,Nepal,,,Nepal_Mebrak_2125BP_o.SG,,Nepal_Mebrak_2125BP_o.SG,,..,..,M,"Mebrak Tomb, Nepal",,M9a1a2,..,,,450 BCE - 100 CE,,Unknown,Jeong et al. 2016,0,..,..,fasta,,,,,,,
M344,M344_noUDG.SG,Nepal,,,Nepal_Mebrak_2125BP.SG,,Nepal_Mebrak_2125BP.SG,,..,..,M,Morocco_Jews,,Z3a1a,..,,,450 BCE - 100 CE,,Unknown,Jeong et al. 2016,0,..,..,fasta,,,,,,,
M63,M63_noUDG.SG,Nepal,,,Nepal_Mebrak_2125BP.SG,,Nepal_Mebrak_2125BP.SG,,..,..,M,"Mebrak Tomb, Nepal",,M9a1a1c1b1a,..,,,450 BCE - 100 CE,,Unknown,Jeong et al. 2016,0,..,..,fasta,,,,,,,
S10,S10_noUDG.SG,Nepal,,,Nepal_Samdzong_1500BP.SG,,Nepal_Samdzong_1500BP.SG,,..,..,M,"Samdzong Tomb, Nepal",,M9a1a1c1b1a,..,,,200-700 CE,,Unknown,Jeong et al. 2016,0,..,..,fasta,,,,,,,
S35,S35_noUDG.SG,Nepal,,,Nepal_Samdzong_1500BP.SG,,Nepal_Samdzong_1500BP.SG,,..,..,M,"Samdzong Tomb, Nepal",,M9a1a,..,,,200-700 CE,,Unknown,Jeong et al. 2016,0,..,..,fasta,,,,,,,
S40,S40_noUDG.SG,Nepal,,,Nepal_Samdzong_1500BP.SG,,Nepal_Samdzong_1500BP.SG,,..,..,F,"Samdzong Tomb, Nepal",,F1c1a1a,n/a (female),,,200-700 CE,,Unknown,Jeong et al. 2016,0,n/a (female),..,fasta,,,,,,,
S41,S41_noUDG.SG,Nepal,,,Nepal_Samdzong_1500BP.SG,,Nepal_Samdzong_1500BP.SG,,..,..,M,"Samdzong Tomb, Nepal",,F1d,..,,,200-700 CE,,Unknown,Jeong et al. 2016,0,..,..,fasta,,,,,,,
RISE1,RISE1_noUDG.SG,Poland,,,Poland_CordedWare_3.SG,,Poland_CordedWare_3.SG,,52.29,17.54,M,Oblaczkowo,,K1b1a1,..,-4117.0,-4061.0,"2866-2577 calBCE (4117±28 BP, UBA-16633)",4117,Unknown,Allentoft et al. 2015,0,..,..,fasta,,,,,,,
RISE139,RISE139_noUDG.SG,Poland,,,Poland_EBA_Unetice.SG,,Poland_EBA_Unetice.SG,,50.796,17.094,M,Chociwel,,U2e1f1,..,-3645.0,-3579.0,"2137-1926 calBCE (3645±33 BP, Ua-44034)",3645,44034,Allentoft et al. 2015,0,..,..,fasta,,,,,,,
RISE145,RISE145_noUDG.SG,Poland,,,Poland_EBA_Unetice.SG,,Poland_EBA_Unetice.SG,,50.913,17.177,F,Polwica,,H6a1b,n/a (female),-3677.0,-3615.0,"2191-1956 calBCE (3677±31 BP, UB-16564)",3677,Unknown,Allentoft et al. 2015,0,n/a (female),..,fasta,,,,,,,
I11592,I11592,Portugal,,,Portugal_C,,Portugal_C,,39.083333,9.266667,M,"Torres Vedra, Bolores",,U5b2b,..,,,2800-2600 BCE,,Unknown,Olalde et al. 2019,0,..,157.9,fasta,11467G;12308G;12372A;12634G;13637G;150T;16270T,11467;12308;12372;12634;13637;150;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Thyroid Cancer Cell Line;Possible LHON factor;Longevity / Cervical Carcinoma / HPV infection risk;Melanoma patients,Reported;Conflicting reports,+;nr,-;+;nr
I11599,I11599,Portugal,,,Portugal_C,,Portugal_C,,39.110833,-8.663583,M,"Lisbon, Torres Vedras, Cabeço da Arruda I",,J2b1a2,..,,,3350-2850 BCE,,Unknown,Olalde et al. 2019,0,..,128.9,fasta,10398G;11251G;13708A;150T;15257A;15812A;295T;4216C;489C,10398;11251;13708;150;15257;15812;295;4216;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-CYB;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Longevity / Cervical Carcinoma / HPV infection risk;LHON;Low VO2max response;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports;Reported / Secondary,+;nr,-;nr;+
I11601,I11601,Portugal,,,Portugal_C,,Portugal_C,,39.110833,-8.663583,F,"Lisbon, Torres Vedras, Cabeço da Arruda I",,V,n/a (female),,,3350-2850 BCE,,Unknown,Olalde et al. 2019,0,n/a (female),17.02,fasta,,,,,,,
I11604,I11604,Portugal,,,Portugal_C,,Portugal_C,,39.233333,-9.3,M,"Lisbon, Lourinhã, Tholos of Paimogo I",,K1a1,..,,,3100-2500 BCE,,Unknown,Olalde et al. 2019,0,..,142.7,fasta,10398G;11467G;114T;12308G;12372A;16093C;9055A,10398;11467;114;12308;12372;16093;9055,MT-ND3;MT-ND4;MT-CR;MT-TL2;MT-ND5;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;BD-associated;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Cyclic Vomiting Syndrome;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+;-,-;+
I11605,I11605,Portugal,,,Portugal_C,,Portugal_C,,39.233333,-9.3,M,"Lisbon, Lourinhã, Tholos of Paimogo I",,HV0d,..,,,3100-2500 BCE,,Unknown,Olalde et al. 2019,0,..,266.3,fasta,195C,195,MT-CR,BD-associated / melanoma pts,Reported,+,+
I11614,I11614,Portugal,,,Portugal_C,,Portugal_C,,39.083333,9.266667,F,"Torres Vedra, Bolores",,H4a1a,n/a (female),,,2800-2600 BCE,,Unknown,Olalde et al. 2019,0,n/a (female),218.1,fasta,14582G,14582,MT-ND6,LHON synergistic combo 14258A + 14582G,Reported: individually neutral variants causing LHON in combination,+,-
I3432,I3432,Portugal,,,Portugal_C,,Portugal_C,,38.387,-7.55,F,"Évora, Reguengos de Monsaraz, Perdigões",,U5b2b3,n/a (female),-4365.0,-4315.0,"3081-2907 calBCE (4365±25 BP, PSUAMS-1882)",4365,Unknown,Olalde et al. 2019,0,n/a (female),223,fasta,11467G;12308G;12372A;12634G;13637G;150T;16270T;2755G,11467;12308;12372;12634;13637;150;16270;2755,MT-ND4;MT-TL2;MT-ND5;MT-CR;MT-RNR2,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Thyroid Cancer Cell Line;Possible LHON factor;Longevity / Cervical Carcinoma / HPV infection risk;Melanoma patients;Possibly LVNC-associated,Reported;Conflicting reports,+;nr,-;+;nr
I5076,I5076,Portugal,,,Portugal_C,,Portugal_C,,37.196772,-8.588546,F,Monte Canelas 1,,H1,n/a (female),-4465.0,-4415.0,"3336-3026 calBCE (4465±25 BP, PSUAMS-3902)",4465,Unknown,Olalde et al. 2019,0,n/a (female),205.418492,fasta,3010A,3010,MT-RNR2,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor,Reported,+,-
I5428,I5428,Portugal,,,Portugal_C,,Portugal_C,,39.624062,-9.047189,M,Cova das Lapas,,U5b1+16189+@16192,..,-4510.0,-4460.0,"3352-3101 calBCE (4510±25 BP, PSUAMS-8227)",4510,Unknown,Olalde et al. 2019,0,..,24.5,fasta,11467G;12308G;12372A;150T;16270T,11467;12308;12372;150;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Longevity / Cervical Carcinoma / HPV infection risk;Melanoma patients,Reported;Conflicting reports,+;nr,-;+;nr
I5429,I5429,Portugal,,,Portugal_C,,Portugal_C,,38.387,-7.55,M,"Évora, Reguengos de Monsaraz, Perdigões",,J2b1a3,..,-4310.0,-4270.0,"3010-2886 calBCE (4310±20 BP, PSUAMS-2692)",4310,Unknown,Olalde et al. 2019,0,..,75.4,fasta,10398G;11251G;13708A;150T;15257A;15812A;295T;4216C;489C,10398;11251;13708;150;15257;15812;295;4216;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-CYB;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Longevity / Cervical Carcinoma / HPV infection risk;LHON;Low VO2max response;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports;Reported / Secondary,+;nr,-;nr;+
I7691,I7691,Portugal,,,Portugal_EBA,,Portugal_EBA,,39.6686,-8.1303,M,"Évora, São Manços, Monte da Cabida 3",,J1c1,..,,,2200-1700 BCE,,Unknown,Olalde et al. 2019,0,..,30.8,fasta,10398G;11251G;13708A;185A;295T;3010A;3394C;4216C;462T;489C,10398;11251;13708;185;295;3010;3394;4216;462;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-RNR2;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Low VO2max response;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;LHON / Diabetes / CPTdeficiency / high altitude adaptation;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports;Reported / Population-dependent,+;nr,-;nr;+
I7692,I7692,Portugal,,,Portugal_EBA,,Portugal_EBA,,39.6686,-8.1303,F,"Évora, São Manços, Monte da Cabida 3",,U5b1+16189+@16192,n/a (female),,,2200-1700 BCE,,Unknown,Olalde et al. 2019,0,n/a (female),7.89,fasta,11467G;12308G;12372A;150T;16192T;16270T,11467;12308;12372;150;16192;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Longevity / Cervical Carcinoma / HPV infection risk;Melanoma patients,Reported;Conflicting reports,+;nr,-;+;nr
I7689,I7689,Portugal,,,Portugal_EBA_lc,,Portugal_EBA_lc,,39.6686,-8.1303,F,"Évora, São Manços, Monte da Cabida 3",,H1+16311,n/a (female),,,2200-1700 BCE,,Unknown,Olalde et al. 2019,0,n/a (female),11.1,fasta,16189C;3010A,16189;3010,MT-CR;MT-RNR2,Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor,Reported,+,-
I7687,I7687,Portugal,,,Portugal_LBA,,Portugal_LBA,,40.08694,-8.5166,M,"Coimbra, Arrifana, Gruta do Medronhal",,V,..,,,1200-700 BCE,,Unknown,Olalde et al. 2019,0,..,44.7,fasta,,,,,,,
I7688,I7688,Portugal,,,Portugal_LBA,,Portugal_LBA,,40.08694,-8.5166,F,"Coimbra, Arrifana, Gruta do Medronhal",,H3ap,n/a (female),,,1200-700 BCE,,Unknown,Olalde et al. 2019,0,n/a (female),49.6,fasta,,,,,,,
I8045,I8045,Portugal,,,Portugal_MBA,,Portugal_MBA,,38.1988,-8.71,F,"Setúbal, Melides, Casas Velhas",,U5b,n/a (female),,,1700-1300 BCE,,Unknown,Olalde et al. 2019,0,n/a (female),3.32,fasta,150T;12308G;16270T;12372A,150;12308;16270;12372,MT-CR;MT-TL2;MT-ND5,Longevity / Cervical Carcinoma / HPV infection risk;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Melanoma patients;Altered brain pH / sCJD patients,Conflicting reports;Reported,+;nr,+;nr;-
AfontovaGora3,AfontovaGora3_noUDG_d,Russia,,,Russia_AfontovaGora3,,Russia_AfontovaGora3,,56.05,92.87,F,Afontova Gora,,R1b,n/a (female),-4710.0,-4590.0,"16257-15905 calBCE (14710±60 BP, MAMS-27186)",4710,Unknown,Fu et al. 2016,0,n/a (female),..,fasta,,,,,,,
RISE515,RISE515_noUDG.SG,Russia,,,Russia_BA_Okunevo.SG,,Russia_BA_Okunevo.SG,,53.156486,90.207811,F,Verkhni Askiz,,A8a,n/a (female),-3810.0,-3760.0,"2343-2144 calBCE (3810±25 BP, UCIAMS-147669)",3810,Unknown,Damgaard et al. 2018,0,n/a (female),..,fasta,,,,,,,
RISE516,RISE516_noUDG.SG,Russia,,,Russia_BA_Okunevo.SG_sister.RISE672.SG,,Russia_BA_Okunevo.SG_sister.RISE672.SG,,53.156486,90.207811,F,Verkhni Askiz,,H6a1b,n/a (female),-3725.0,-3675.0,"2201-2035 calBCE (3725±25 BP, UCIAMS-147668)",3725,Unknown,Damgaard et al. 2018,0,n/a (female),..,fasta,,,,,,,
Pr10,Pr10_noUDG.SG,Russia,,,Russia_EarlySarmatian.SG,,Russia_EarlySarmatian.SG,,51.763,55.127,M,"Orenburg, Pokrovka cemetery",,..,..,,,400-100 BCE,,Unknown,Veeramah et al. 2018,0,..,..,fasta,,,,,,,
Pr4,Pr4_noUDG.SG,Russia,,,Russia_EarlySarmatian.SG,,Russia_EarlySarmatian.SG,,51.763,55.127,M,"Orenburg, Pokrovka cemetery",,..,..,,,400-100 BCE,,Unknown,Veeramah et al. 2018,0,..,..,fasta,,,,,,,
RISE555,RISE555_noUDG.SG,Russia,,,Russia_EBA_o1.SG,,Russia_EBA_o1.SG,,48.716,44.5,M,Stalingrad Quarry,,N1a1a-T152C,..,-4082.0,-4026.0,"2853-2495 calBCE (4082±28 BP, AA-R-20358)",4082,Unknown,Allentoft et al. 2015,0,..,..,fasta,,,,,,,
RISE504,RISE504_noUDG.SG,Russia,,,Russia_IA_2.SG,,Russia_IA_2.SG,,53.456,85.447,M,Kytmanovo,,C4a1d,..,-1208.0,-1160.0,"709-888 calCE (1208±24 BP, OxA-31215)",1208,Unknown,Allentoft et al. 2015,0,..,..,fasta,,,,,,,
RISE547,RISE547_noUDG.SG,Russia,,,Russia_Kalmykia_EBA_Yamnaya.SG,,Russia_Kalmykia_EBA_Yamnaya.SG,,46.539,43.699,M,Temrta IV,,T2a1a,..,-4175.0,-4105.0,"2886-2631 calBCE (4175±35 BP, GrA-58960)",4175,Unknown,Allentoft et al. 2015,0,..,..,fasta,,,,,,,
RISE548,RISE548_noUDG.SG,Russia,,,Russia_Kalmykia_EBA_Yamnaya.SG,,Russia_Kalmykia_EBA_Yamnaya.SG,,46.539,43.699,M,Temrta IV,,U4,..,,,3300-2500 BCE,,Unknown,Allentoft et al. 2015,0,..,..,fasta,,,,,,,
RISE497,RISE497_noUDG.SG,Russia,,,Russia_Karasuk_o1.SG,,Russia_Karasuk_o1.SG,,52.954,90.187,F,Arban 1,,A+152+16362,n/a (female),,,1400-900 BCE,,Unknown,Allentoft et al. 2015,0,n/a (female),..,fasta,,,,,,,
RISE493,RISE493_noUDG.SG,Russia,,,Russia_Karasuk_oRISE.SG,,Russia_Karasuk_oRISE.SG,,53.152,91.05,M,Sabinka 2,,C4a1c,..,-3214.0,-3162.0,"1518-1427 calBCE (3214±26 BP, OxA-31211)",3214,Unknown,Allentoft et al. 2015,0,..,..,fasta,,,,,,,
RISE495,RISE495_noUDG.SG,Russia,,,Russia_Karasuk_oRISE.SG,,Russia_Karasuk_oRISE.SG,,52.954,90.187,M,Arban 1,,D4j1,..,,,1400-900 BCE,,Unknown,Allentoft et al. 2015,0,..,..,fasta,,,,,,,
RISE496,RISE496_noUDG.SG,Russia,,,Russia_Karasuk_oRISE.SG,,Russia_Karasuk_oRISE.SG,,52.954,90.187,F,Arban 1,,U5a1a2a,n/a (female),-3070.0,-3014.0,"1416-1260 calBCE (3070±28 BP, OxA-31213)",3070,Unknown,Allentoft et al. 2015,0,n/a (female),..,fasta,,,,,,,
RISE499,RISE499_noUDG.SG,Russia,,,Russia_Karasuk_oRISE.SG,,Russia_Karasuk_oRISE.SG,,51.909,88.574,F,Bystrovka,,H5a1,n/a (female),,,1400-900 BCE,,Unknown,Allentoft et al. 2015,0,n/a (female),..,fasta,,,,,,,
RISE502,RISE502_noUDG.SG,Russia,,,Russia_Karasuk_oRISE.SG,,Russia_Karasuk_oRISE.SG,,51.909,88.574,F,Bystrovka,,U5a1d,n/a (female),-3140.0,-3086.0,"1497-1308 calBCE (3140±27 BP, OxA-31214)",3140,Unknown,Allentoft et al. 2015,0,n/a (female),..,fasta,,,,,,,
I0211,I0211,Russia,,,Russia_Karelia_HG,,Russia_Karelia_HG,,61.65,35.65,M,"Karelia, Yuzhnyy Oleni Ostrov",,U4a,..,,,7050-5950 BCE,,Unknown,Mathieson et al. 2015,0,..,23.153178,fasta,11467G;12308G;12372A;15693C;195C;499A,11467;12308;12372;15693;195;499,MT-ND4;MT-TL2;MT-ND5;MT-CYB;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Possibly LVNC cardiomyopathy-associated;BD-associated / melanoma pts;Endometriosis,Reported,+,-;+
Kostenki14,Kostenki14,Russia,,,Russia_Kostenki14,,Russia_Kostenki14,,51.23,39.3,M,Kostenki,,..,..,-3250.0,-3150.0,"37426-34726 calBCE (33250±500 BP, OxA-X-2395-15)",3250,Unknown,Fu et al. 2016,0,..,..,fasta,,,,,,,
Kostenki14,Kostenki14_noUDG.SG,Russia,,,Russia_Kostenki14.SG,,Russia_Kostenki14.SG,,51.23,39.3,M,Kostenki,,U2,..,-3250.0,-3150.0,"37426-34726 calBCE (33250±500 BP, OxA-X-2395-15)",3250,Unknown,Seguin et al. 2014,0,..,..,fasta,,,,,,,
RISE553,RISE553_noUDG.SG,Russia,,,Russia_LBA_1.SG,,Russia_LBA_1.SG,,56.016,92.866,M,Afontova Gora,,F1b,..,-2731.0,-2675.0,"927-812 calBCE (2731±28 BP, OxA-31140)",2731,Unknown,Allentoft et al. 2015,0,..,..,fasta,,,,,,,
RISE554,RISE554_noUDG.SG,Russia,,,Russia_LBA_2.SG,,Russia_LBA_2.SG,,56.016,92.866,M,Afontova Gora,,F1b1b,..,-2782.0,-2722.0,"1009-835 calBCE (2782±30 BP, OxA-31141)",2782,Unknown,Allentoft et al. 2015,0,..,..,fasta,,,,,,,
RISE523,RISE523_noUDG.SG,Russia,,,Russia_Mezhovskaya.SG,,Russia_Mezhovskaya.SG,,53.043,57.066,F,Kapova cave,,M12'G,n/a (female),-3192.0,-3118.0,"1531-1403 calBCE (3192±37 BP, OxA-31447)",3192,Unknown,Allentoft et al. 2015,0,n/a (female),..,fasta,,,,,,,
RISE524,RISE524_noUDG.SG,Russia,,,Russia_Mezhovskaya.SG,,Russia_Mezhovskaya.SG,,53.043,57.066,M,Kapova cave,,J2b1a,..,,,1300-800 BCE,,Unknown,Allentoft et al. 2015,0,..,..,fasta,,,,,,,
RISE525,RISE525_noUDG.SG,Russia,,,Russia_Mezhovskaya.SG,,Russia_Mezhovskaya.SG,,53.043,57.066,M,Kapova cave,,I5c,..,,,1300-800 BCE,,Unknown,Allentoft et al. 2015,0,..,..,fasta,,,,,,,
DA136,DA136_noUDG.SG,Russia,,,Russia_Sarmatian.SG,,Russia_Sarmatian.SG,,47.28429,39.533315,M,Caspian steppe,,A+152+16362,..,,,800 BCE - 100 CE,,Unknown,Damgaard et al. 2018,0,..,..,fasta,,,,,,,
I4246,I4246,Spain,,,Spain_BellBeaker_oAfrica,,Spain_BellBeaker_oAfrica,,40.439,-3.501,M,"Madrid, San Fernando de Henares, Camino de las Yeseras",,M1a1b1,..,-3819.0,-3769.0,"2401-2146 calBCE (3819±25 BP) [R_combine: (3910±30 BP, PSUAMS-2119); (3650±40 BP, Beta-184837)]",3819,Unknown,Olalde et al. 2019,0,..,13.062526,fasta,10398G;12705T;15043A;16129A;16189C;195C;489C,10398;12705;15043;16129;16189;195;489,MT-ND3;MT-CO1;MT-CYB;MT-CR,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Possible protective factor for normal tension glaucoma;MDD-associated;Cyclic Vomiting Syndrome with Migraine;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;BD-associated / melanoma pts;Low VO2max response,Reported / lineage L & M marker / also hg IJK;Reported,+;<NA>;-,-;<NA>;+
I1271,I1271,Spain,,,Spain_C,,Spain_C,,42.33333333,-3.5,F,"Burgos, Atapuerca, El Mirador Cave",,K1a+195,n/a (female),,,2900-2300 BCE,,Unknown,Mathieson et al. 2015,0,n/a (female),180,fasta,10398G;11467G;12308G;12372A;16093C;195C;9055A,10398;11467;12308;12372;16093;195;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-CR;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Cyclic Vomiting Syndrome;BD-associated / melanoma pts;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+;-,-;+
I1272,I1272,Spain,,,Spain_C,,Spain_C,,42.33333333,-3.5,F,"Burgos, Atapuerca, El Mirador Cave",,K1b1a,n/a (female),-4080.0,-4020.0,"2857-2492 calBCE (4080±30 BP, Beta-416456)",4080,Unknown,Mathieson et al. 2015,0,n/a (female),810,fasta,10398G;11467G;12308G;12372A;15257A;16093C;5913A;9055A,10398;11467;12308;12372;15257;16093;5913;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-CYB;MT-CR;MT-CO1;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;LHON;Cyclic Vomiting Syndrome;Prostate Cancer / hypertension;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports,+;-,-;+
I1276,I1276,Spain,,,Spain_C,,Spain_C,,42.33333333,-3.5,F,"Burgos, Atapuerca, El Mirador Cave",,H3c3,n/a (female),,,2900-2300 BCE,,Unknown,Mathieson et al. 2015,0,n/a (female),365,fasta,,,,,,,
I1277,I1277,Spain,,,Spain_C,,Spain_C,,42.33333333,-3.5,M,"Burgos, Atapuerca, El Mirador Cave",,H3,I2a2a,-3950.0,-3890.0,"2570-2342 calBCE (3950±30 BP, Beta-416457)",3950,Unknown,Mathieson et al. 2015,0,..,519,fasta,,,,,,,
I1280,I1280,Spain,,,Spain_C,,Spain_C,,42.33333333,-3.5,F,"Burgos, Atapuerca, El Mirador Cave",,J1c1,n/a (female),,,2900-2300 BCE,,Unknown,Mathieson et al. 2015,0,n/a (female),563,fasta,10398G;11251G;13708A;185A;228A;295T;3010A;3394C;4216C;462T;489C,10398;11251;13708;185;228;295;3010;3394;4216;462;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-RNR2;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Low VO2max response;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;LHON / Diabetes / CPTdeficiency / high altitude adaptation;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports;Reported / Population-dependent,+;nr,-;nr;+
I1281,I1281,Spain,,,Spain_C,,Spain_C,,42.33333333,-3.5,F,"Burgos, Atapuerca, El Mirador Cave",,H1t,n/a (female),-4110.0,-4050.0,"2867-2573 calBCE (4110±30 BP, Beta-416458)",4110,Unknown,Mathieson et al. 2015,0,n/a (female),419,fasta,3010A,3010,MT-RNR2,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor,Reported,+,-
I1282,I1282,Spain,,,Spain_C,,Spain_C,,42.33333333,-3.5,M,"Burgos, Atapuerca, El Mirador Cave",,H3,..,,,2900-2300 BCE,,Unknown,Mathieson et al. 2015,0,..,484,fasta,,,,,,,
I1284,I1284,Spain,,,Spain_C,,Spain_C,,42.33333333,-3.5,M,"Burgos, Atapuerca, El Mirador Cave",,H3,..,,,2900-2300 BCE,,Unknown,Mathieson et al. 2015,0,..,178,fasta,,,,,,,
I1300,I1300,Spain,,,Spain_C,,Spain_C,,42.33333333,-3.5,F,"Burgos, Atapuerca, El Mirador Cave",,K1a2a,n/a (female),,,2900-2300 BCE,,Unknown,Mathieson et al. 2015,0,n/a (female),726,fasta,10398G;11467G;12308G;12372A;9055A,10398;11467;12308;12372;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+,-;+
I1303,I1303,Spain,,,Spain_C,,Spain_C,,42.33333333,-3.5,M,"Burgos, Atapuerca, El Mirador Cave",,U3a1,I2a1a1,,,2900-2300 BCE,,Unknown,Mathieson et al. 2015,0,..,234,fasta,11467G;12308G;12372A;150T;16390A;3010A,11467;12308;12372;150;16390;3010,MT-ND4;MT-TL2;MT-ND5;MT-CR;MT-RNR2,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Longevity / Cervical Carcinoma / HPV infection risk;POAG - potential for association;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor,Reported;Conflicting reports,+,-;+
I1314,I1314,Spain,,,Spain_C,,Spain_C,,42.33333333,-3.5,M,"Burgos, Atapuerca, El Mirador Cave",,J2a1a1,G2a,,,2900-2300 BCE,,Unknown,Mathieson et al. 2015,0,..,119,fasta,10398G;11251G;13708A;150T;15257A;195C;295T;4216C;489C,10398;11251;13708;150;15257;195;295;4216;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-CYB;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Longevity / Cervical Carcinoma / HPV infection risk;LHON;BD-associated / melanoma pts;Low VO2max response;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports,+;nr,-;nr;+
I1838,I1838,Spain,,,Spain_C,,Spain_C,,42.63,-2.7,F,"Basque Country, Alava, Las Yurdinas II",,J1c3,n/a (female),-4470.0,-4370.0,"3356-2936 calBCE (4470±50 BP, Poz-83429)",4470,Unknown,Lipson et al. 2017,0,n/a (female),978,fasta,10398G;11251G;13708A;185A;228A;295T;3010A;4216C;462T;489C,10398;11251;13708;185;228;295;3010;4216;462;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-RNR2;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Low VO2max response;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports,+;nr,-;nr;+
I1842,I1842,Spain,,,Spain_C,,Spain_C,,42.63,-2.7,M,"Basque Country, Araba/Álava, Peñacerrada-Urizaharra, Las Yurdinas II",,H1e1a,..,,,3000-2800 BCE,,Unknown,Olalde et al. 2019,0,..,155,fasta,3010A;5460A,3010;5460,MT-RNR2;MT-ND2,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;AD / PD / LHON,Reported;Conflicting reports,+,-;+
I1843,I1843,Spain,,,Spain_C,,Spain_C,,42.57,-2.57,F,"Basque Country, Alava, Alto de la Huesera",,U5b1+16189+@16192,n/a (female),-4340.0,-4296.0,"3015-2901 calBCE (4340±22 BP) [R_combine: (4390±30 BP, Beta-301225); (4290±30 BP, Beta-301226)]",4340,Unknown,Lipson et al. 2017,0,n/a (female),702,fasta,11467G;12308G;12372A;150T;16189C;16270T,11467;12308;12372;150;16189;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Longevity / Cervical Carcinoma / HPV infection risk;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;Melanoma patients,Reported;Conflicting reports,+;nr,-;+;nr
I1845,I1845,Spain,,,Spain_C,,Spain_C,,42.57,-2.57,M,"Basque Country, Araba/Álava, Laguardia, Alto de la Huesera",,K1a2c,..,,,3100-2650 BCE,,Unknown,Olalde et al. 2019,0,..,15.1,fasta,10398G;11467G;12308G;12372A;16093C;4216C;9055A,10398;11467;12308;12372;16093;4216;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-CR;MT-ND1;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Cyclic Vomiting Syndrome;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports,+;-,-;+
I1846,I1846,Spain,,,Spain_C,,Spain_C,,42.57,-2.57,F,"Basque Country, Araba/Álava, Laguardia, Alto de la Huesera",,T2b3+151,n/a (female),,,3100-2650 BCE,,Unknown,Olalde et al. 2019,0,n/a (female),70.6,fasta,11251G;15928A;4216C;4917G,11251;15928;4216;4917,MT-ND4;MT-TT;MT-ND1;MT-ND2,Reduced risk of PD;Multiple Sclerosis / idiopathic repeat miscarriage / AD protection;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;LHON / Insulin Resistance / AMD / NRTI-PN,Reported;Conflicting reports,nr;+,nr;-
I1975,I1975,Spain,,,Spain_C,,Spain_C,,42.57,-2.55,M,"Basque Country, Alava, La Chabola de la Hechicera",,J1c,..,-4350.0,-4270.0,"3092-2893 calBCE (4350±40 BP, Beta-288937)",4350,Unknown,Lipson et al. 2017,0,..,20.1,fasta,10398G;11251G;13708A;185A;228A;295T;3010A;3394C;4216C;462T;489C,10398;11251;13708;185;228;295;3010;3394;4216;462;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-RNR2;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Low VO2max response;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;LHON / Diabetes / CPTdeficiency / high altitude adaptation;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports;Reported / Population-dependent,+;nr,-;nr;+
I1976,I1976,Spain,,,Spain_C,,Spain_C,,42.57,-2.62,M,"Basque Country, Araba/Álava, Laguardia, El Sotillo",,H3,I2a1b1,-3960.0,-3900.0,"2571-2347 calBCE (3960±30 BP, Beta-299306)",3960,Unknown,Olalde et al. 2019,0,I-Y3259,110.65864,fasta,,,,,,,
I1978,I1978,Spain,,,Spain_C,,Spain_C,,42.57,-2.57,F,"Basque Country, Araba/Álava, Laguardia, Alto de la Huesera",,K1a4a1,n/a (female),,,3100-2650 BCE,,Unknown,Olalde et al. 2019,0,n/a (female),55,fasta,10398G;11467G;12308G;12372A;9055A,10398;11467;12308;12372;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+,-;+
I1981,I1981,Spain,,,Spain_C,,Spain_C,,42.57,-2.57,F,"Basque Country, Alava, Alto de la Huesera",,J1c1,n/a (female),-4320.0,-4260.0,"3013-2889 calBCE (4320±30 BP, Beta-301223)",4320,Unknown,Lipson et al. 2017,0,n/a (female),162,fasta,10398G;11251G;13708A;185A;228A;295T;3010A;3394C;4216C;462T;489C,10398;11251;13708;185;228;295;3010;3394;4216;462;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-RNR2;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Low VO2max response;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;LHON / Diabetes / CPTdeficiency / high altitude adaptation;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports;Reported / Population-dependent,+;nr,-;nr;+
I2467,I2467,Spain,,,Spain_C,,Spain_C,,42.57,-2.62,M,"Basque Country, Alava, El Sotillo",,X2,..,-3900.0,-3820.0,"2474-2209 calBCE (3900±40 BP, Beta-299300)",3900,Unknown,Lipson et al. 2017,0,..,132,fasta,12705T;13708A;15927A;16189C;195C;8393T,12705;13708;15927;16189;195;8393,MT-CO1;MT-ND5;MT-TT;MT-CR;MT-ATP8,Possible protective factor for normal tension glaucoma;LHON / Increased MS risk / higher freq in PD-ADS;LHON / Multiple Sclerosis / DEAF1555 increased penetrance / CHD;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;BD-associated / melanoma pts;Reversible brain pseudoatrophy,Reported;Conflicting reports,<NA>;+;-,<NA>;+;-
I2473,I2473,Spain,,,Spain_C,,Spain_C,,42.57,-2.62,M,"Basque Country, Araba/Álava, Laguardia, El Sotillo",,H3,..,-4250.0,-4190.0,"2916-2704 calBCE (4250±30 BP, Beta-299305)",4250,Unknown,Olalde et al. 2019,0,..,33.567445,fasta,,,,,,,
I3269,I3269,Spain,,,Spain_C,,Spain_C,,42.63,-2.7,M,"Basque Country, Alava, Las Yurdinas II",,U5b2b3a,I2a2a,,,3000-2800 BCE,,Unknown,Lipson et al. 2017,0,..,387,fasta,11467G;12308G;12372A;12634G;13637G;150T;16270T;2755G,11467;12308;12372;12634;13637;150;16270;2755,MT-ND4;MT-TL2;MT-ND5;MT-CR;MT-RNR2,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Thyroid Cancer Cell Line;Possible LHON factor;Longevity / Cervical Carcinoma / HPV infection risk;Melanoma patients;Possibly LVNC-associated,Reported;Conflicting reports,+;nr,-;+;nr
I3270,I3270,Spain,,,Spain_C,,Spain_C,,42.63,-2.7,F,"Basque Country, Alava, Las Yurdinas II",,J2a1a1,n/a (female),,,3000-2800 BCE,,Unknown,Lipson et al. 2017,0,n/a (female),827,fasta,10398G;11251G;13708A;150T;15257A;195C;295T;4216C;489C,10398;11251;13708;150;15257;195;295;4216;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-CYB;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Longevity / Cervical Carcinoma / HPV infection risk;LHON;BD-associated / melanoma pts;Low VO2max response;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports,+;nr,-;nr;+
I3271,I3271,Spain,,,Spain_C,,Spain_C,,42.63,-2.7,F,"Basque Country, Alava, Las Yurdinas II",,K1a4a1,n/a (female),,,3000-2800 BCE,,Unknown,Lipson et al. 2017,0,n/a (female),771,fasta,10398G;11467G;12308G;12372A;9055A,10398;11467;12308;12372;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+,-;+
I3272,I3272,Spain,,,Spain_C,,Spain_C,,42.57,-2.55,M,"Basque Country, Alava, La Chabola de la Hechicera",,X2b+226,..,-4380.0,-4300.0,"3307-2899 calBCE (4380±40 BP, Beta-288933)",4380,Unknown,Lipson et al. 2017,0,..,45,fasta,12705T;13708A;15927A;16189C;195C;8393T,12705;13708;15927;16189;195;8393,MT-CO1;MT-ND5;MT-TT;MT-CR;MT-ATP8,Possible protective factor for normal tension glaucoma;LHON / Increased MS risk / higher freq in PD-ADS;LHON / Multiple Sclerosis / DEAF1555 increased penetrance / CHD;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;BD-associated / melanoma pts;Reversible brain pseudoatrophy,Reported;Conflicting reports,<NA>;+;-,<NA>;+;-
I3277,I3277,Spain,,,Spain_C,,Spain_C,,42.57,-2.57,F,"Basque Country, Alava, Alto de la Huesera",,U5b2b,n/a (female),,,3150-2850 BCE,,Unknown,Olalde et al. 2019,0,n/a (female),136.58706,fasta,11467G;12308G;12372A;12634G;13637G;150T;16270T,11467;12308;12372;12634;13637;150;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Thyroid Cancer Cell Line;Possible LHON factor;Longevity / Cervical Carcinoma / HPV infection risk;Melanoma patients,Reported;Conflicting reports,+;nr,-;+;nr
I4565,I4565,Spain,,,Spain_C,,Spain_C,,41.2916,1.0638,M,"Tarragona, Galls Carboners",,H5,..,-4355.0,-4315.0,"3022-2907 calBCE (4355±20 BP, PSUAMS-2866)",4355,Unknown,Olalde et al. 2019,0,..,509,fasta,,,,,,,
I5838,I5838,Spain,,,Spain_C,,Spain_C,,42.33333333,-3.5,M,"Burgos, Atapuerca, El Mirador Cave",,K1a+195,I2a2a,,,2900-2300 BCE,,Unknown,Lipson et al. 2017,0,..,261,fasta,10398G;11467G;12308G;12372A;16093C;195C;9055A,10398;11467;12308;12372;16093;195;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-CR;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Cyclic Vomiting Syndrome;BD-associated / melanoma pts;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+;-,-;+
I7587,I7587,Spain,,,Spain_C,,Spain_C,,37.24,-4.24,M,"Andalusia, Córdoba, Lucena, Sima del Ángel",,T2b3,..,,,2900-2500 BCE,,Unknown,Olalde et al. 2019,0,..,43,fasta,11251G;15928A;4216C;4917G,11251;15928;4216;4917,MT-ND4;MT-TT;MT-ND1;MT-ND2,Reduced risk of PD;Multiple Sclerosis / idiopathic repeat miscarriage / AD protection;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;LHON / Insulin Resistance / AMD / NRTI-PN,Reported;Conflicting reports,nr;+,nr;-
I8048,I8048,Spain,,,Spain_C,,Spain_C,,37.005,-3.8947,M,"Granada, Arenas del Rey",,U5b1,..,,,2200-2000 BCE,,Unknown,Olalde et al. 2019,0,..,17.6,fasta,11467G;12308G;12372A;150T;16192T;16270T,11467;12308;12372;150;16192;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Longevity / Cervical Carcinoma / HPV infection risk;Melanoma patients,Reported;Conflicting reports,+;nr,-;+;nr
I8131,I8131,Spain,,,Spain_C,,Spain_C,,38.9777,-0.16037,F,"Valencian Community, València/Valencia, La Vital, Gandia",,J2b1,n/a (female),-3980.0,-3920.0,"2576-2356 calBCE (3980±30 BP, Beta-504712)",3980,Unknown,Olalde et al. 2019,0,n/a (female),3.919911,fasta,150T;13708A;489C;10398G;15257A;295T;4216C;11251G;15812A,150;13708;489;10398;15257;295;4216;11251;15812,MT-CR;MT-ND5;MT-ND3;MT-CYB;MT-ND1;MT-ND4,Longevity / Cervical Carcinoma / HPV infection risk;LHON / Increased MS risk / higher freq in PD-ADS;Low VO2max response;PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;LHON;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;Reduced risk of PD,Conflicting reports;Reported;Reported / lineage L & M marker / also hg IJK;Reported / Secondary,+;nr,+;-;nr
I8141,I8141,Spain,,,Spain_C,,Spain_C,,37.005,-3.8947,F,"Granada, Arenas del Rey",,K1a1b1,n/a (female),,,2200-2000 BCE,,Unknown,Olalde et al. 2019,0,n/a (female),41.6,fasta,10398G;11467G;114T;12308G;12372A;15924G;16093C;9055A,10398;11467;114;12308;12372;15924;16093;9055,MT-ND3;MT-ND4;MT-CR;MT-TL2;MT-ND5;MT-TT;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;BD-associated;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;LIMM;Cyclic Vomiting Syndrome;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+;nr;-,-;+;nr
I8148,I8148,Spain,,,Spain_C,,Spain_C,,37.24,-4.24,M,"Andalusia, Córdoba, Lucena, Sima del Ángel",,T2b3+151,..,,,2900-2500 BCE,,Unknown,Olalde et al. 2019,0,..,18.4,fasta,11251G;15928A;4216C;4917G,11251;15928;4216;4917,MT-ND4;MT-TT;MT-ND1;MT-ND2,Reduced risk of PD;Multiple Sclerosis / idiopathic repeat miscarriage / AD protection;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;LHON / Insulin Resistance / AMD / NRTI-PN,Reported;Conflicting reports,nr;+,nr;-
I8149,I8149,Spain,,,Spain_C,,Spain_C,,37.24,-4.24,F,"Andalusia, Córdoba, Lucena, Sima del Ángel",,T,n/a (female),,,2900-2500 BCE,,Unknown,Olalde et al. 2019,0,n/a (female),16,fasta,11251G;15928A;4216C;4917G,11251;15928;4216;4917,MT-ND4;MT-TT;MT-ND1;MT-ND2,Reduced risk of PD;Multiple Sclerosis / idiopathic repeat miscarriage / AD protection;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;LHON / Insulin Resistance / AMD / NRTI-PN,Reported;Conflicting reports,nr;+,nr;-
I8150,I8150,Spain,,,Spain_C,,Spain_C,,37.24,-4.24,F,"Andalusia, Córdoba, Lucena, Sima del Ángel",,J1c3,n/a (female),,,2900-2500 BCE,,Unknown,Olalde et al. 2019,0,n/a (female),8.86,fasta,10398G;11251G;13708A;228A;295T;3010A;4216C;462T;489C,10398;11251;13708;228;295;3010;4216;462;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-RNR2;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Low VO2max response;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports,+;nr,-;nr;+
I8153,I8153,Spain,,,Spain_C,,Spain_C,,37.24,-4.24,M,"Andalusia, Córdoba, Lucena, Sima del Ángel",,J2b1a1,..,,,2900-2500 BCE,,Unknown,Olalde et al. 2019,0,..,46.2,fasta,10398G;11251G;13708A;150T;15257A;15812A;295T;4216C;489C,10398;11251;13708;150;15257;15812;295;4216;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-CYB;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Longevity / Cervical Carcinoma / HPV infection risk;LHON;Low VO2max response;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports;Reported / Secondary,+;nr,-;nr;+
I8154,I8154,Spain,,,Spain_C,,Spain_C,,37.24,-4.24,F,"Andalusia, Córdoba, Lucena, Sima del Ángel",,U5b1,n/a (female),,,2900-2500 BCE,,Unknown,Olalde et al. 2019,0,n/a (female),2.59,fasta,12308G;150T;16189C,12308;150;16189,MT-TL2;MT-CR,CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Longevity / Cervical Carcinoma / HPV infection risk;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients,Reported;Conflicting reports,+,+;-
I8156,I8156,Spain,,,Spain_C,,Spain_C,,37.24,-4.24,M,"Andalusia, Córdoba, Lucena, Sima del Ángel",,K1a4a1,..,,,2900-2500 BCE,,Unknown,Olalde et al. 2019,0,..,24.7,fasta,10398G;11467G;12308G;12372A;16093C;9055A,10398;11467;12308;12372;16093;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-CR;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Cyclic Vomiting Syndrome;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+;-,-;+
I8158,I8158,Spain,,,Spain_C,,Spain_C,,37.24,-4.24,M,"Andalusia, Córdoba, Lucena, Sima del Ángel",,H1ah,..,,,2900-2500 BCE,,Unknown,Olalde et al. 2019,0,..,38.7,fasta,3010A;8950A,3010;8950,MT-RNR2;MT-ATP6,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;LDYT,Reported,+,-
I8197,I8197,Spain,,,Spain_C,,Spain_C,,37.24,-4.24,F,"Andalusia, Córdoba, Lucena, Sima del Ángel",,H4a1,n/a (female),,,2900-2500 BCE,,Unknown,Olalde et al. 2019,0,n/a (female),140,fasta,14582G,14582,MT-ND6,LHON synergistic combo 14258A + 14582G,Reported: individually neutral variants causing LHON in combination,+,-
I8198,I8198,Spain,,,Spain_C,,Spain_C,,37.24,-4.24,F,"Andalusia, Córdoba, Lucena, Sima del Ángel",,J2b1a,n/a (female),,,2900-2500 BCE,,Unknown,Olalde et al. 2019,0,n/a (female),104,fasta,10398G;11251G;13708A;150T;15257A;15812A;295T;4216C;489C,10398;11251;13708;150;15257;15812;295;4216;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-CYB;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Longevity / Cervical Carcinoma / HPV infection risk;LHON;Low VO2max response;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports;Reported / Secondary,+;nr,-;nr;+
I8199,I8199,Spain,,,Spain_C,,Spain_C,,37.24,-4.24,M,"Andalusia, Córdoba, Lucena, Sima del Ángel",,U5b1+16189+@16192,..,,,2900-2500 BCE,,Unknown,Olalde et al. 2019,0,..,157,fasta,11467G;12308G;12372A;150T;16189C;16270T,11467;12308;12372;150;16189;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Longevity / Cervical Carcinoma / HPV infection risk;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;Melanoma patients,Reported;Conflicting reports,+;nr,-;+;nr
I8364,I8364,Spain,,,Spain_C,,Spain_C,,37.24,-4.24,M,"Andalusia, Córdoba, Lucena, Sima del Ángel",,J2b1a2a,..,,,2706-2569 BCE,,Unknown,Olalde et al. 2019,0,..,352,fasta,10398G;11251G;13708A;150T;15257A;15812A;295T;4216C;489C,10398;11251;13708;150;15257;15812;295;4216;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-CYB;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Longevity / Cervical Carcinoma / HPV infection risk;LHON;Low VO2max response;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports;Reported / Secondary,+;nr,-;nr;+
I8365,I8365,Spain,,,Spain_C,,Spain_C,,37.24,-4.24,M,"Andalusia, Córdoba, Lucena, Sima del Ángel",,H,..,,,2706-2569 BCE,,Unknown,Olalde et al. 2019,0,..,109,fasta,,,,,,,
I8566,I8566,Spain,,,Spain_C,,Spain_C,,38.824511,-0.864165,F,"Valencian Community, València/Valencia, La Font de la Figuera, Cova de Sant Gomengo",,J2b1a,n/a (female),,,3800-2500 BCE,,Unknown,Olalde et al. 2019,0,n/a (female),222,fasta,10398G;11251G;13708A;150T;15257A;15812A;295T;4216C;489C,10398;11251;13708;150;15257;15812;295;4216;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-CYB;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Longevity / Cervical Carcinoma / HPV infection risk;LHON;Low VO2max response;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports;Reported / Secondary,+;nr,-;nr;+
I8569,I8569,Spain,,,Spain_C,,Spain_C,,40.302777,0.2797,M,"Valencian Community, Castelló/Castellón, Alcalá de Xivert, Cova dels Diablets",,H1ah,..,-4141.0,-4099.0,"2872-2626 calBCE (4141±21 BP, MAMS-18651)",4141,Unknown,Olalde et al. 2019,0,..,71.4,fasta,3010A;8950A,3010;8950,MT-RNR2;MT-ATP6,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;LDYT,Reported,+,-
I7588,I7588,Spain,,,Spain_C_contam,,Spain_C_contam,,37.24,-4.24,U,"Andalusia, Córdoba, Lucena, Sima del Ángel",,J1c1b,n/a  (sex unknown),,,2900-2500 BCE,,Unknown,Olalde et al. 2019,0,n/a  (sex unknown),133,fasta,10398G;11251G;13708A;185A;228A;295T;3010A;3394C;4216C;462T;489C,10398;11251;13708;185;228;295;3010;3394;4216;462;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-RNR2;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Low VO2max response;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;LHON / Diabetes / CPTdeficiency / high altitude adaptation;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports;Reported / Population-dependent,+;nr,-;nr;+
I8132,I8132,Spain,,,Spain_C_lc,,Spain_C_lc,,38.9777,-0.16037,F,"Valencian Community, València/Valencia, La Vital, Gandia",,H1aq,n/a (female),,,2600-2400 BCE,,Unknown,Olalde et al. 2019,0,n/a (female),12.8,fasta,3010A,3010,MT-RNR2,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor,Reported,+,-
EHU001,EHU001,Spain,,,Spain_C_oSteppe,,Spain_C_oSteppe,,42.419214,-3.484745,M,"Castilla y León, Burgos, Monasterio de Rodilla, El Hundido",,U5a1b1,..,-3760.0,-3700.0,"2287-2041 calBCE (3760±30 BP, Beta-492280)",3760,Unknown,Olalde et al. 2019,0,..,..,fasta,,,,,,,
EHU002,EHU002,Spain,,,Spain_C_oSteppe,,Spain_C_oSteppe,,42.419214,-3.484745,M,"Castilla y León, Burgos, Monasterio de Rodilla, El Hundido",,K1a4a1,..,-3933.0,-3869.0,"2564-2299 calBCE (3933±32 BP, CSIC-1896)",3933,Unknown,Olalde et al. 2019,0,..,..,fasta,,,,,,,
I3238,I3238,Spain,,,Spain_C_oSteppe,,Spain_C_oSteppe,,43.41022,-5.98496,M,"Asturias, Soto de las Regueras, Cueva de la Paloma",,H3+152,..,,,2500-2200 BCE,,Unknown,Olalde et al. 2019,0,..,24.153057,fasta,,,,,,,
I3239,I3239,Spain,,,Spain_C_oSteppe,,Spain_C_oSteppe,,43.41022,-5.98496,F,"Asturias, Soto de las Regueras, Cueva de la Paloma",,U5b1d2,n/a (female),,,2500-2200 BCE,,Unknown,Olalde et al. 2019,0,n/a (female),6.576076,fasta,11467G;12308G;12372A;150T;16270T,11467;12308;12372;150;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Longevity / Cervical Carcinoma / HPV infection risk;Melanoma patients,Reported;Conflicting reports,+;nr,-;+;nr
I3243,I3243,Spain,,,Spain_C_oSteppe,,Spain_C_oSteppe,,43.41022,-5.98496,M,"Asturias, Soto de las Regueras, Cueva de la Paloma",,U5a1a2b,..,,,2500-2200 BCE,,Unknown,Olalde et al. 2019,0,..,2.878267,fasta,12308G;16270T;11467G,12308;16270;11467,MT-TL2;MT-CR;MT-ND4,CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Melanoma patients;Altered brain pH / sCJD patients,Reported,+;nr,+;nr;-
I0581,I0581_d,Spain,,,Spain_C,,Spain_C,,42.33333333,-3.5,M,"Burgos, Atapuerca, El Mirador Cave",,X2b,..,-4210.0,-4150.0,"2900-2675 calBCE (4210±30 BP, Beta-416455)",4210,Unknown,Mathieson et al. 2015,0,..,..,fasta,,,,,,,
I3276,I3276,Spain,,,Spain_C,,Spain_C,,42.57,-2.57,M,"Basque Country, Alava, Alto de la Huesera",,V,G2a2a,-4390.0,-4330.0,"3096-2913 calBCE (4390±30 BP, Beta-301225)",4390,Unknown,Lipson et al. 2017,0,..,284.099946,fasta,,,,,,,
I8155,I8155,Spain,,,Spain_C_lc,,Spain_C_lc,,37.24,-4.24,F,"Andalusia, Córdoba, Lucena, Sima del Ángel",,H4a1a,n/a (female),,,2900-2500 BCE,,Unknown,Olalde et al. 2019,0,n/a (female),6.37,fasta,14582G,14582,MT-ND6,LHON synergistic combo 14258A + 14582G,Reported: individually neutral variants causing LHON in combination,+,-
I8157,I8157,Spain,,,Spain_C_lc,,Spain_C_lc,,37.24,-4.24,M,"Andalusia, Córdoba, Lucena, Sima del Ángel",,HV0+195,..,,,2900-2500 BCE,,Unknown,Olalde et al. 2019,0,..,20.3,fasta,195C,195,MT-CR,BD-associated / melanoma pts,Reported,+,+
I7672,I7672,Spain,,,Spain_Carolingian,,Spain_Carolingian,,41.981377,2.309824,M,"Barcelona, Roda de Ter, L'Esquerda",,T2h,..,,,785-810 CE,,Unknown,Olalde et al. 2019,0,..,59.8,fasta,11251G;12397G;15928A;4216C;4917G,11251;12397;15928;4216;4917,MT-ND4;MT-ND5;MT-TT;MT-ND1;MT-ND2,Reduced risk of PD;PD / early onset;Multiple Sclerosis / idiopathic repeat miscarriage / AD protection;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;LHON / Insulin Resistance / AMD / NRTI-PN,Reported;Conflicting reports,nr;+,nr;-
I7673,I7673,Spain,,,Spain_Carolingian,,Spain_Carolingian,,41.981377,2.309824,F,"Barcelona, Roda de Ter, L'Esquerda",,W1+119,n/a (female),,,785-810 CE,,Unknown,Olalde et al. 2019,0,n/a (female),50.7,fasta,12705T;195C;5460A,12705;195;5460,MT-CO1;MT-CR;MT-ND2,Possible protective factor for normal tension glaucoma;BD-associated / melanoma pts;AD / PD / LHON,Reported;Conflicting reports,<NA>;+,<NA>;+
I7674,I7674,Spain,,,Spain_Carolingian,,Spain_Carolingian,,41.981377,2.309824,F,"Barcelona, Roda de Ter, L'Esquerda",,H42,n/a (female),,,785-810 CE,,Unknown,Olalde et al. 2019,0,n/a (female),69.9,fasta,,,,,,,
I7675,I7675,Spain,,,Spain_Carolingian,,Spain_Carolingian,,41.981377,2.309824,M,"Barcelona, Roda de Ter, L'Esquerda",,U3a1,..,,,785-810 CE,,Unknown,Olalde et al. 2019,0,..,214,fasta,11467G;12308G;12372A;150T;16390A;3010A,11467;12308;12372;150;16390;3010,MT-ND4;MT-TL2;MT-ND5;MT-CR;MT-RNR2,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Longevity / Cervical Carcinoma / HPV infection risk;POAG - potential for association;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor,Reported;Conflicting reports,+,-;+
I7676,I7676,Spain,,,Spain_Carolingian,,Spain_Carolingian,,41.981377,2.309824,F,"Barcelona, Roda de Ter, L'Esquerda",,U5a1c,n/a (female),,,785-810 CE,,Unknown,Olalde et al. 2019,0,n/a (female),27.1,fasta,11467G;12308G;12372A;16192T;16270T,11467;12308;12372;16192;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Melanoma patients,Reported,+;nr,-;+;nr
I12809,I12809,Spain,,,Spain_EBA,,Spain_EBA,,38.5781,-2.8417,M,"Ciudad Real, Terrinches, Castillejo del Bonete",,H1j,..,,,1880-1770 BCE,,Unknown,Olalde et al. 2019,0,..,14.28,fasta,3010A,3010,MT-RNR2,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor,Reported,+,-
I12855,I12855,Spain,,,Spain_EBA,,Spain_EBA,,38.5781,-2.8417,M,"Ciudad Real, Terrinches, Castillejo del Bonete",,K1a+195,..,,,1880-1770 BCE,,Unknown,Olalde et al. 2019,0,..,29.65,fasta,10398G;11467G;12308G;12372A;16093C;195C;9055A,10398;11467;12308;12372;16093;195;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-CR;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Cyclic Vomiting Syndrome;BD-associated / melanoma pts;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+;-,-;+
I1310,I1310,Spain,,,Spain_EBA,,Spain_EBA,,41.5373,2.1329,F,"Barcelona, Sabadell, Can Roquetes",,U5b1c,n/a (female),,,2000-1400 BCE,,Unknown,Olalde et al. 2019,0,n/a (female),63.6,fasta,11467G;12308G;12372A;150T;16189C;16270T,11467;12308;12372;150;16189;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Longevity / Cervical Carcinoma / HPV infection risk;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;Melanoma patients,Reported;Conflicting reports,+;nr,-;+;nr
I1836,I1836,Spain,,,Spain_EBA,,Spain_EBA,,41.223,1.7742,M,"Sitges, Barcelona, Cova del Gegant",,U,..,-3310.0,-3240.0,"1684-1503 calBCE (3310±35 BP, Poz-83482)",3310,Unknown,Olalde et al. 2019,0,..,45.7,fasta,11467G;12308G;12372A;16192T;16270T,11467;12308;12372;16192;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Melanoma patients,Reported,+;nr,-;+;nr
I1840,I1840,Spain,,,Spain_EBA,,Spain_EBA,,42.57,-2.62,M,"Basque Country, Araba/Álava, Laguardia, El Sotillo",,H3ap,..,-3260.0,-3200.0,"1613-1450 calBCE (3260±30 BP, Beta-299302)",3260,Unknown,Olalde et al. 2019,0,..,489,fasta,,,,,,,
I1977,I1977,Spain,,,Spain_EBA,,Spain_EBA,,42.57,-2.62,F,"Basque Country, Araba/Álava, Laguardia, El Sotillo",,U5b1+16189+@16192,n/a (female),-3260.0,-3200.0,"1613-1450 calBCE (3260±30 BP, Beta-299312)",3260,Unknown,Olalde et al. 2019,0,n/a (female),266,fasta,11467G;12308G;12372A;150T;16189C;16270T,11467;12308;12372;150;16189;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Longevity / Cervical Carcinoma / HPV infection risk;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;Melanoma patients,Reported;Conflicting reports,+;nr,-;+;nr
I1982,I1982,Spain,,,Spain_EBA,,Spain_EBA,,42.9933,-2.11339,F,Ondarre,,X2,n/a (female),-3340.0,-3280.0,"1735-1532 calBCE (3340±30 BP, Beta-350136)",3340,Unknown,Olalde et al. 2019,0,n/a (female),3.06,fasta,13708A;195C;8393T;15927A;12705T,13708;195;8393;15927;12705,MT-ND5;MT-CR;MT-ATP8;MT-TT;MT-CO1,LHON / Increased MS risk / higher freq in PD-ADS;BD-associated / melanoma pts;Reversible brain pseudoatrophy;LHON / Multiple Sclerosis / DEAF1555 increased penetrance / CHD;Possible protective factor for normal tension glaucoma,Conflicting reports;Reported,+;-;<NA>,+;-;<NA>
I2471,I2471,Spain,,,Spain_EBA,,Spain_EBA,,42.57,-2.62,F,"Basque Country, Araba/Álava, Laguardia, El Sotillo",,K1b1a,n/a (female),-3280.0,-3220.0,"1620-1462 calBCE (3280±30 BP, Beta-299311)",3280,Unknown,Olalde et al. 2019,0,n/a (female),29.909288,fasta,10398G;11467G;12308G;12372A;15257A;16093C;5913A;9055A,10398;11467;12308;12372;15257;16093;5913;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-CYB;MT-CR;MT-CO1;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;LHON;Cyclic Vomiting Syndrome;Prostate Cancer / hypertension;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports,+;-,-;+
I3484,I3484,Spain,,,Spain_EBA,,Spain_EBA,,38.5781,-2.8417,M,"Ciudad Real, Terrinches, Castillejo del Bonete",,J1c1,..,-3720.0,-3580.0,"2343-1905 calBCE (3720±70 BP, Rome-1687)",3720,Unknown,Olalde et al. 2019,0,..,18.2,fasta,10398G;11251G;13708A;185A;228A;295T;3010A;3394C;4216C;462T;489C,10398;11251;13708;185;228;295;3010;3394;4216;462;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-RNR2;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Low VO2max response;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;LHON / Diabetes / CPTdeficiency / high altitude adaptation;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports;Reported / Population-dependent,+;nr,-;nr;+
I3485,I3485,Spain,,,Spain_EBA,,Spain_EBA,,38.5781,-2.8417,F,"Ciudad Real, Terrinches, Castillejo del Bonete",,K1a4a1,n/a (female),,,2300-1900 BCE,,Unknown,Olalde et al. 2019,0,n/a (female),96.5,fasta,10398G;11467G;12308G;12372A;9055A,10398;11467;12308;12372;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+,-;+
I3486,I3486,Spain,,,Spain_EBA,,Spain_EBA,,38.6314,-0.8615,M,"Valencian Community, Alacant/Alicante, Villena, Cabezo Redondo",,H1q,..,,,1750-1500 BCE,,Unknown,Olalde et al. 2019,0,..,558,fasta,3010A,3010,MT-RNR2,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor,Reported,+,-
I3487,I3487,Spain,,,Spain_EBA,,Spain_EBA,,38.6314,-0.8615,M,"Valencian Community, Alacant/Alicante, Villena, Cabezo Redondo",,H1e1a,..,-3365.0,-3325.0,"1739-1546 calBCE (3365±20 BP, PSUAMS-2161)",3365,Unknown,Olalde et al. 2019,0,..,136,fasta,3010A;5460A,3010;5460,MT-RNR2;MT-ND2,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;AD / PD / LHON,Reported;Conflicting reports,+,-;+
I3488,I3488,Spain,,,Spain_EBA,,Spain_EBA,,38.6314,-0.8615,M,"Valencian Community, Alacant/Alicante, Villena, Cabezo Redondo",,HV0+195,..,,,1750-1500 BCE,,Unknown,Olalde et al. 2019,0,..,1430,fasta,195C,195,MT-CR,BD-associated / melanoma pts,Reported,+,+
I3490,I3490,Spain,,,Spain_EBA,,Spain_EBA,,41.7412,-3.8744,F,"Burgos, La Horra",,HV0b,n/a (female),,,1850-1150 BCE,,Unknown,Olalde et al. 2019,0,n/a (female),462,fasta,195C,195,MT-CR,BD-associated / melanoma pts,Reported,+,+
I3491,I3491,Spain,,,Spain_EBA,,Spain_EBA,,41.6565,-4.6695,F,"Castilla y León, Valladolid, Fuente la Mora",,T2b,n/a (female),,,1850-1150 BCE,,Unknown,Olalde et al. 2019,0,n/a (female),130,fasta,11251G;15928A;4216C;4917G,11251;15928;4216;4917,MT-ND4;MT-TT;MT-ND1;MT-ND2,Reduced risk of PD;Multiple Sclerosis / idiopathic repeat miscarriage / AD protection;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;LHON / Insulin Resistance / AMD / NRTI-PN,Reported;Conflicting reports,nr;+,nr;-
I3492,I3492,Spain,,,Spain_EBA,,Spain_EBA,,40.8586,-5.3518,M,"Salamanca, Aldeaseca de la Frontera, Tordillos",,U5b1+16189,..,,,1850-1150 BCE,,Unknown,Olalde et al. 2019,0,..,101.134106,fasta,11467G;12308G;12372A;150T;16189C;16192T;16270T,11467;12308;12372;150;16189;16192;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Longevity / Cervical Carcinoma / HPV infection risk;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;Melanoma patients,Reported;Conflicting reports,+;nr,-;+;nr
I3494,I3494,Spain,,,Spain_EBA,,Spain_EBA,,38.8494,-0.87138,M,"Valencian Community, València/Valencia, La Font de la Figuera, Coveta del Frare",,J1c1b,..,-3515.0,-3455.0,"1928-1747 calBCE (3515±30 BP, CNA-1661.1.1)",3515,Unknown,Olalde et al. 2019,0,..,641,fasta,10398G;11251G;13708A;228A;295T;3010A;3394C;4216C;462T;489C,10398;11251;13708;228;295;3010;3394;4216;462;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-RNR2;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Low VO2max response;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;LHON / Diabetes / CPTdeficiency / high altitude adaptation;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports;Reported / Population-dependent,+;nr,-;nr;+
I3756,I3756,Spain,,,Spain_EBA,,Spain_EBA,,38.5781,-2.8417,M,"Ciudad Real, Terrinches, Castillejo del Bonete",,H1,..,-3565.0,-3515.0,"2017-1778 calBCE (3565±25 BP, PSUAMS-2077)",3565,Unknown,Olalde et al. 2019,0,..,264,fasta,3010A,3010,MT-RNR2,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor,Reported,+,-
I3997,I3997,Spain,,,Spain_EBA,,Spain_EBA,,39.526799,-0.509749,M,"Valencia, Paterna, Lloma de Betxí",,K1a2b,..,-3400.0,-3320.0,"1874-1544 calBCE (3400±40 BP, Beta-195318)",3400,Unknown,Olalde et al. 2019,0,..,158.361518,fasta,10398G;11467G;12308G;12372A;16093C;9055A,10398;11467;12308;12372;16093;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-CR;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Cyclic Vomiting Syndrome;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+;-,-;+
I4559,I4559,Spain,,,Spain_EBA,,Spain_EBA,,41.2916,1.0638,M,"Tarragona, Galls Carboners",,J1c1,..,,,1700-1500 BCE,,Unknown,Olalde et al. 2019,0,..,663.095419,fasta,10398G;11251G;13708A;228A;295T;3010A;3394C;4216C;462T;489C,10398;11251;13708;228;295;3010;3394;4216;462;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-RNR2;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Low VO2max response;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;LHON / Diabetes / CPTdeficiency / high altitude adaptation;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports;Reported / Population-dependent,+;nr,-;nr;+
I4560,I4560,Spain,,,Spain_EBA,,Spain_EBA,,41.2916,1.0638,F,"Tarragona, Galls Carboners",,K1a3a,n/a (female),,,1700-1500 BCE,,Unknown,Olalde et al. 2019,0,n/a (female),580.573903,fasta,10398G;11467G;12308G;12372A;9055A,10398;11467;12308;12372;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+,-;+
I4561,I4561,Spain,,,Spain_EBA,,Spain_EBA,,41.2916,1.0638,F,"Tarragona, Galls Carboners",,H84,n/a (female),,,1700-1500 BCE,,Unknown,Olalde et al. 2019,0,n/a (female),389.542278,fasta,,,,,,,
I4562,I4562,Spain,,,Spain_EBA,,Spain_EBA,,41.2916,1.0638,F,"Tarragona, Galls Carboners",,H1,n/a (female),-3375.0,-3335.0,"1741-1613 calBCE (3375±20 BP, PSUAMS-3191)",3375,Unknown,Olalde et al. 2019,0,n/a (female),193,fasta,3010A,3010,MT-RNR2,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor,Reported,+,-
I6470,I6470,Spain,,,Spain_EBA,,Spain_EBA,,42.725112,-3.84239,M,"Castilla y León, Ciempozuelos, Burgos, Tablada de Rudrón, Virgazal",,J1c1,R1b1a1b1a1a2a (R-DF27),-3375.0,-3305.0,"1746-1540 calBCE (3375±35 BP, Poz-49177)",3375,Unknown,Olalde et al. 2019,0,R-L151 > P312 > DF27 > ZZ12 > Y30817,1012.714044,fasta,10398G;11251G;13708A;185A;295T;3010A;3394C;4216C;462T;489C,10398;11251;13708;185;295;3010;3394;4216;462;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-RNR2;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Low VO2max response;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;LHON / Diabetes / CPTdeficiency / high altitude adaptation;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports;Reported / Population-dependent,+;nr,-;nr;+
I6618,I6618,Spain,,,Spain_EBA,,Spain_EBA,,40.22,-3.76,M,"Madrid, Humanejos",,U5b3,..,-3458.0,-3410.0,"1880-1691 calBCE (3458±24 BP, MAMS-32475)",3458,Unknown,Olalde et al. 2019,0,..,504.086547,fasta,11467G;12308G;12372A;150T;16192T;16270T;228A,11467;12308;12372;150;16192;16270;228,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Longevity / Cervical Carcinoma / HPV infection risk;Melanoma patients;Low VO2max response,Reported;Conflicting reports,+;nr,-;+;nr
I8136,I8136,Spain,,,Spain_EBA,,Spain_EBA,,37.7263,-2.5141,F,"Granada, Orce",,K1b1a1,n/a (female),-3216.0,-3150.0,"1534-1422 calBCE (3216±33 BP, Ua-39408)",3216,39408,Olalde et al. 2019,0,n/a (female),54.3,fasta,10398G;11467G;12308G;12372A;13967T;15257A;16093C;5913A;9055A,10398;11467;12308;12372;13967;15257;16093;5913;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-CYB;MT-CR;MT-CO1;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Possible LHON factor;LHON;Cyclic Vomiting Syndrome;Prostate Cancer / hypertension;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports,+;-,-;+
I8144,I8144,Spain,,,Spain_EBA,,Spain_EBA,,37.7263,-2.5141,F,"Granada, Orce",,U5b3f,n/a (female),-3426.0,-3358.0,"1876-1622 calBCE (3426±34 BP, Ua-39403)",3426,39403,Olalde et al. 2019,0,n/a (female),21,fasta,11467G;12308G;12372A;150T;16129A;16192T;16270T;228A,11467;12308;12372;150;16129;16192;16270;228,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Longevity / Cervical Carcinoma / HPV infection risk;Cyclic Vomiting Syndrome with Migraine;Melanoma patients;Low VO2max response,Reported;Conflicting reports,+;-;nr,-;+;nr
VAD001,VAD001,Spain,,,Spain_EBA,,Spain_EBA,,42.44,-2.8867,M,"La Rioja, Hervías, Valdescusa",,U5b1,..,-3400.0,-3330.0,"1872-1547 calBCE (3400±35 BP, Ua-36345)",3400,36345,Olalde et al. 2019,0,..,..,fasta,,,,,,,
VAD002,VAD002,Spain,,,Spain_EBA,,Spain_EBA,,42.44,-2.8867,M,"La Rioja, Hervías, Valdescusa",,J2b1a2,..,,,1900-1500 BCE,,Unknown,Olalde et al. 2019,0,..,..,fasta,,,,,,,
VAD003,VAD003,Spain,,,Spain_EBA,,Spain_EBA,,42.44,-2.8867,F,"La Rioja, Hervías, Valdescusa",,HV0,n/a (female),,,1900-1500 BCE,,Unknown,Olalde et al. 2019,0,n/a (female),..,fasta,,,,,,,
VAD004,VAD004,Spain,,,Spain_EBA,,Spain_EBA,,42.44,-2.8867,M,"La Rioja, Hervías, Valdescusa",,J1c3,..,,,1900-1500 BCE,,Unknown,Olalde et al. 2019,0,..,..,fasta,,,,,,,
VAD005,VAD005,Spain,,,Spain_EBA,,Spain_EBA,,42.44,-2.8867,M,"La Rioja, Hervías, Valdescusa",,J2b1a2,..,-3360.0,-3300.0,"1740-1539 calBCE (3360±30 BP, Beta-479535)",3360,Unknown,Olalde et al. 2019,0,..,..,fasta,,,,,,,
I4558,I4558,Spain,,,Spain_EBA_oNorthEurope_1d.rel.I4560,,Spain_EBA_oNorthEurope_1d.rel.I4560,,41.2916,1.0638,F,"Tarragona, Galls Carboners",,K1a3a,n/a (female),,,1700-1500 BCE,,Unknown,Olalde et al. 2019,0,n/a (female),462.172189,fasta,10398G;11467G;12308G;12372A;9055A,10398;11467;12308;12372;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+,-;+
I4563,I4563,Spain,,,Spain_EBA_1d.rel.I4561,,Spain_EBA_1d.rel.I4561,,41.2916,1.0638,M,"Tarragona, Galls Carboners",,H84,..,,,1700-1500 BCE,,Unknown,Olalde et al. 2019,0,..,310.434003,fasta,,,,,,,
I7162,I7162,Spain,,,Spain_EBA_Africa,,Spain_EBA_Africa,,36.391401,-6.168503,F,"Andalusia, Cádiz, Chiclana de la Frontera, Loma del Puerco",,T2e,n/a (female),-3483.0,-3449.0,"1881-1744 calBCE (3483±17 BP) [R_combine: (3524±30 BP, CNA4237.1.1); (3465±20 BP, PSUAMS-4262)]",3483,Unknown,Olalde et al. 2019,0,n/a (female),27.5,fasta,11251G;150T;15928A;4216C;4917G,11251;150;15928;4216;4917,MT-ND4;MT-CR;MT-TT;MT-ND1;MT-ND2,Reduced risk of PD;Longevity / Cervical Carcinoma / HPV infection risk;Multiple Sclerosis / idiopathic repeat miscarriage / AD protection;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;LHON / Insulin Resistance / AMD / NRTI-PN,Reported;Conflicting reports,nr;+,nr;+;-
I1311,I1311,Spain,,,Spain_EBA_lc,,Spain_EBA_lc,,41.5373,2.1329,F,"Barcelona, Sabadell, Can Roquetes",,J2b1a,n/a (female),,,2000-1400 BCE,,Unknown,Olalde et al. 2019,0,n/a (female),33.8,fasta,10398G;11251G;13708A;150T;15257A;15812A;295T;4216C;489C,10398;11251;13708;150;15257;15812;295;4216;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-CYB;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Longevity / Cervical Carcinoma / HPV infection risk;LHON;Low VO2max response;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports;Reported / Secondary,+;nr,-;nr;+
I12171,I12171,Spain,,,Spain_EIA_Tartessian,,Spain_EIA_Tartessian,,37.51833,-5.97833,F,"Andalusia, Sevilla, Alcalá del Río, La Angorrilla",,J1c1b,n/a (female),-2520.0,-2480.0,"779-549 calBCE (2520±20 BP, PSUAMS-9549)",2520,Unknown,Patterson et al. 2021,0,n/a (female),35.599916,fasta,10398G;11251G;13708A;185A;228A;295T;3010A;3394C;4216C;462T;489C,10398;11251;13708;185;228;295;3010;3394;4216;462;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-RNR2;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Low VO2max response;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;LHON / Diabetes / CPTdeficiency / high altitude adaptation;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports;Reported / Population-dependent,+;nr,-;nr;+
ElMiron,ElMiron_d,Spain,,,Spain_ElMiron,,Spain_ElMiron,,43.26,-3.45,F,El Miron,,U5b,n/a (female),-5460.0,-5380.0,"16898-16747 calBCE (15460±40 BP, MAMS-14585)",5460,Unknown,Fu et al. 2016,0,n/a (female),..,fasta,,,,,,,
I0409,I0409,Spain,,,Spain_EN,,Spain_EN,,42.5,0.5,F,Els Trocs,,J1c3,n/a (female),-6280.0,-6230.0,"5312-5212 calBCE (6280±25 BP, MAMS-16159)",6280,Unknown,Mathieson et al. 2015,0,n/a (female),521.130123,fasta,10398G;11251G;13708A;185A;228A;295T;3010A;4216C;462T;489C,10398;11251;13708;185;228;295;3010;4216;462;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-RNR2;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Low VO2max response;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports,+;nr,-;nr;+
I0410,I0410,Spain,,,Spain_EN,,Spain_EN,,42.5,0.5,M,Els Trocs,,T2c1d+152,R1b1a ,-6217.0,-6167.0,"5298-5057 calBCE (6217±25 BP, MAMS-16161)",6217,Unknown,Mathieson et al. 2015,0,..,353.211902,fasta,11251G;146C;15928A;4216C;4917G;6261A,11251;146;15928;4216;4917;6261,MT-ND4;MT-CR;MT-TT;MT-ND1;MT-ND2;MT-CO1,Reduced risk of PD;Absence of Endometriosis;Multiple Sclerosis / idiopathic repeat miscarriage / AD protection;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;LHON / Insulin Resistance / AMD / NRTI-PN;Prostate Cancer / LHON,Reported;Conflicting reports,nr;+,nr;-
I0412,I0412,Spain,,,Spain_EN,,Spain_EN,,42.5,0.5,M,Els Trocs,,N1a1a1,..,-6249.0,-6193.0,"5309-5073 calBCE (6249±28 BP, MAMS-16164)",6249,Unknown,Mathieson et al. 2015,0,..,831.404551,fasta,10398G;12705T;15043A;3336C;669C,10398;12705;15043;3336;669,MT-ND3;MT-CO1;MT-CYB;MT-ND1;MT-RNR1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Possible protective factor for normal tension glaucoma;MDD-associated;Carotid atherosclerosis risk;DEAF,Reported / lineage L & M marker / also hg IJK;Reported,+;<NA>;-,-;<NA>;+
I0413,I0413,Spain,,,Spain_EN,,Spain_EN,,42.5,0.5,F,Els Trocs,,V,n/a (female),-6234.0,-6178.0,"5304-5065 calBCE (6234±28 BP, MAMS-16166)",6234,Unknown,Mathieson et al. 2015,0,n/a (female),596.214738,fasta,,,,,,,
I1972,I1972,Spain,,,Spain_EN,,Spain_EN,,42.6282,-3.11649,F,"Burgos, El Prado de Pancorbo",,K1a4a1,n/a (female),-5880.0,-5820.0,"4836-4687 calBCE (5880±30 BP, Beta-366569)",5880,Unknown,Lipson et al. 2017,0,n/a (female),438,fasta,10398G;11467G;12308G;12372A;9055A,10398;11467;12308;12372;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+,-;+
I2199,I2199,Spain,,,Spain_EN,,Spain_EN,,42.6282,-3.11649,F,"Burgos, El Prado de Pancorbo",,H1,n/a (female),-6170.0,-6110.0,"5214-5015 calBCE (6170±30 BP, Beta-438208)",6170,Unknown,Lipson et al. 2017,0,n/a (female),273,fasta,3010A,3010,MT-RNR2,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor,Reported,+,-
CB13,CB13_noUDG.SG,Spain,,,Spain_EN.SG,,Spain_EN.SG,,41.37,1.89,F,"Cova Bonica, Vallirana, Barcelona",,K1a2a,n/a (female),-6410.0,-6350.0,"5474-5318 calBCE (6410±30 BP, Beta-384724)",6410,Unknown,Olalde et al. 2015,0,n/a (female),..,fasta,,,,,,,
I8215,I8215,Spain,,,Spain_Greek_oAegean,,Spain_Greek_oAegean,,42.1333,3.1083,F,"Girona, Empuries, necropolis Centre de Visitants",,HV11,n/a (female),-2445.0,-2415.0,"746-415 calBCE (2445±15 BP, PSUAMS-8174)",2445,Unknown,Olalde et al. 2019,0,n/a (female),..,fasta,,,,,,,
I8209,I8209,Spain,,,Spain_Greek_oLocal,,Spain_Greek_oLocal,,42.1333,3.1083,M,"Girona, Empuries, necropolis Centre de Visitants",,U1a1a,..,-2455.0,-2415.0,"752-417 calBCE (2455±20 BP, PSUAMS-8221)",2455,Unknown,Olalde et al. 2019,0,..,..,fasta,11467G;12308G;12372A;16189C,11467;12308;12372;16189,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients,Reported,+,-;+
I8210,I8210,Spain,,,Spain_Greek_oLocal,,Spain_Greek_oLocal,,42.1333,3.1083,M,"Girona, Empuries, necropolis Centre de Visitants",,U5b3,..,,,500-350 BCE,,Unknown,Olalde et al. 2019,0,..,..,fasta,11467G;12308G;12372A;150T;16192T;16270T,11467;12308;12372;150;16192;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Longevity / Cervical Carcinoma / HPV infection risk;Melanoma patients,Reported;Conflicting reports,+;nr,-;+;nr
I8211,I8211,Spain,,,Spain_Greek_oLocal,,Spain_Greek_oLocal,,42.1333,3.1083,M,"Girona, Empuries, necropolis Centre de Visitants",,HV0+195,..,,,500-450 BCE,,Unknown,Olalde et al. 2019,0,..,..,fasta,195C,195,MT-CR,BD-associated / melanoma pts,Reported,+,+
I8212,I8212,Spain,,,Spain_Greek_oLocal,,Spain_Greek_oLocal,,42.1333,3.1083,M,"Girona, Empuries, necropolis Centre de Visitants",,H27+16093,..,,,500-350 BCE,,Unknown,Olalde et al. 2019,0,..,..,fasta,16093C;16129A,16093;16129,MT-CR,Cyclic Vomiting Syndrome;Cyclic Vomiting Syndrome with Migraine,Reported,-,+
I8214,I8214,Spain,,,Spain_Greek_oLocal,,Spain_Greek_oLocal,,42.1333,3.1083,F,"Girona, Empuries, necropolis Centre de Visitants",,H3+152,n/a (female),,,500-350 BCE,,Unknown,Olalde et al. 2019,0,n/a (female),..,fasta,,,,,,,
I8340,I8340,Spain,,,Spain_Greek_oLocal,,Spain_Greek_oLocal,,42.1333,3.1083,F,"Girona, Empuries, necropolis Centre de Visitants",,K1a+195,n/a (female),,,500-350 BCE,,Unknown,Olalde et al. 2019,0,n/a (female),93.3,fasta,10398G;11467G;12308G;12372A;16093C;195C;9055A,10398;11467;12308;12372;16093;195;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-CR;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Cyclic Vomiting Syndrome;BD-associated / melanoma pts;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+;-,-;+
I8341,I8341,Spain,,,Spain_Greek_oLocal,,Spain_Greek_oLocal,,42.1333,3.1083,M,"Girona, Empuries, necropolis Centre de Visitants",,H1,..,,,500-350 BCE,,Unknown,Olalde et al. 2019,0,..,110,fasta,16189C;3010A,16189;3010,MT-CR;MT-RNR2,Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor,Reported,+,-
I8344,I8344,Spain,,,Spain_Greek_oLocal,,Spain_Greek_oLocal,,42.1333,3.1083,M,"Girona, Empuries, necropolis Centre de Visitants",,H3,..,,,500-400 BCE,,Unknown,Olalde et al. 2019,0,..,178,fasta,,,,,,,
I8213,I8213,Spain,,,Spain_Greek_oLocal_lc,,Spain_Greek_oLocal_lc,,42.1333,3.1083,F,"Girona, Empuries, necropolis Centre de Visitants",,K2a,n/a (female),,,500-400 BCE,,Unknown,Olalde et al. 2019,0,n/a (female),..,fasta,11467G;12308G;12372A;146C;9055A,11467;12308;12372;146;9055,MT-ND4;MT-TL2;MT-ND5;MT-CR;MT-ATP6,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Absence of Endometriosis;PD protective factor,Reported,+,-;+
I8205,I8205,Spain,,,Spain_Hellenistic_oAegean,,Spain_Hellenistic_oAegean,,42.1333,3.1083,M,"Girona, Empuries, necropolis Centre de Visitants",,H14a2c,..,,,300-100 BCE,,Unknown,Olalde et al. 2019,0,..,..,fasta,,,,,,,
I8208,I8208,Spain,,,Spain_Hellenistic_oAegean,,Spain_Hellenistic_oAegean,,42.1333,3.1083,M,"Girona, Empuries, necropolis Centre de Visitants",,H33,..,-2220.0,-2180.0,"376-201 calBCE (2220±20 BP, PSUAMS-4277)",2220,Unknown,Olalde et al. 2019,0,..,..,fasta,,,,,,,
I8203,I8203,Spain,,,Spain_Hellenistic_oLocal,,Spain_Hellenistic_oLocal,,42.1333,3.1083,F,"Girona, Empuries, necropolis Centre de Visitants",,H13a1a1,n/a (female),,,300-100 BCE,,Unknown,Olalde et al. 2019,0,n/a (female),..,fasta,,,,,,,
I8206,I8206,Spain,,,Spain_Hellenistic_oLocal,,Spain_Hellenistic_oLocal,,42.1333,3.1083,M,"Girona, Empuries, necropolis Centre de Visitants",,H7a1,..,-2130.0,-2100.0,"340-57 calBCE (2130±15 BP, PSUAMS-8173)",2130,Unknown,Olalde et al. 2019,0,..,..,fasta,,,,,,,
I8204,I8204,Spain,,,Spain_Hellenistic_oMixed,,Spain_Hellenistic_oMixed,,42.1333,3.1083,F,"Girona, Empuries, necropolis Centre de Visitants",,H1e,n/a (female),-2155.0,-2125.0,"350-111 calBCE (2155±15 BP, PSUAMS-8172)",2155,Unknown,Olalde et al. 2019,0,n/a (female),..,fasta,,,,,,,
I3209,I3209,Spain,,,Spain_HG,,Spain_HG,,40.41819566,-0.11675,M,"Valencian Community, Castelló/Castellón, Ares del Maestre, Cingle del Mas Nou",,U5b1d1,..,-6980.0,-6930.0,"5978-5773 calBCE (6980±25 BP, PSUAMS-4414)",6980,Unknown,Olalde et al. 2019,0,..,4.466353,fasta,150T;16270T;12372A;11467G,150;16270;12372;11467,MT-CR;MT-ND5;MT-ND4,Longevity / Cervical Carcinoma / HPV infection risk;Melanoma patients;Altered brain pH / sCJD patients,Conflicting reports;Reported,+;nr,+;nr;-
I0843,I0843,Spain,,,Spain_HG_brother.I0585,,Spain_HG_brother.I0585,,42.911,-5.3778,M,"Castilla y León, León, La Brana-Arintero",,U5b2c1,..,-7030.0,-6930.0,"6015-5789 calBCE (7030±50 BP, Beta-226473)",7030,Unknown,Olalde et al. 2019,0,..,138,fasta,11467G;12308G;12372A;13637G;150T;16192T;16270T,11467;12308;12372;13637;150;16192;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Possible LHON factor;Longevity / Cervical Carcinoma / HPV infection risk;Melanoma patients,Reported;Conflicting reports,+;nr,-;+;nr
I8130,I8130,Spain,,,Spain_HG_lc,,Spain_HG_lc,,39.79,-1.033333,M,"Valencian Community, València/Valencia, Dos Aguas, Cueva de la Cocina",,U5b2b,..,-7135.0,-7085.0,"6064-5926 calBCE (7135±25 BP, PSUAMS-4429)",7135,Unknown,Olalde et al. 2019,0,..,15,fasta,11467G;12308G;12372A;12634G;13637G;150T;16270T,11467;12308;12372;12634;13637;150;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Thyroid Cancer Cell Line;Possible LHON factor;Longevity / Cervical Carcinoma / HPV infection risk;Melanoma patients,Reported;Conflicting reports,+;nr,-;+;nr
I10899,I10899_d,Spain,,,Spain_HG,,Spain_HG,,37.439437,-3.437567,M,"Andalusia, Piñar, Granada, Cueva de la Carigüela",,U5b1,..,,,40000-5000 BCE,,Unknown,Olalde et al. 2019,0,..,112.678556,fasta,11467G;12308G;12372A;150T;16192T;16270T,11467;12308;12372;150;16192;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Longevity / Cervical Carcinoma / HPV infection risk;Melanoma patients,Reported;Conflicting reports,+;nr,-;+;nr
I10899,I10899,Spain,,,Spain_HG_contam,,Spain_HG_contam,,37.439437,-3.437567,M,"Andalusia, Piñar, Granada, Cueva de la Carigüela",,U5b1,..,,,40000-5000 BCE,,Unknown,Olalde et al. 2019,0,..,112.7,fasta,11467G;12308G;12372A;150T;16192T;16270T,11467;12308;12372;150;16192;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Longevity / Cervical Carcinoma / HPV infection risk;Melanoma patients,Reported;Conflicting reports,+;nr,-;+;nr
I12410,I12410,Spain,,,Spain_IA,,Spain_IA,,41.3616,1.6694,M,"Catalonia, Barcelona, Pacs del Penedès, Mas d'en Boixos-1",,H,..,-2350.0,-2290.0,"537-381 calBCE (2350±30 BP, Beta-495153)",2350,Unknown,Olalde et al. 2019,0,..,648.4,fasta,,,,,,,
I12640,I12640,Spain,,,Spain_IA,,Spain_IA,,41.5373,2.1329,M,"Barcelona, Can Roqueta-Can Revella",,H1t,..,,,700-500 BCE,,Unknown,Olalde et al. 2019,0,..,16.57,fasta,3010A,3010,MT-RNR2,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor,Reported,+,-
I12641,I12641,Spain,,,Spain_IA,,Spain_IA,,41.5373,2.1329,M,"Barcelona, Can Roqueta-Can Revella",,HV0d,..,-2510.0,-2450.0,"786-541 calBCE (2510±30 BP, Beta-449093)",2510,Unknown,Olalde et al. 2019,0,..,62.06,fasta,195C,195,MT-CR,BD-associated / melanoma pts,Reported,+,+
I12877,I12877,Spain,,,Spain_IA,,Spain_IA,,41.3616,1.6694,M,"Barcelona, Pacs del Penedès, Mas d'en Boixos-1",,J1c1,..,,,550-350 BCE,,Unknown,Olalde et al. 2019,0,..,41.54,fasta,10398G;11251G;13708A;185A;228A;295T;3010A;3394C;4216C;462T;489C,10398;11251;13708;185;228;295;3010;3394;4216;462;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-RNR2;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Low VO2max response;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;LHON / Diabetes / CPTdeficiency / high altitude adaptation;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports;Reported / Population-dependent,+;nr,-;nr;+
I12878,I12878,Spain,,,Spain_IA,,Spain_IA,,41.3616,1.6694,F,"Barcelona, Pacs del Penedès, Mas d'en Boixos-1",,H3,n/a (female),-2340.0,-2280.0,"516-364 calBCE (2340±30 BP, Beta-495155)",2340,Unknown,Olalde et al. 2019,0,n/a (female),74.15,fasta,,,,,,,
I12879,I12879,Spain,,,Spain_IA,,Spain_IA,,41.3324,1.5943,F,"Barcelona, Castellví de la Marca, Hort d'en Grimau",,HV0+195,n/a (female),-2390.0,-2330.0,"725-394 calBCE (2390±30 BP, Beta-495156)",2390,Unknown,Olalde et al. 2019,0,n/a (female),364.7,fasta,195C,195,MT-CR,BD-associated / melanoma pts,Reported,+,+
I3320,I3320,Spain,,,Spain_IA,,Spain_IA,,40.138,-0.07,M,"Valencian Community, Castelló/Castellón, Vilafamés, Els Estrets de la Rata",,I1,..,,,300-100 BCE,,Unknown,Patterson et al. 2021,0,..,1554.916833,fasta,10398G;12705T;15043A;15924G;16129A;9966A,10398;12705;15043;15924;16129;9966,MT-ND3;MT-CO1;MT-CYB;MT-TT;MT-CR;MT-CO3,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Possible protective factor for normal tension glaucoma;MDD-associated;LIMM;Cyclic Vomiting Syndrome with Migraine;LHON possible helper variant,Reported / lineage L & M marker / also hg IJK;Reported,+;<NA>;nr;-,-;<NA>;nr;+
I3321,I3321_d,Spain,,,Spain_IA,,Spain_IA,,40.138,-0.07,M,"Valencian Community, Castelló/Castellón, Vilafamés, Els Estrets de la Rata",,U3a1,..,,,300-100 BCE,,Unknown,Patterson et al. 2021,0,..,82.807955,fasta,11467G;12308G;12372A;150T;16390A;3010A,11467;12308;12372;150;16390;3010,MT-ND4;MT-TL2;MT-ND5;MT-CR;MT-RNR2,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Longevity / Cervical Carcinoma / HPV infection risk;POAG - potential for association;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor,Reported;Conflicting reports,+,-;+
I3322,I3322,Spain,,,Spain_IA,,Spain_IA,,40.5067,0.4314,F,"Valencian Community, Castelló/Castellón, Vinaròs, Puig de la Misericordia",,H1t,n/a (female),,,600-500 BCE,,Unknown,Olalde et al. 2019,0,n/a (female),632,fasta,3010A,3010,MT-RNR2,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor,Reported,+,-
I3323,I3323,Spain,,,Spain_IA,,Spain_IA,,42.006615,3.078667,M,"Girona, Ullastret, Puig de Sant Andreu",,X2b,..,-2215.0,-2175.0,"373-199 calBCE (2215±20 BP, PSUAMS-2158)",2215,Unknown,Olalde et al. 2019,0,..,424.543364,fasta,12705T;13708A;15927A;16189C;195C;8393T,12705;13708;15927;16189;195;8393,MT-CO1;MT-ND5;MT-TT;MT-CR;MT-ATP8,Possible protective factor for normal tension glaucoma;LHON / Increased MS risk / higher freq in PD-ADS;LHON / Multiple Sclerosis / DEAF1555 increased penetrance / CHD;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;BD-associated / melanoma pts;Reversible brain pseudoatrophy,Reported;Conflicting reports,<NA>;+;-,<NA>;+;-
I3327,I3327,Spain,,,Spain_IA,,Spain_IA,,42.006615,3.078667,M,"Girona, Ullastret, Puig de Sant Andreu",,J2b1a,..,,,250-200 BCE,,Unknown,Olalde et al. 2019,0,..,411.165188,fasta,10398G;11251G;13708A;150T;15257A;15812A;295T;4216C;489C,10398;11251;13708;150;15257;15812;295;4216;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-CYB;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Longevity / Cervical Carcinoma / HPV infection risk;LHON;Low VO2max response;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports;Reported / Secondary,+;nr,-;nr;+
I4556,I4556,Spain,,,Spain_IA,,Spain_IA,,41.370876,1.774193,F,"Catalonia, Barcelona, Avinyonet del Penedés, Font de la Canya",,K1a12a,n/a (female),,,700-500 BCE,,Unknown,Olalde et al. 2019,0,n/a (female),1347.940552,fasta,10398G;11467G;12308G;12372A;16093C;5460A;9055A,10398;11467;12308;12372;16093;5460;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-CR;MT-ND2;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Cyclic Vomiting Syndrome;AD / PD / LHON;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports,+;-,-;+
I3758,I3758,Spain,,,Spain_IA_Celt,,Spain_IA_Celt,,42.565,-2.58635,F,"Basque Country, Araba/Álava, Laguardia, La Hoya",,U5b1+16189+@16192,n/a (female),-2215.0,-2175.0,"373-199 calBCE (2215±20 BP, PSUAMS-3466)",2215,Unknown,Olalde et al. 2019,0,n/a (female),34.461947,fasta,11467G;12308G;12372A;150T;16189C;16270T,11467;12308;12372;150;16189;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Longevity / Cervical Carcinoma / HPV infection risk;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;Melanoma patients,Reported;Conflicting reports,+;nr,-;+;nr
I3759,I3759,Spain,,,Spain_IA_Celt,,Spain_IA_Celt,,42.565,-2.58635,M,"Basque Country, Araba/Álava, Laguardia, La Hoya",,H1,..,-2195.0,-2145.0,"361-173 calBCE (2195±25 BP, PSUAMS-2078)",2195,Unknown,Olalde et al. 2019,0,..,291,fasta,3010A,3010,MT-RNR2,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor,Reported,+,-
I3757,I3757,Spain,,,Spain_IA_Celt_o,,Spain_IA_Celt_o,,42.565,-2.58635,F,"Basque Country, Araba/Álava, Laguardia, La Hoya",,J1c1,n/a (female),,,400-300 BCE,,Unknown,Olalde et al. 2019,0,n/a (female),303.527612,fasta,10398G;11251G;13708A;185A;228A;295T;3010A;3394C;4216C;462T;489C,10398;11251;13708;185;228;295;3010;3394;4216;462;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-RNR2;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Low VO2max response;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;LHON / Diabetes / CPTdeficiency / high altitude adaptation;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports;Reported / Population-dependent,+;nr,-;nr;+
I12642,I12642,Spain,,,Spain_IA_lc,,Spain_IA_lc,,41.5373,2.1329,F,"Barcelona, Can Roqueta II",,H,n/a (female),-2400.0,-2340.0,"733-397 calBCE (2400±30 BP, Beta 463858)",2400,Unknown,Olalde et al. 2019,0,n/a (female),168,fasta,,,,,,,
I12643,I12643,Spain,,,Spain_IA_lc,,Spain_IA_lc,,41.5373,2.1329,F,"Barcelona, Can Roqueta II",,J2a1a1c,n/a (female),-2460.0,-2400.0,"758-416 calBCE (2460±30 BP, Beta 449091)",2460,Unknown,Olalde et al. 2019,0,n/a (female),46.63,fasta,10398G;11251G;13708A;150T;15257A;195C;295T;4216C;489C,10398;11251;13708;150;15257;195;295;4216;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-CYB;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Longevity / Cervical Carcinoma / HPV infection risk;LHON;BD-associated / melanoma pts;Low VO2max response;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports,+;nr,-;nr;+
I3324,I3324,Spain,,,Spain_IA_o,,Spain_IA_o,,42.006615,3.078667,M,"Girona, Ullastret, Puig de Sant Andreu",,H1,..,-2190.0,-2150.0,"359-172 calBCE (2190±20 BP, PSUAMS-2159)",2190,Unknown,Olalde et al. 2019,0,..,577,fasta,3010A,3010,MT-RNR2,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor,Reported,+,-
I3326,I3326,Spain,,,Spain_IA_o,,Spain_IA_o,,42.006615,3.078667,M,"Girona, Ullastret, Puig de Sant Andreu",,J1c,..,,,250-200 BCE,,Unknown,Olalde et al. 2019,0,..,34.019675,fasta,10398G;11251G;13708A;185A;228A;295T;3010A;4216C;462T;489C,10398;11251;13708;185;228;295;3010;4216;462;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-RNR2;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Low VO2max response;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports,+;nr,-;nr;+
I3321,I3321,Spain,,,Spain_IA,,Spain_IA,,40.138,-0.07,M,"Valencian Community, Castelló/Castellón, Vilafamés, Els Estrets de la Rata",,U3a1,R1b1a1a2a1a2,,,300-100 BCE,,Unknown,Olalde et al. 2019,0,..,..,fasta,11467G;12308G;12372A;150T;16390A;3010A,11467;12308;12372;150;16390;3010,MT-ND4;MT-TL2;MT-ND5;MT-CR;MT-RNR2,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Longevity / Cervical Carcinoma / HPV infection risk;POAG - potential for association;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor,Reported;Conflicting reports,+,-;+
I3496,I3496,Spain,,,Spain_IA,,Spain_IA,,41.4966,2.14694,U,"Barcelona, Cerdanyola, Can Olivé",,H1,n/a  (sex unknown),,,300-200 BCE,,Unknown,Olalde et al. 2019,0,n/a  (sex unknown),105.278411,fasta,3010A;5460A,3010;5460,MT-RNR2;MT-ND2,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;AD / PD / LHON,Reported;Conflicting reports,+,-;+
I12561,I12561,Spain,,,Spain_IA_Tartessian,,Spain_IA_Tartessian,,37.51833,-5.97833,M,"Sevilla, Alcalá del Río, La Angorrilla",,H1,..,,,700-500 BCE,,Unknown,Olalde et al. 2019,0,..,..,fasta,3010A,3010,MT-RNR2,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor,Reported,+,-
I12560,I12560,Spain,,,Spain_IA_Tartessian_lc,,Spain_IA_Tartessian_lc,,37.51833,-5.97833,F,"Sevilla, Alcalá del Río, La Angorrilla",,H4a1,n/a (female),,,700-500 BCE,,Unknown,Olalde et al. 2019,0,n/a (female),3.982,fasta,14582G,14582,MT-ND6,LHON synergistic combo 14258A + 14582G,Reported: individually neutral variants causing LHON in combination,+,-
I12173,I12173,Spain,,,Spain_IA_Tartessian_lc,,Spain_IA_Tartessian_lc,,37.51833,-5.97833,F,"Andalusia, Sevilla, Alcalá del Río, La Angorrilla",,T2b23,n/a (female),,,700-500 BCE,,Unknown,Olalde et al. 2019,0,n/a (female),3.144,fasta,4917G;4216C;11251G,4917;4216;11251,MT-ND2;MT-ND1;MT-ND4,LHON / Insulin Resistance / AMD / NRTI-PN;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;Reduced risk of PD,Reported;Conflicting reports,+;nr,-;nr
I12514,I12514,Spain,,,Spain_Islamic,,Spain_Islamic,,39.9333,-0.2,M,"Valencian Community, Castelló/Castellón, Betxí, Palau Castell de Betxí",,HV0+195,..,,,"1025-1160 calCE (960±30 BP, Beta-459794)",,Unknown,Olalde et al. 2019,0,..,402.7,fasta,195C,195,MT-CR,BD-associated / melanoma pts,Reported,+,+
I12515,I12515,Spain,,,Spain_Islamic,,Spain_Islamic,,39.9333,-0.2,M,"Valencian Community, Castelló/Castellón, Betxí, Palau Castell de Betxí",,H3,..,,,1100-1300 CE,,Unknown,Olalde et al. 2019,0,..,221.6,fasta,961C,961,MT-RNR1,DEAF / possibly LVNC-associated,Unclear,+,-
I12516,I12516,Spain,,,Spain_Islamic,,Spain_Islamic,,40.4703,0.4756,F,"Valencian Community, Castelló/Castellón, Vinaròs, Plaza Parroquial",,U5b2b2,n/a (female),-1030.0,-970.0,"899-1147 calCE (1030±30 BP, Beta-372984)",1030,Unknown,Olalde et al. 2019,0,n/a (female),147.1,fasta,11467G;12308G;12372A;12634G;13637G;150T;16270T,11467;12308;12372;12634;13637;150;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Thyroid Cancer Cell Line;Possible LHON factor;Longevity / Cervical Carcinoma / HPV infection risk;Melanoma patients,Reported;Conflicting reports,+;nr,-;+;nr
I12644,I12644,Spain,,,Spain_Islamic,,Spain_Islamic,,39.4697,-0.3774,M,"Valencia, Carrer Sagunto 49",,U4a2,..,,,1100-1300 CE,,Unknown,Olalde et al. 2019,0,..,212.7,fasta,11467G;12308G;12372A;15693C;195C;310C;499A,11467;12308;12372;15693;195;310;499,MT-ND4;MT-TL2;MT-ND5;MT-CYB;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Possibly LVNC cardiomyopathy-associated;BD-associated / melanoma pts;Possible protective factor for normal tension glaucoma;Endometriosis,Reported,+;<NA>,-;+;<NA>
I12645,I12645,Spain,,,Spain_Islamic,,Spain_Islamic,,39.4697,-0.3774,F,"Valencia, Carrer Sagunto 49",,U5b1f1a,n/a (female),,,1100-1300 CE,,Unknown,Olalde et al. 2019,0,n/a (female),96.09,fasta,11467G;12308G;12372A;150T;16192T;16270T,11467;12308;12372;150;16192;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Longevity / Cervical Carcinoma / HPV infection risk;Melanoma patients,Reported;Conflicting reports,+;nr,-;+;nr
I12647,I12647,Spain,,,Spain_Islamic,,Spain_Islamic,,39.4697,-0.3774,F,"Valencia, Carrer Sagunto 49",,H1ak1,n/a (female),,,1100-1300 CE,,Unknown,Olalde et al. 2019,0,n/a (female),151.6,fasta,3010A,3010,MT-RNR2,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor,Reported,+,-
I12648,I12648,Spain,,,Spain_Islamic,,Spain_Islamic,,39.4697,-0.3774,M,"Valencia, Carrer Sagunto 49",,H1,..,,,1100-1300 CE,,Unknown,Olalde et al. 2019,0,..,68.99,fasta,3010A,3010,MT-RNR2,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor,Reported,+,-
I12649,I12649,Spain,,,Spain_Islamic,,Spain_Islamic,,39.4697,-0.3774,M,"Valencia, Carrer Sagunto 49",,H13a1a,..,,,1100-1300 CE,,Unknown,Olalde et al. 2019,0,..,168.5,fasta,,,,,,,
I7457,I7457,Spain,,,Spain_Islamic_Almohade,,Spain_Islamic_Almohade,,37.0010611,-3.9930305,M,"Granada, Alhama de Granada, Casa Cuartel Guardia Civil",,H3+152,..,,,1100-1300 CE,,Unknown,Olalde et al. 2019,0,..,201,fasta,,,,,,,
I7458,I7458,Spain,,,Spain_Islamic_Almohade_lc,,Spain_Islamic_Almohade_lc,,37.0010611,-3.9930305,U,"Granada, Alhama de Granada, Casa Cuartel Guardia Civil",,H3ap,n/a  (sex unknown),,,1100-1300 CE,,Unknown,Olalde et al. 2019,0,n/a  (sex unknown),139,fasta,,,,,,,
I7500,I7500,Spain,,,Spain_Islamic_Emirate,,Spain_Islamic_Emirate,,36.7,-3.483333333,M,"Granada, Motril, Torrenueva, El Maraute",,M1b1a,..,,,900-1100 CE,,Unknown,Olalde et al. 2019,0,..,8.83,fasta,10398G;12705T;15043A;16129A;16189C;195C;489C,10398;12705;15043;16129;16189;195;489,MT-ND3;MT-CO1;MT-CYB;MT-CR,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Possible protective factor for normal tension glaucoma;MDD-associated;Cyclic Vomiting Syndrome with Migraine;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;BD-associated / melanoma pts;Low VO2max response,Reported / lineage L & M marker / also hg IJK;Reported,+;<NA>;-,-;<NA>;+
I12646,I12646,Spain,,,Spain_Islamic_lc,,Spain_Islamic_lc,,39.4697,-0.3774,M,"Valencia, Carrer Sagunto 49",,K2b1a1,..,,,1100-1300 CE,,Unknown,Olalde et al. 2019,0,..,132.8,fasta,11467G;12308G;12372A;13135A;146C;16270T;9055A,11467;12308;12372;13135;146;16270;9055,MT-ND4;MT-TL2;MT-ND5;MT-CR;MT-ATP6,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;possible HCM susceptibility;Absence of Endometriosis;Melanoma patients;PD protective factor,Reported,+;nr,-;+;nr
I7427,I7427,Spain,,,Spain_Islamic_oAfrica,,Spain_Islamic_oAfrica,,37.1825306,-3.592291667,M,"Granada, Calle Panaderos 21-23",,H1+16189,..,,,900-1000 CE,,Unknown,Olalde et al. 2019,0,..,..,fasta,16189C;3010A,16189;3010,MT-CR;MT-RNR2,Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor,Reported,+,-
I12650,I12650,Spain,,,Spain_Islamic_lc,,Spain_Islamic_lc,,39.4697,-0.3774,M,"Valencia, Carrer Sagunto 49",,H1e1a,..,,,1100-1300 CE,,Unknown,Olalde et al. 2019,0,..,16.99,fasta,3010A;5460A,3010;5460,MT-RNR2;MT-ND2,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;AD / PD / LHON,Reported;Conflicting reports,+,-;+
I7497,I7497,Spain,,,Spain_Islamic_Zira,,Spain_Islamic_Zira,,37.8071083,-2.543041667,F,"Granada, Huéscar, Cueva Romero",,H20a,n/a (female),,,1000-1100 CE,,Unknown,Olalde et al. 2019,0,n/a (female),114,fasta,,,,,,,
I7498,I7498,Spain,,,Spain_Islamic_Zira,,Spain_Islamic_Zira,,37.8071083,-2.543041667,M,"Granada, Huéscar, Cueva Romero",,H3a1,..,,,1000-1100 CE,,Unknown,Olalde et al. 2019,0,..,88.5,fasta,,,,,,,
I7499,I7499,Spain,,,Spain_Islamic_Zira,,Spain_Islamic_Zira,,37.8071083,-2.543041667,F,"Granada, Huéscar, Cueva Romero",,H5,n/a (female),,,1000-1100 CE,,Unknown,Olalde et al. 2019,0,n/a (female),83.4,fasta,,,,,,,
I2469,I2469_enhanced,Spain,,,Spain_LBA,,Spain_LBA,,42.57,-2.62,F,"Basque Country, Araba/Álava, Laguardia, El Sotillo",,H3an,n/a (female),-2740.0,-2680.0,"971-813 calBCE (2740±30 BP, Beta-299308)",2740,Unknown,Patterson et al. 2021,0,n/a (female),..,fasta,,,,,,,
I8570,I8570,Spain,,,Spain_LBA,,Spain_LBA,,40.1391,0.1054,M,"Castellón, Cabanes, Túmulo Mortorum",,J1c3,..,,,1300-1000 BCE,,Unknown,Olalde et al. 2019,0,..,31.1,fasta,10398G;11251G;13708A;185A;228A;295T;3010A;4216C;462T;489C,10398;11251;13708;185;228;295;3010;4216;462;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-RNR2;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Low VO2max response;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports,+;nr,-;nr;+
I8571,I8571,Spain,,,Spain_LBA,,Spain_LBA,,40.1391,0.1054,M,"Valencian Community, Castelló/Castellón, Cabanes, Túmulo Mortorum",,K1a2c,..,,,1800-1000 BCE,,Unknown,Olalde et al. 2019,0,..,48.5,fasta,10398G;11467G;12308G;12372A;16093C;4216C;9055A,10398;11467;12308;12372;16093;4216;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-CR;MT-ND1;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Cyclic Vomiting Syndrome;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports,+;-,-;+
I12208,I12208,Spain,,,Spain_MBA,,Spain_MBA,,41.4584,-5.2872,F,"Castilla y León, Valladolid, San Román de Hornija, La Requejada",,K1a1b1,n/a (female),,,1400-1200 BCE,,Unknown,Olalde et al. 2019,0,n/a (female),389.4,fasta,10398G;11467G;114T;12308G;12372A;15924G;16093C;9055A,10398;11467;114;12308;12372;15924;16093;9055,MT-ND3;MT-ND4;MT-CR;MT-TL2;MT-ND5;MT-TT;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;BD-associated;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;LIMM;Cyclic Vomiting Syndrome;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+;nr;-,-;+;nr
I12209,I12209,Spain,,,Spain_MBA,,Spain_MBA,,41.4584,-5.2872,M,"Castilla y León, Valladolid, San Román de Hornija, La Requejada",,H1ah,..,,,1400-1200 BCE,,Unknown,Olalde et al. 2019,0,..,656,fasta,3010A;8950A,3010;8950,MT-RNR2;MT-ATP6,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;LDYT,Reported,+,-
I2470,I2470_enhanced,Spain,,,Spain_MBA,,Spain_MBA,,42.57,-2.62,M,"Basque Country, Alava, El Sotillo",,J2a1a1,..,-3060.0,-3000.0,"1412-1227 calBCE (3060±30 BP, Beta-299307)",3060,Unknown,Patterson et al. 2021,0,..,1401.585069,fasta,10398G;11251G;13708A;150T;15257A;195C;295T;4216C;489C,10398;11251;13708;150;15257;195;295;4216;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-CYB;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Longevity / Cervical Carcinoma / HPV infection risk;LHON;BD-associated / melanoma pts;Low VO2max response;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports,+;nr,-;nr;+
I2472,I2472,Spain,,,Spain_MBA,,Spain_MBA,,42.57,-2.62,M,"Basque Country, Araba/Álava, Laguardia, El Sotillo",,K1a+195,..,-3220.0,-3160.0,"1533-1427 calBCE (3220±30 BP, Beta-299309)",3220,Unknown,Olalde et al. 2019,0,..,321,fasta,10398G;11467G;12308G;12372A;16093C;195C;9055A,10398;11467;12308;12372;16093;195;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-CR;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Cyclic Vomiting Syndrome;BD-associated / melanoma pts;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+;-,-;+
I3493,I3493,Spain,,,Spain_MBA,,Spain_MBA,,40.8586,-5.3518,F,"Salamanca, Aldeaseca de la Frontera, Tordillos",,H1,n/a (female),-3090.0,-3040.0,"1422-1281 calBCE (3090±25 BP, PSUAMS-2072)",3090,Unknown,Olalde et al. 2019,0,n/a (female),94.9,fasta,3010A,3010,MT-RNR2,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor,Reported,+,-
I2470,I2470,Spain,,,Spain_MBA,,Spain_MBA,,42.57,-2.62,M,"Basque Country, Alava, El Sotillo",,J2a1a1,..,-3060.0,-3000.0,"1412-1227 calBCE (3060±30 BP, Beta-299307)",3060,Unknown,Olalde et al. 2019,0,..,85.429597,fasta,10398G;11251G;13708A;150T;15257A;195C;295T;4216C;489C,10398;11251;13708;150;15257;195;295;4216;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-CYB;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Longevity / Cervical Carcinoma / HPV infection risk;LHON;BD-associated / melanoma pts;Low VO2max response;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports,+;nr,-;nr;+
I10892,I10892,Spain,,,Spain_Medieval,,Spain_Medieval,,42.0507,2.867,F,"Catalonia, Girona, Sant Julià de Ramis",,H1e1a3,n/a (female),,,750-1250 CE,,Unknown,Olalde et al. 2019,0,n/a (female),232,fasta,3010A;5460A,3010;5460,MT-RNR2;MT-ND2,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;AD / PD / LHON,Reported;Conflicting reports,+,-;+
I10895,I10895,Spain,,,Spain_Medieval,,Spain_Medieval,,42.0507,2.867,M,"Catalonia, Girona, Sant Julià de Ramis",,H1ap1,..,-1140.0,-1080.0,"774-992 calCE (1140±30 BP, Beta-448953)",1140,Unknown,Olalde et al. 2019,0,..,304.2,fasta,16189C;3010A;5780A,16189;3010;5780,MT-CR;MT-RNR2;MT-TC,Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;SNHL,Reported,+;-,-;+
I10851,I10851,Spain,,,Spain_Medieval,,Spain_Medieval,,42.0507,2.867,F,"Catalonia, Girona, Sant Julià de Ramis",,H3,n/a (female),-1100.0,-1040.0,"887-1017 calCE (1100±30 BP, Beta-458691)",1100,Unknown,Olalde et al. 2019,0,n/a (female),71.19,fasta,16189C,16189,MT-CR,Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients,Reported,+,-
I10852,I10852,Spain,,,Spain_Medieval,,Spain_Medieval,,42.0507,2.867,F,"Catalonia, Girona, Sant Julià de Ramis",,H6c,n/a (female),-1010.0,-950.0,"990-1154 calCE (1010±30 BP, Beta-458692)",1010,Unknown,Olalde et al. 2019,0,n/a (female),213.8,fasta,9804A,9804,MT-CO3,LHON / MS,Reported,+,+
I10853,I10853,Spain,,,Spain_Medieval,,Spain_Medieval,,42.0507,2.867,M,"Catalonia, Girona, Sant Julià de Ramis",,U4a1,..,,,"993-1155 calCE (990±30 BP, Beta-448950)",,Unknown,Olalde et al. 2019,0,..,326.1,fasta,11467G;12308G;12372A;15693C;195C;499A;961C,11467;12308;12372;15693;195;499;961,MT-ND4;MT-TL2;MT-ND5;MT-CYB;MT-CR;MT-RNR1,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Possibly LVNC cardiomyopathy-associated;BD-associated / melanoma pts;Endometriosis;DEAF / possibly LVNC-associated,Reported;Unclear,+,-;+
I10897,I10897,Spain,,,Spain_Medieval,,Spain_Medieval,,42.0507,2.867,F,"Catalonia, Girona, Sant Julià de Ramis",,I1c,n/a (female),,,"1040-1214 calCE (910±30 BP, Beta-477258)",,Unknown,Olalde et al. 2019,0,n/a (female),244.4,fasta,10398G;12705T;15043A;15924G;16129A;8573A;9966A,10398;12705;15043;15924;16129;8573;9966,MT-ND3;MT-CO1;MT-CYB;MT-TT;MT-CR;MT-ATP6;MT-CO3,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Possible protective factor for normal tension glaucoma;MDD-associated;LIMM;Cyclic Vomiting Syndrome with Migraine;Patient with suspected mitochondrial disease;LHON possible helper variant,Reported / lineage L & M marker / also hg IJK;Reported;Reported as Benign,+;<NA>;nr;-,-;<NA>;nr;+
I10854,I10854,Spain,,,Spain_Medieval_lc,,Spain_Medieval_lc,,42.0507,2.867,M,"Catalonia, Girona, Sant Julià de Ramis",,H1n+146,..,-1010.0,-950.0,"990-1154 calCE (1010±30 BP, Beta-448952)",1010,Unknown,Olalde et al. 2019,0,..,78.4,fasta,146C;3010A,146;3010,MT-CR;MT-RNR2,Absence of Endometriosis;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor,Reported,+,-
I0405,I0405,Spain,,,Spain_MLN,,Spain_MLN,,41.2522,-2.32622,M,La Mina,,K1a1b1,..,,,3900-3600 BCE,,Unknown,Mathieson et al. 2015,0,..,419.745308,fasta,10398G;11467G;114T;12308G;12372A;15924G;16093C;9055A,10398;11467;114;12308;12372;15924;16093;9055,MT-ND3;MT-ND4;MT-CR;MT-TL2;MT-ND5;MT-TT;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;BD-associated;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;LIMM;Cyclic Vomiting Syndrome;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+;nr;-,-;+;nr
I0406,I0406,Spain,,,Spain_MLN,,Spain_MLN,,41.2522,-2.32622,M,La Mina,,H1,..,,,3900-3600 BCE,,Unknown,Mathieson et al. 2015,0,..,527.098558,fasta,3010A,3010,MT-RNR2,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor,Reported,+,-
I0407,I0407,Spain,,,Spain_MLN,,Spain_MLN,,41.2522,-2.32622,F,La Mina,,K1b1a1,n/a (female),,,3900-3600 BCE,,Unknown,Mathieson et al. 2015,0,n/a (female),363.222765,fasta,10398G;11467G;12308G;12372A;13967T;15257A;16093C;5913A;9055A,10398;11467;12308;12372;13967;15257;16093;5913;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-CYB;MT-CR;MT-CO1;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Possible LHON factor;LHON;Cyclic Vomiting Syndrome;Prostate Cancer / hypertension;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports,+;-,-;+
I0408,I0408,Spain,,,Spain_MLN,,Spain_MLN,,41.2522,-2.32622,F,La Mina,,U5b1+16189+@16192,n/a (female),-4970.0,-4910.0,"3895-3651 calBCE (4970±30 BP, Beta-316132)",4970,Unknown,Mathieson et al. 2015,0,n/a (female),513.621341,fasta,11467G;12308G;12372A;150T;16270T,11467;12308;12372;150;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Longevity / Cervical Carcinoma / HPV infection risk;Melanoma patients,Reported;Conflicting reports,+;nr,-;+;nr
I10277,I10277,Spain,,,Spain_MLN,,Spain_MLN,,41.4391,1.5733,M,"Barcelona, Cova de la Guineu",,X2c1,..,,,3400-2500 BCE,,Unknown,Olalde et al. 2019,0,..,..,fasta,12705T;16189C;195C,12705;16189;195,MT-CO1;MT-CR,Possible protective factor for normal tension glaucoma;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;BD-associated / melanoma pts,Reported,<NA>;+,<NA>;-;+
I10278,I10278,Spain,,,Spain_MLN,,Spain_MLN,,41.4391,1.5733,M,"Barcelona, Cova de la Guineu",,U5b1,..,,,3400-2500 BCE,,Unknown,Olalde et al. 2019,0,..,..,fasta,11467G;12308G;12372A;150T;16192T;16270T,11467;12308;12372;150;16192;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Longevity / Cervical Carcinoma / HPV infection risk;Melanoma patients,Reported;Conflicting reports,+;nr,-;+;nr
I10280,I10280,Spain,,,Spain_MLN,,Spain_MLN,,41.4391,1.5733,M,"Barcelona, Cova de la Guineu",,J1c1,..,,,3400-2500 BCE,,Unknown,Olalde et al. 2019,0,..,..,fasta,10398G;11251G;13708A;185A;228A;295T;3010A;3394C;4216C;462T;489C,10398;11251;13708;185;228;295;3010;3394;4216;462;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-RNR2;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Low VO2max response;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;LHON / Diabetes / CPTdeficiency / high altitude adaptation;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports;Reported / Population-dependent,+;nr,-;nr;+
I10283,I10283,Spain,,,Spain_MLN,,Spain_MLN,,41.4391,1.5733,M,"Barcelona, Cova de la Guineu",,H,..,,,3400-2500 BCE,,Unknown,Olalde et al. 2019,0,..,..,fasta,,,,,,,
I10284,I10284,Spain,,,Spain_MLN,,Spain_MLN,,41.4391,1.5733,M,"Barcelona, Cova de la Guineu",,U5b1,..,,,3400-2500 BCE,,Unknown,Olalde et al. 2019,0,..,..,fasta,11467G;12308G;12372A;150T;16192T;16270T,11467;12308;12372;150;16192;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Longevity / Cervical Carcinoma / HPV infection risk;Melanoma patients,Reported;Conflicting reports,+;nr,-;+;nr
I10285,I10285,Spain,,,Spain_MLN,,Spain_MLN,,41.4391,1.5733,F,"Barcelona, Cova de la Guineu",,T2b,n/a (female),,,3400-2500 BCE,,Unknown,Olalde et al. 2019,0,n/a (female),..,fasta,11251G;15928A;4216C;4917G,11251;15928;4216;4917,MT-ND4;MT-TT;MT-ND1;MT-ND2,Reduced risk of PD;Multiple Sclerosis / idiopathic repeat miscarriage / AD protection;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;LHON / Insulin Resistance / AMD / NRTI-PN,Reported;Conflicting reports,nr;+,nr;-
I10286,I10286,Spain,,,Spain_MLN,,Spain_MLN,,41.4391,1.5733,M,"Barcelona, Cova de la Guineu",,U5b1,..,,,3400-2500 BCE,,Unknown,Olalde et al. 2019,0,..,..,fasta,150T;12308G;16270T;12372A;11467G,150;12308;16270;12372;11467,MT-CR;MT-TL2;MT-ND5;MT-ND4,Longevity / Cervical Carcinoma / HPV infection risk;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Melanoma patients;Altered brain pH / sCJD patients,Conflicting reports;Reported,+;nr,+;nr;-
I11248,I11248,Spain,,,Spain_MLN,,Spain_MLN,,43.0866,-2.2154,M,Basque Country,,J2a1a1a,..,,,3500-2700 BCE,,Unknown,Olalde et al. 2019,0,..,991.3,fasta,10398G;11251G;13708A;150T;15257A;195C;295T;4216C;489C,10398;11251;13708;150;15257;195;295;4216;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-CYB;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Longevity / Cervical Carcinoma / HPV infection risk;LHON;BD-associated / melanoma pts;Low VO2max response;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports,+;nr,-;nr;+
I11249,I11249,Spain,,,Spain_MLN,,Spain_MLN,,43.0866,-2.2154,M,Basque Country,,U5b1,..,,,3500-2700 BCE,,Unknown,Olalde et al. 2019,0,..,629.4,fasta,11467G;12308G;12372A;150T;16192T;16270T,11467;12308;12372;150;16192;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Longevity / Cervical Carcinoma / HPV infection risk;Melanoma patients,Reported;Conflicting reports,+;nr,-;+;nr
I11300,I11300,Spain,,,Spain_MLN,,Spain_MLN,,43.0866,-2.2154,F,Basque Country,,J2a1a1a,n/a (female),,,3500-2700 BCE,,Unknown,Olalde et al. 2019,0,n/a (female),74.29,fasta,10398G;11251G;13708A;150T;15257A;195C;295T;4216C;489C,10398;11251;13708;150;15257;195;295;4216;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-CYB;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Longevity / Cervical Carcinoma / HPV infection risk;LHON;BD-associated / melanoma pts;Low VO2max response;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports,+;nr,-;nr;+
I11301,I11301,Spain,,,Spain_MLN,,Spain_MLN,,43.0866,-2.2154,F,Basque Country,,H1j8,n/a (female),,,3500-2700 BCE,,Unknown,Olalde et al. 2019,0,n/a (female),421,fasta,3010A,3010,MT-RNR2,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor,Reported,+,-
I11303,I11303,Spain,,,Spain_MLN,,Spain_MLN,,41.4391,1.5733,F,"Barcelona, Cova de la Guineu",,H1j,n/a (female),,,3400-2500 BCE,,Unknown,Olalde et al. 2019,0,n/a (female),28.1,fasta,3010A,3010,MT-RNR2,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor,Reported,+,-
I11305,I11305,Spain,,,Spain_MLN,,Spain_MLN,,41.4391,1.5733,M,"Barcelona, Cova de la Guineu",,J1c1b,..,,,3400-2500 BCE,,Unknown,Olalde et al. 2019,0,..,511,fasta,10398G;11251G;13708A;185A;228A;295T;3010A;3394C;4216C;462T;489C,10398;11251;13708;185;228;295;3010;3394;4216;462;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-RNR2;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Low VO2max response;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;LHON / Diabetes / CPTdeficiency / high altitude adaptation;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports;Reported / Population-dependent,+;nr,-;nr;+
I11306,I11306,Spain,,,Spain_MLN,,Spain_MLN,,41.4391,1.5733,F,"Barcelona, Cova de la Guineu",,J2b1a2,n/a (female),,,3400-2500 BCE,,Unknown,Olalde et al. 2019,0,n/a (female),256,fasta,10398G;11251G;13708A;150T;15257A;15812A;295T;4216C;489C,10398;11251;13708;150;15257;15812;295;4216;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-CYB;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Longevity / Cervical Carcinoma / HPV infection risk;LHON;Low VO2max response;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports;Reported / Secondary,+;nr,-;nr;+
I3214,I3214,Spain,,,Spain_MLN,,Spain_MLN,,43.41022,-5.98496,M,"Asturias, Soto de las Regueras, Cueva de la Paloma",,V3,..,,,3400-3100 BCE,,Unknown,Olalde et al. 2019,0,..,13.616573,fasta,,,,,,,
I7547,I7547,Spain,,,Spain_MLN,,Spain_MLN,,36.445,-6.21,F,"Cádiz, San Fernando, Campo de Hockey",,K1a+195,n/a (female),,,4300-3700 BCE,,Unknown,Olalde et al. 2019,0,n/a (female),17.6,fasta,10398G;11467G;12308G;12372A;16093C;195C;9055A,10398;11467;12308;12372;16093;195;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-CR;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Cyclic Vomiting Syndrome;BD-associated / melanoma pts;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+;-,-;+
I7549,I7549,Spain,,,Spain_MLN,,Spain_MLN,,36.445,-6.21,F,"Cádiz, San Fernando, Campo de Hockey",,K1a4a1,n/a (female),,,4300-3700 BCE,,Unknown,Olalde et al. 2019,0,n/a (female),34.9,fasta,10398G;11467G;12308G;12372A;9055A,10398;11467;12308;12372;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+,-;+
I7550,I7550,Spain,,,Spain_MLN,,Spain_MLN,,36.445,-6.21,F,"Cádiz, San Fernando, Campo de Hockey",,K1b1a,n/a (female),,,4700-3600 BCE,,Unknown,Olalde et al. 2019,0,n/a (female),49.8,fasta,10398G;11467G;12308G;12372A;15257A;16093C;5913A;9055A,10398;11467;12308;12372;15257;16093;5913;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-CYB;MT-CR;MT-CO1;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;LHON;Cyclic Vomiting Syndrome;Prostate Cancer / hypertension;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports,+;-,-;+
I7594,I7594,Spain,,,Spain_MLN,,Spain_MLN,,38.7025,-0.48631,F,"Alicante, Alcoi, Llometes",,U5b2b,n/a (female),-4670.0,-4626.0,"3518-3371 calBCE (4670±22 BP, MAMS-16356)",4670,Unknown,Olalde et al. 2019,0,n/a (female),15.4,fasta,11467G;12308G;12372A;12634G;13637G;150T;16270T,11467;12308;12372;12634;13637;150;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Thyroid Cancer Cell Line;Possible LHON factor;Longevity / Cervical Carcinoma / HPV infection risk;Melanoma patients,Reported;Conflicting reports,+;nr,-;+;nr
I7598,I7598,Spain,,,Spain_MLN,,Spain_MLN,,38.7025,-0.48631,M,"Alicante, Alcoi, Llometes",,U5b3,..,-4710.0,-4666.0,"3622-3375 calBCE (4710±22 BP, MAMS-16346)",4710,Unknown,Olalde et al. 2019,0,..,31.2,fasta,11467G;12308G;12372A;150T;16192T;16270T,11467;12308;12372;150;16192;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Longevity / Cervical Carcinoma / HPV infection risk;Melanoma patients,Reported;Conflicting reports,+;nr,-;+;nr
I7600,I7600,Spain,,,Spain_MLN,,Spain_MLN,,38.7025,-0.48631,F,"Alicante, Alcoi, Llometes",,K1a2a,n/a (female),,,4000-3350 BCE,,Unknown,Olalde et al. 2019,0,n/a (female),30.3,fasta,10398G;11467G;12308G;12372A;9055A,10398;11467;12308;12372;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+,-;+
I7601,I7601,Spain,,,Spain_MLN,,Spain_MLN,,38.7025,-0.48631,M,"Alicante, Alcoi, Llometes",,X2b+226,..,-4810.0,-4766.0,"3644-3528 calBCE (4810±22 BP, MAMS-16354)",4810,Unknown,Olalde et al. 2019,0,..,21.1,fasta,12705T;13708A;15927A;16189C;195C;8393T,12705;13708;15927;16189;195;8393,MT-CO1;MT-ND5;MT-TT;MT-CR;MT-ATP8,Possible protective factor for normal tension glaucoma;LHON / Increased MS risk / higher freq in PD-ADS;LHON / Multiple Sclerosis / DEAF1555 increased penetrance / CHD;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;BD-associated / melanoma pts;Reversible brain pseudoatrophy,Reported;Conflicting reports,<NA>;+;-,<NA>;+;-
I7602,I7602,Spain,,,Spain_MLN,,Spain_MLN,,43.085823,-2.251197,M,Mandubi Zelaia,,J1c1,..,,,3500-2700 BCE,,Unknown,Olalde et al. 2019,0,..,47.3,fasta,10398G;11251G;13708A;185A;228A;295T;3010A;3394C;4216C;462T;489C,10398;11251;13708;185;228;295;3010;3394;4216;462;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-RNR2;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Low VO2max response;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;LHON / Diabetes / CPTdeficiency / high altitude adaptation;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports;Reported / Population-dependent,+;nr,-;nr;+
I7603,I7603,Spain,,,Spain_MLN,,Spain_MLN,,43.085823,-2.251197,M,Mandubi Zelaia,,K1a2b,..,,,3500-2700 BCE,,Unknown,Olalde et al. 2019,0,..,37.7,fasta,10398G;11467G;12308G;12372A;16093C;9055A,10398;11467;12308;12372;16093;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-CR;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Cyclic Vomiting Syndrome;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+;-,-;+
I7604,I7604,Spain,,,Spain_MLN,,Spain_MLN,,43.085823,-2.251197,M,Mandubi Zelaia,,H1ak,..,,,3500-2700 BCE,,Unknown,Olalde et al. 2019,0,..,29.7,fasta,3010A,3010,MT-RNR2,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor,Reported,+,-
I7605,I7605,Spain,,,Spain_MLN,,Spain_MLN,,43.085823,-2.251197,M,Mandubi Zelaia,,H3,..,,,3500-2700 BCE,,Unknown,Olalde et al. 2019,0,..,13.6,fasta,,,,,,,
I7606,I7606,Spain,,,Spain_MLN,,Spain_MLN,,43.085823,-2.251197,M,Mandubi Zelaia,,U5b1+16189+@16192,..,,,3500-2700 BCE,,Unknown,Olalde et al. 2019,0,..,85.7,fasta,11467G;12308G;12372A;150T;16189C;16270T,11467;12308;12372;150;16189;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Longevity / Cervical Carcinoma / HPV infection risk;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;Melanoma patients,Reported;Conflicting reports,+;nr,-;+;nr
I7642,I7642,Spain,,,Spain_MLN,,Spain_MLN,,38.7025,-0.48631,M,"Valencian Community, Alacant/Alicante, Alcoi, Les Llometes",,J2b1a,..,-4240.0,-4194.0,"2909-2706 calBCE (4240±23 BP, MAMS-16338)",4240,Unknown,Olalde et al. 2019,0,..,30.2,fasta,10398G;11251G;13708A;150T;15257A;15812A;295T;4216C;489C,10398;11251;13708;150;15257;15812;295;4216;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-CYB;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Longevity / Cervical Carcinoma / HPV infection risk;LHON;Low VO2max response;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports;Reported / Secondary,+;nr,-;nr;+
I7643,I7643,Spain,,,Spain_MLN,,Spain_MLN,,38.7025,-0.48631,M,"Valencian Community, Alacant/Alicante, Alcoi, Les Llometes",,K1a1b1,..,-5040.0,-4974.0,"3952-3713 calBCE (5040±33 BP, MAMS-16344)",5040,Unknown,Olalde et al. 2019,0,..,27.2,fasta,10398G;11467G;114T;12308G;12372A;15924G;16093C;9055A,10398;11467;114;12308;12372;15924;16093;9055,MT-ND3;MT-ND4;MT-CR;MT-TL2;MT-ND5;MT-TT;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;BD-associated;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;LIMM;Cyclic Vomiting Syndrome;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+;nr;-,-;+;nr
I7644,I7644,Spain,,,Spain_MLN,,Spain_MLN,,38.7025,-0.48631,M,"Valencian Community, Alacant/Alicante, Alcoi, Les Llometes",,n/a (<2x),..,-4760.0,-4716.0,"3635-3386 calBCE (4760±22 BP, MAMS-16353)",4760,Unknown,Olalde et al. 2019,0,..,0.708,fasta,,,,,,,
I7645,I7645,Spain,,,Spain_MLN,,Spain_MLN,,38.7025,-0.48631,M,"Valencian Community, Alacant/Alicante, Alcoi, Les Llometes",,HV0d,..,-5120.0,-5070.0,"3981-3804 calBCE (5120±25 BP, MAMS-16340)",5120,Unknown,Olalde et al. 2019,0,..,7.09,fasta,195C,195,MT-CR,BD-associated / melanoma pts,Reported,+,+
I7646,I7646,Spain,,,Spain_MLN,,Spain_MLN,,38.7025,-0.48631,F,"Valencian Community, Alacant/Alicante, Alcoi, Les Llometes",,H1e1c,n/a (female),-4880.0,-4824.0,"3711-3540 calBCE (4880±28 BP, MAMS-16339)",4880,Unknown,Olalde et al. 2019,0,n/a (female),21.2,fasta,3010A;3745A;5460A,3010;3745;5460,MT-RNR2;MT-ND1;MT-ND2,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;LHON / high altitude variant;AD / PD / LHON,Reported;Reported / Population-dependent;Conflicting reports,+,-;+
I7647,I7647,Spain,,,Spain_MLN,,Spain_MLN,,38.7025,-0.48631,M,"Valencian Community, Alacant/Alicante, Alcoi, Les Llometes",,K1b1a,..,-5180.0,-5132.0,"4045-3955 calBCE (5180±24 BP, MAMS-16335)",5180,Unknown,Olalde et al. 2019,0,..,5.73,fasta,12308G;5913A;9055A;11467G;13967T;10398G;15257A;16093C,12308;5913;9055;11467;13967;10398;15257;16093,MT-TL2;MT-CO1;MT-ATP6;MT-ND4;MT-ND5;MT-ND3;MT-CYB;MT-CR,CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Prostate Cancer / hypertension;PD protective factor;Altered brain pH / sCJD patients;Possible LHON factor;PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;LHON;Cyclic Vomiting Syndrome,Reported;Reported / lineage L & M marker / also hg IJK;Conflicting reports,+;-,+;-
I8134,I8134,Spain,,,Spain_MLN,,Spain_MLN,,36.445,-6.21,F,"Cádiz, San Fernando, Campo de Hockey",,U5b3,n/a (female),,,4700-3600 BCE,,Unknown,Olalde et al. 2019,0,n/a (female),56,fasta,150T;12308G;16192T;11467G;16270T;228A;12372A,150;12308;16192;11467;16270;228;12372,MT-CR;MT-TL2;MT-ND4;MT-ND5,Longevity / Cervical Carcinoma / HPV infection risk;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Melanoma patients;Altered brain pH / sCJD patients;Low VO2max response,Conflicting reports;Reported,+;nr,+;nr;-
I8567,I8567,Spain,,,Spain_MLN,,Spain_MLN,,38.762271,-0.586981,M,"Valencian Community, València/Valencia, Bocairent, La Coveta Emparetà",,X2,..,,,3500-3300 BCE,,Unknown,Olalde et al. 2019,0,..,96.8,fasta,12705T;13708A;15927A;16189C;195C;8393T,12705;13708;15927;16189;195;8393,MT-CO1;MT-ND5;MT-TT;MT-CR;MT-ATP8,Possible protective factor for normal tension glaucoma;LHON / Increased MS risk / higher freq in PD-ADS;LHON / Multiple Sclerosis / DEAF1555 increased penetrance / CHD;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;BD-associated / melanoma pts;Reversible brain pseudoatrophy,Reported;Conflicting reports,<NA>;+;-,<NA>;+;-
I8568,I8568,Spain,,,Spain_MLN,,Spain_MLN,,38.762271,-0.586981,F,"Valencian Community, València/Valencia, Bocairent, La Coveta Emparetà",,X2b+226,n/a (female),-4615.0,-4575.0,"3496-3355 calBCE (4615±20 BP, PSUAMS-4432)",4615,Unknown,Olalde et al. 2019,0,n/a (female),157,fasta,12705T;13708A;15927A;16189C;195C;8393T,12705;13708;15927;16189;195;8393,MT-CO1;MT-ND5;MT-TT;MT-CR;MT-ATP8,Possible protective factor for normal tension glaucoma;LHON / Increased MS risk / higher freq in PD-ADS;LHON / Multiple Sclerosis / DEAF1555 increased penetrance / CHD;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;BD-associated / melanoma pts;Reversible brain pseudoatrophy,Reported;Conflicting reports,<NA>;+;-,<NA>;+;-
I7595,I7595,Spain,,,Spain_MLN_1d.rel.I7594,,Spain_MLN_1d.rel.I7594,,38.7025,-0.48631,F,"Alicante, Alcoi, Llometes",,U5b2b5,n/a (female),-4670.0,-4624.0,"3518-3371 calBCE (4670±23 BP, MAMS-16332)",4670,Unknown,Olalde et al. 2019,0,n/a (female),22,fasta,11467G;12308G;12372A;12634G;13637G;150T;16270T,11467;12308;12372;12634;13637;150;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Thyroid Cancer Cell Line;Possible LHON factor;Longevity / Cervical Carcinoma / HPV infection risk;Melanoma patients,Reported;Conflicting reports,+;nr,-;+;nr
I7597,I7597,Spain,,,Spain_MLN_o_contam_lc,,Spain_MLN_o_contam_lc,,38.7025,-0.48631,U,"Alicante, Alcoi, Llometes",,J2b1,n/a  (sex unknown),,,4000-3350 BCE,,Unknown,Olalde et al. 2019,0,n/a  (sex unknown),11.7,fasta,10398G;11251G;13708A;150T;15257A;15812A;295T;4216C;489C,10398;11251;13708;150;15257;15812;295;4216;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-CYB;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Longevity / Cervical Carcinoma / HPV infection risk;LHON;Low VO2max response;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports;Reported / Secondary,+;nr,-;nr;+
I10287,I10287,Spain,,,Spain_MLN,,Spain_MLN,,41.4391,1.5733,M,"Barcelona, Cova de la Guineu",,U2e3,..,,,3400-2500 BCE,,Unknown,Olalde et al. 2019,0,..,356.130847,fasta,11251G;15928A;4216C;4917G,11251;15928;4216;4917,MT-ND4;MT-TT;MT-ND1;MT-ND2,Reduced risk of PD;Multiple Sclerosis / idiopathic repeat miscarriage / AD protection;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;LHON / Insulin Resistance / AMD / NRTI-PN,Reported;Conflicting reports,nr;+,nr;-
I11304,I11304,Spain,,,Spain_MLN,,Spain_MLN,,41.4391,1.5733,M,"Barcelona, Cova de la Guineu",,U5a2+16294,..,,,3400-2500 BCE,,Unknown,Olalde et al. 2019,0,..,38.65,fasta,11467G;12308G;12372A;16192T;16270T,11467;12308;12372;16192;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Melanoma patients,Reported,+;nr,-;+;nr
I3273,I3273,Spain,,,Spain_MLN,,Spain_MLN,,42.57,-2.55,F,"Basque Country, Alava, La Chabola de la Hechicera",,J2a1a1,n/a (female),-4670.0,-4590.0,"3606-3363 calBCE (4670±40 BP, Beta-288935)",4670,Unknown,Lipson et al. 2017,0,n/a (female),..,fasta,10398G;11251G;13708A;150T;15257A;195C;295T;4216C;489C,10398;11251;13708;150;15257;195;295;4216;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-CYB;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Longevity / Cervical Carcinoma / HPV infection risk;LHON;BD-associated / melanoma pts;Low VO2max response;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports,+;nr,-;nr;+
I7679,I7679,Spain,,,Spain_MLN,,Spain_MLN,,36.445,-6.21,F,"Cádiz, San Fernando, Campo de Hockey",,H,n/a (female),,,4300-3700 BCE,,Unknown,Olalde et al. 2019,0,n/a (female),4.56,fasta,,,,,,,
I10282,I10282,Spain,,,Spain_MLN_lc,,Spain_MLN_lc,,41.4391,1.5733,M,"Barcelona, Cova de la Guineu",,K1a3,..,,,3400-2500 BCE,,Unknown,Olalde et al. 2019,0,..,..,fasta,12308G;9055A;11467G;10398G;12372A,12308;9055;11467;10398;12372,MT-TL2;MT-ATP6;MT-ND4;MT-ND3;MT-ND5,CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;PD protective factor;Altered brain pH / sCJD patients;PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy,Reported;Reported / lineage L & M marker / also hg IJK,+,+;-
I7160,I7160,Spain,,,Spain_MLN_lc,,Spain_MLN_lc,,36.445,-6.21,F,"Andalusia, Cádiz, San Fernando, Campo de Hockey",,T2c1d,n/a (female),-5140.0,-5070.0,"4042-3803 calBCE (5140±35 BP, CNA4579.1.1)",5140,Unknown,Olalde et al. 2019,0,n/a (female),2.17,fasta,146C;4917G;4216C;15928A;11251G;6261A,146;4917;4216;15928;11251;6261,MT-CR;MT-ND2;MT-ND1;MT-TT;MT-ND4;MT-CO1,Absence of Endometriosis;LHON / Insulin Resistance / AMD / NRTI-PN;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;Multiple Sclerosis / idiopathic repeat miscarriage / AD protection;Reduced risk of PD;Prostate Cancer / LHON,Reported;Conflicting reports,+;nr,-;nr
I8145,I8145,Spain,,,Spain_NazariPeriod_LateMuslim,,Spain_NazariPeriod_LateMuslim,,37.1461,-3.5913,M,Granada,,H,..,,,1300-1500 CE,,Unknown,Olalde et al. 2019,0,..,29.8,fasta,,,,,,,
I8146,I8146,Spain,,,Spain_NazariPeriod_LateMuslim,,Spain_NazariPeriod_LateMuslim,,37.1461,-3.5913,F,Granada,,H3a1,n/a (female),,,1300-1500 CE,,Unknown,Olalde et al. 2019,0,n/a (female),120,fasta,,,,,,,
I8147,I8147,Spain,,,Spain_NazariPeriod_LateMuslim,,Spain_NazariPeriod_LateMuslim,,37.1461,-3.5913,U,Granada,,H1,n/a  (sex unknown),,,1300-1500 CE,,Unknown,Olalde et al. 2019,0,n/a  (sex unknown),3.14,fasta,3010A,3010,MT-RNR2,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor,Reported,+,-
I3807,I3807,Spain,,,Spain_NazariPeriod_Muslim,,Spain_NazariPeriod_Muslim,,36.9508333,-3.547222222,M,"Andalusia, Granada, Mondújar (Lecrín), Nécropolis de Torna Alta",,U6a,..,,,1500-1600 CE,,Unknown,Olalde et al. 2019,0,..,301.239363,fasta,11467G;12308G;12372A;14179G,11467;12308;12372;14179,MT-ND4;MT-TL2;MT-ND5;MT-ND6,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Recurrent pregnancy loss,Reported,+;nr,-;+;nr
I3808,I3808,Spain,,,Spain_NazariPeriod_Muslim,,Spain_NazariPeriod_Muslim,,36.9508333,-3.547222222,F,"Andalusia, Granada, Mondújar (Lecrín), Nécropolis de Torna Alta",,H1,n/a (female),,,1500-1600 CE,,Unknown,Olalde et al. 2019,0,n/a (female),368,fasta,3010A,3010,MT-RNR2,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor,Reported,+,-
I7424,I7424,Spain,,,Spain_NazariPeriod_Muslim,,Spain_NazariPeriod_Muslim,,36.9508333,-3.547222222,F,"Andalusia, Granada, Mondújar (Lecrín), Nécropolis de Torna Alta",,U5b1+16189+@16192,n/a (female),,,1500-1600 CE,,Unknown,Olalde et al. 2019,0,n/a (female),116,fasta,11467G;12308G;12372A;150T;16189C;16270T,11467;12308;12372;150;16189;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Longevity / Cervical Carcinoma / HPV infection risk;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;Melanoma patients,Reported;Conflicting reports,+;nr,-;+;nr
I7425,I7425,Spain,,,Spain_NazariPeriod_Muslim,,Spain_NazariPeriod_Muslim,,36.9508333,-3.547222222,F,"Andalusia, Granada, Mondújar (Lecrín), Nécropolis de Torna Alta",,W6,n/a (female),,,1500-1600 CE,,Unknown,Olalde et al. 2019,0,n/a (female),51.1,fasta,12705T;16192T;195C;5460A,12705;16192;195;5460,MT-CO1;MT-CR;MT-ND2,Possible protective factor for normal tension glaucoma;Melanoma patients;BD-associated / melanoma pts;AD / PD / LHON,Reported;Conflicting reports,<NA>;nr;+,<NA>;nr;+
I3810,I3810,Spain,,,Spain_NazariPeriod_Muslim_African,,Spain_NazariPeriod_Muslim_African,,36.9508333,-3.547222222,F,"Andalusia, Granada, Mondújar (Lecrín), Nécropolis de Torna Alta",,L2e1,n/a (female),,,1500-1600 CE,,Unknown,Olalde et al. 2019,0,n/a (female),163,fasta,150T;13708A;146C;16390A;10398G;12705T,150;13708;146;16390;10398;12705,MT-CR;MT-ND5;MT-ND3;MT-CO1,Longevity / Cervical Carcinoma / HPV infection risk;LHON / Increased MS risk / higher freq in PD-ADS;Absence of Endometriosis;POAG - potential for association;PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Possible protective factor for normal tension glaucoma,Conflicting reports;Reported;Reported / lineage L & M marker / also hg IJK,+;<NA>,+;-;<NA>
I7423,I7423,Spain,,,Spain_NazariPeriod_Muslim_o,,Spain_NazariPeriod_Muslim_o,,36.9508333,-3.547222222,M,"Andalusia, Granada, Mondújar (Lecrín), Nécropolis de Torna Alta",,H20c,..,,,1500-1600 CE,,Unknown,Olalde et al. 2019,0,..,118,fasta,,,,,,,
I3809,I3809,Spain,,,Spain_NazariPeriod_Muslim,,Spain_NazariPeriod_Muslim,,36.9508333,-3.547222222,M,"Andalusia, Granada, Mondújar (Lecrín), Nécropolis de Torna Alta",,U6a3b,..,,,1500-1600 CE,,Unknown,Olalde et al. 2019,0,..,46.048162,fasta,11467G;12308G;12372A;14179G;146C;185A,11467;12308;12372;14179;146;185,MT-ND4;MT-TL2;MT-ND5;MT-ND6;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Recurrent pregnancy loss;Absence of Endometriosis;Low VO2max response,Reported,+;nr,-;+;nr
I7426,I7426,Spain,,,Spain_NazariPeriod_Muslim_lc,,Spain_NazariPeriod_Muslim_lc,,36.9508333,-3.547222222,M,"Andalusia, Granada, Mondújar (Lecrín), Nécropolis de Torna Alta",,n/a (<2x),..,,,1500-1600 CE,,Unknown,Olalde et al. 2019,0,..,1.83,fasta,,,,,,,
I10865,I10865,Spain,,,Spain_Roman_oAfrica,,Spain_Roman_oAfrica,,42.1333,3.1083,M,"Girona, Empuries, necropolis Centre de Visitants",,U5a1a1,..,,,100-200 CE,,Unknown,Olalde et al. 2019,0,..,16.55,fasta,11467G;12308G;12372A;15924G;16270T,11467;12308;12372;15924;16270,MT-ND4;MT-TL2;MT-ND5;MT-TT;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;LIMM;Melanoma patients,Reported,+;nr,-;+;nr
I3980,I3980,Spain,,,Spain_Roman_oAfrica,,Spain_Roman_oAfrica,,37.1775,-3.609166667,F,"Andalusia, Granada, Paseíllos universitarios-Fuentenueva",,H1e1c,n/a (female),-1520.0,-1480.0,"483-603 calCE (1520±20 BP, PSUAMS-2110)",1520,Unknown,Olalde et al. 2019,0,n/a (female),112,fasta,3010A;3745A;5460A,3010;3745;5460,MT-RNR2;MT-ND1;MT-ND2,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;LHON / high altitude variant;AD / PD / LHON,Reported;Reported / Population-dependent;Conflicting reports,+,-;+
I3981,I3981,Spain,,,Spain_Roman_oAfrica,,Spain_Roman_oAfrica,,37.1775,-3.609166667,M,"Andalusia, Granada, Paseíllos universitarios-Fuentenueva",,T2b32,..,,,400-600 CE,,Unknown,Olalde et al. 2019,0,..,108.757016,fasta,11251G;15928A;4216C;4917G,11251;15928;4216;4917,MT-ND4;MT-TT;MT-ND1;MT-ND2,Reduced risk of PD;Multiple Sclerosis / idiopathic repeat miscarriage / AD protection;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;LHON / Insulin Resistance / AMD / NRTI-PN,Reported;Conflicting reports,nr;+,nr;-
I3982,I3982,Spain,,,Spain_Roman,,Spain_Roman,,37.1775,-3.609166667,F,"Granada, Plaza Einstein",,HV0+195,n/a (female),,,200-400 CE,,Unknown,Olalde et al. 2019,0,n/a (female),9.815137,fasta,195C,195,MT-CR,BD-associated / melanoma pts,Reported,+,+
I3983,I3983,Spain,,,Spain_Roman_oAfrica,,Spain_Roman_oAfrica,,37.1775,-3.609166667,M,"Granada, Plaza Einstein",,H4a1c2,..,-1660.0,-1610.0,"261-531 calCE (1660±25 BP, PSUAMS-2081)",1660,Unknown,Olalde et al. 2019,0,..,76,fasta,14582G;7859A,14582;7859,MT-ND6;MT-CO2,LHON synergistic combo 14258A + 14582G;Progressive Encephalomyopathy,Reported: individually neutral variants causing LHON in combination;Reported,+,-
I4054,I4054,Spain,,,Spain_Roman_oAfrica_brother.I3983,,Spain_Roman_oAfrica_brother.I3983,,37.1775,-3.609166667,M,"Granada, Plaza Einstein",,H4a1c2,..,,,200-400 CE,,Unknown,Olalde et al. 2019,0,..,98,fasta,14582G;7859A,14582;7859,MT-ND6;MT-CO2,LHON synergistic combo 14258A + 14582G;Progressive Encephalomyopathy,Reported: individually neutral variants causing LHON in combination;Reported,+,-
I6492,I6492,Spain,,,Spain_Roman_lc,,Spain_Roman_lc,,41.274,1.178,M,"Tarragona, Mas Gassol, Alcover",,T2b11,..,,,200-500 CE,,Unknown,Olalde et al. 2019,0,..,32.9,fasta,11251G;15928A;3398C;4216C;4917G,11251;15928;3398;4216;4917,MT-ND4;MT-TT;MT-ND1;MT-ND2,Reduced risk of PD;Multiple Sclerosis / idiopathic repeat miscarriage / AD protection;DMDF+HCM / GDM / possibly LVNC cardiomyopathy-associated;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;LHON / Insulin Resistance / AMD / NRTI-PN,Reported;Conflicting reports,nr;+,nr;-
I7158,I7158,Spain,,,Spain_Roman_lc,,Spain_Roman_lc,,41.274,1.178,M,"Tarragona, Mas Gassol, Alcover",,T2b,..,,,200-500 CE,,Unknown,Olalde et al. 2019,0,..,5.47,fasta,15928A;4917G;3398C;4216C;11251G,15928;4917;3398;4216;11251,MT-TT;MT-ND2;MT-ND1;MT-ND4,Multiple Sclerosis / idiopathic repeat miscarriage / AD protection;LHON / Insulin Resistance / AMD / NRTI-PN;DMDF+HCM / GDM / possibly LVNC cardiomyopathy-associated;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;Reduced risk of PD,Reported;Conflicting reports,+;nr,-;nr
I8338,I8338,Spain,,,Spain_Roman_oAegean,,Spain_Roman_oAegean,,42.1333,3.1083,F,"Girona, Empuries, necropolis Centre de Visitants",,HV0+195,n/a (female),-1900.0,-1860.0,"79-213 calCE (1900±20 BP, PSUAMS-8222)",1900,Unknown,Olalde et al. 2019,0,n/a (female),107,fasta,195C,195,MT-CR,BD-associated / melanoma pts,Reported,+,+
I6490,I6490,Spain,,,Spain_Roman_oLocal,,Spain_Roman_oLocal,,41.274,1.178,F,"Tarragona, Mas Gassol, Alcover",,K1c2,n/a (female),,,200-500 CE,,Unknown,Olalde et al. 2019,0,n/a (female),132,fasta,10398G;11467G;12308G;12372A;14002G;146C;9055A,10398;11467;12308;12372;14002;146;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-CR;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;High altitude pulmonary edema susceptibility;Absence of Endometriosis;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+,-;+
I8202,I8202,Spain,,,Spain_Roman_oLocal,,Spain_Roman_oLocal,,42.1333,3.1083,M,"Girona, Empuries, necropolis Centre de Visitants",,K2b1,..,,,100-300 CE,,Unknown,Olalde et al. 2019,0,..,..,fasta,11467G;12308G;12372A;146C;9055A,11467;12308;12372;146;9055,MT-ND4;MT-TL2;MT-ND5;MT-CR;MT-ATP6,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Absence of Endometriosis;PD protective factor,Reported,+,-;+
I8339,I8339,Spain,,,Spain_Roman_oLocal,,Spain_Roman_oLocal,,42.1333,3.1083,F,"Girona, Empuries, necropolis Centre de Visitants",,K1a+195,n/a (female),-1870.0,-1840.0,"125-220 calCE (1870±15 BP, PSUAMS-8175)",1870,Unknown,Olalde et al. 2019,0,n/a (female),83.6,fasta,10398G;11467G;12308G;12372A;16093C;195C;9055A,10398;11467;12308;12372;16093;195;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-CR;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Cyclic Vomiting Syndrome;BD-associated / melanoma pts;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+;-,-;+
I8474,I8474,Spain,,,Spain_Roman_oLocal,,Spain_Roman_oLocal,,42.1333,3.1083,F,"Girona, Empuries, necropolis Centre de Visitants",,U5a1a2b,n/a (female),,,100-200 CE,,Unknown,Olalde et al. 2019,0,n/a (female),23.4,fasta,11467G;12308G;12372A;16270T,11467;12308;12372;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Melanoma patients,Reported,+;nr,-;+;nr
I10866,I10866,Spain,,,Spain_Roman_oMixed,,Spain_Roman_oMixed,,42.1333,3.1083,F,"Girona, Empuries, necropolis Centre de Visitants",,K1b2a,n/a (female),-2005.0,-1975.0,"44 calBCE - 61 calCE (2005±15 BP, PSUAMS-5281)",2005,Unknown,Olalde et al. 2019,0,n/a (female),1053,fasta,10398G;11467G;12308G;12372A;146C;195C;5913A;9055A,10398;11467;12308;12372;146;195;5913;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-CR;MT-CO1;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Absence of Endometriosis;BD-associated / melanoma pts;Prostate Cancer / hypertension;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+,-;+
I8216,I8216,Spain,,,Spain_Roman_oMixed,,Spain_Roman_oMixed,,42.1333,3.1083,M,"Girona, Empuries, necropolis Centre de Visitants",,H1,..,-1895.0,-1855.0,"80-215 calCE (1895±20 BP, PSUAMS-4212)",1895,Unknown,Olalde et al. 2019,0,..,..,fasta,3010A,3010,MT-RNR2,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor,Reported,+,-
I8343,I8343,Spain,,,Spain_Roman_oMixed,,Spain_Roman_oMixed,,42.1333,3.1083,M,"Girona, Empuries, necropolis Centre de Visitants",,J1c2c2,..,-1355.0,-1325.0,"647-676 calCE (1355±15 BP, PSUAMS-8223)",1355,Unknown,Olalde et al. 2019,0,..,171,fasta,10398G;11251G;13708A;146C;185A;228A;295T;3010A;4216C;462T;489C,10398;11251;13708;146;185;228;295;3010;4216;462;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-RNR2;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Absence of Endometriosis;Low VO2max response;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports,+;nr,-;nr;+
I8475,I8475,Spain,,,Spain_Roman_oMixed,,Spain_Roman_oMixed,,42.1333,3.1083,F,"Girona, Empuries, necropolis Centre de Visitants",,T2b,n/a (female),,,100-200 CE,,Unknown,Olalde et al. 2019,0,n/a (female),83.7,fasta,11251G;15928A;4216C;4917G,11251;15928;4216;4917,MT-ND4;MT-TT;MT-ND1;MT-ND2,Reduced risk of PD;Multiple Sclerosis / idiopathic repeat miscarriage / AD protection;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;LHON / Insulin Resistance / AMD / NRTI-PN,Reported;Conflicting reports,nr;+,nr;-
I4055,I4055,Spain,,,Spain_Roman,,Spain_Roman,,37.1775,-3.609166667,M,"Granada, Plaza Einstein",,U3a1,..,,,200-400 CE,,Unknown,Olalde et al. 2019,0,..,249.885087,fasta,11467G;12308G;12372A;150T;16390A;3010A,11467;12308;12372;150;16390;3010,MT-ND4;MT-TL2;MT-ND5;MT-CR;MT-RNR2,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Longevity / Cervical Carcinoma / HPV infection risk;POAG - potential for association;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor,Reported;Conflicting reports,+,-;+
I6491,I6491,Spain,,,Spain_Roman,,Spain_Roman,,41.274,1.178,M,"Tarragona, Mas Gassol, Alcover",,H4a1a,..,,,200-500 CE,,Unknown,Olalde et al. 2019,0,..,7.524292,fasta,14582G,14582,MT-ND6,LHON synergistic combo 14258A + 14582G,Reported: individually neutral variants causing LHON in combination,+,-
I12031,I12031,Spain,,,Spain_Visigoth,,Spain_Visigoth,,42.01656,2.814897,M,"Girona, Pla de l'Horta",,H1e2,..,,,416-700 CE,,Unknown,Olalde et al. 2019,0,..,216.1,fasta,3010A;5460A,3010;5460,MT-RNR2;MT-ND2,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;AD / PD / LHON,Reported;Conflicting reports,+,-;+
I12034,I12034,Spain,,,Spain_Visigoth,,Spain_Visigoth,,42.01656,2.814897,F,"Girona, Pla de l'Horta",,W6a,n/a (female),,,416-700 CE,,Unknown,Olalde et al. 2019,0,n/a (female),337.2,fasta,12705T;16192T;195C;5460A,12705;16192;195;5460,MT-CO1;MT-CR;MT-ND2,Possible protective factor for normal tension glaucoma;Melanoma patients;BD-associated / melanoma pts;AD / PD / LHON,Reported;Conflicting reports,<NA>;nr;+,<NA>;nr;+
I12162,I12162,Spain,,,Spain_Visigoth,,Spain_Visigoth,,42.01656,2.814897,M,"Girona, Pla de l'Horta",,U5b1b1d,..,,,416-700 CE,,Unknown,Olalde et al. 2019,0,..,134.6,fasta,11467G;12308G;12372A;150T;16189C;16270T,11467;12308;12372;150;16189;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Longevity / Cervical Carcinoma / HPV infection risk;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;Melanoma patients,Reported;Conflicting reports,+;nr,-;+;nr
I12163,I12163,Spain,,,Spain_Visigoth,,Spain_Visigoth,,42.01656,2.814897,F,"Girona, Pla de l'Horta",,J2b1a+16311,n/a (female),,,416-700 CE,,Unknown,Olalde et al. 2019,0,n/a (female),203.2,fasta,10398G;11251G;13708A;150T;15257A;15812A;295T;4216C;489C,10398;11251;13708;150;15257;15812;295;4216;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-CYB;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Longevity / Cervical Carcinoma / HPV infection risk;LHON;Low VO2max response;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports;Reported / Secondary,+;nr,-;nr;+
I12164,I12164,Spain,,,Spain_Visigoth_1d.rel.I12032,,Spain_Visigoth_1d.rel.I12032,,42.01656,2.814897,F,"Girona, Pla de l'Horta",,C4a1a+195,n/a (female),,,416-700 CE,,Unknown,Olalde et al. 2019,0,n/a (female),193.5,fasta,10398G;12705T;15043A;16093C;16129A;195C;3552A;489C,10398;12705;15043;16093;16129;195;3552;489,MT-ND3;MT-CO1;MT-CYB;MT-CR;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Possible protective factor for normal tension glaucoma;MDD-associated;Cyclic Vomiting Syndrome;Cyclic Vomiting Syndrome with Migraine;BD-associated / melanoma pts;Resistance to high altitude pulmonary edema (HAPE);Low VO2max response,Reported / lineage L & M marker / also hg IJK;Reported;Reported /hg C marker,+;<NA>;-,-;<NA>;+
I3775,I3775,Spain,,,Spain_Visigoth_Barcelona,,Spain_Visigoth_Barcelona,,41.981377,2.309824,M,"Barcelona, Roda de Ter, L'Esquerda",,H3t,..,,,600-700 CE,,Unknown,Olalde et al. 2019,0,..,59.9,fasta,,,,,,,
I3776,I3776,Spain,,,Spain_Visigoth_Barcelona,,Spain_Visigoth_Barcelona,,41.981377,2.309824,F,"Barcelona, Roda de Ter, L'Esquerda",,U5a1i1,n/a (female),,,600-700 CE,,Unknown,Olalde et al. 2019,0,n/a (female),189,fasta,11467G;12308G;12372A;16192T;16270T,11467;12308;12372;16192;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Melanoma patients,Reported,+;nr,-;+;nr
I3777,I3777,Spain,,,Spain_Visigoth_Barcelona,,Spain_Visigoth_Barcelona,,41.981377,2.309824,F,"Barcelona, Roda de Ter, L'Esquerda",,V17,n/a (female),,,600-700 CE,,Unknown,Olalde et al. 2019,0,n/a (female),142,fasta,1537T,1537,MT-RNR1,DEAF / intellectual disability,Reported,+,-
I3778,I3778,Spain,,,Spain_Visigoth_Barcelona,,Spain_Visigoth_Barcelona,,41.981377,2.309824,M,"Barcelona, Roda de Ter, L'Esquerda",,H4a1,..,,,600-700 CE,,Unknown,Olalde et al. 2019,0,..,235,fasta,14582G,14582,MT-ND6,LHON synergistic combo 14258A + 14582G,Reported: individually neutral variants causing LHON in combination,+,-
I3866,I3866,Spain,,,Spain_Visigoth_Barcelona,,Spain_Visigoth_Barcelona,,41.981377,2.309824,M,"Barcelona, Roda de Ter, L'Esquerda",,U5a1b1,..,,,600-700 CE,,Unknown,Olalde et al. 2019,0,..,107,fasta,11467G;12308G;12372A;16192T;16270T,11467;12308;12372;16192;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Melanoma patients,Reported,+;nr,-;+;nr
I12029,I12029,Spain,,,Spain_Visigoth_father.or.son.I12031_lc,,Spain_Visigoth_father.or.son.I12031_lc,,42.01656,2.814897,M,"Girona, Pla de l'Horta",,U5a1a1d,..,,,416-700 CE,,Unknown,Olalde et al. 2019,0,..,185.2,fasta,11467G;12308G;12372A;15924G;16270T;185A,11467;12308;12372;15924;16270;185,MT-ND4;MT-TL2;MT-ND5;MT-TT;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;LIMM;Melanoma patients;Low VO2max response,Reported,+;nr,-;+;nr
I3574,I3574,Spain,,,Spain_Visigoth_Granada,,Spain_Visigoth_Granada,,37.3244444,-4.005833333,F,"Granada, Montefrío, El Castillón",,U5b1+16189+@16192,n/a (female),,,400-600 CE,,Unknown,Olalde et al. 2019,0,n/a (female),131,fasta,11467G;12308G;12372A;150T;16189C;16270T,11467;12308;12372;150;16189;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Longevity / Cervical Carcinoma / HPV infection risk;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;Melanoma patients,Reported;Conflicting reports,+;nr,-;+;nr
I3575,I3575,Spain,,,Spain_Visigoth_Granada,,Spain_Visigoth_Granada,,37.3244444,-4.005833333,M,"Granada, Montefrío, El Castillón",,U5b1+16189+@16192,..,,,400-600 CE,,Unknown,Olalde et al. 2019,0,..,53.8,fasta,11467G;12308G;12372A;150T;16189C;16270T,11467;12308;12372;150;16189;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Longevity / Cervical Carcinoma / HPV infection risk;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;Melanoma patients,Reported;Conflicting reports,+;nr,-;+;nr
I3576,I3576,Spain,,,Spain_Visigoth_Granada,,Spain_Visigoth_Granada,,37.3244444,-4.005833333,M,"Granada, Montefrío, El Castillón",,T2c1a2,..,-1595.0,-1545.0,"421-542 calCE (1595±25 BP, PSUAMS-2117)",1595,Unknown,Olalde et al. 2019,0,..,260,fasta,11251G;15928A;4216C;4917G;6261A,11251;15928;4216;4917;6261,MT-ND4;MT-TT;MT-ND1;MT-ND2;MT-CO1,Reduced risk of PD;Multiple Sclerosis / idiopathic repeat miscarriage / AD protection;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;LHON / Insulin Resistance / AMD / NRTI-PN;Prostate Cancer / LHON,Reported;Conflicting reports,nr;+,nr;-
I3577,I3577,Spain,,,Spain_Visigoth_Granada,,Spain_Visigoth_Granada,,37.3244444,-4.005833333,F,"Granada, Montefrío, El Castillón",,H5b,n/a (female),,,400-600 CE,,Unknown,Olalde et al. 2019,0,n/a (female),163,fasta,,,,,,,
I3578,I3578,Spain,,,Spain_Visigoth_Granada,,Spain_Visigoth_Granada,,37.3244444,-4.005833333,F,"Granada, Montefrío, El Castillón",,HV0f,n/a (female),,,400-600 CE,,Unknown,Olalde et al. 2019,0,n/a (female),281,fasta,195C,195,MT-CR,BD-associated / melanoma pts,Reported,+,+
I3579,I3579,Spain,,,Spain_Visigoth_Granada,,Spain_Visigoth_Granada,,37.3244444,-4.005833333,M,"Granada, Montefrío, El Castillón",,H1e1a6,..,,,400-600 CE,,Unknown,Olalde et al. 2019,0,..,183,fasta,150T;3010A;5460A,150;3010;5460,MT-CR;MT-RNR2;MT-ND2,Longevity / Cervical Carcinoma / HPV infection risk;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;AD / PD / LHON,Conflicting reports;Reported,+,+;-
I3581,I3581,Spain,,,Spain_Visigoth_Granada,,Spain_Visigoth_Granada,,37.3244444,-4.005833333,F,"Granada, Montefrío, El Castillón",,H3,n/a (female),,,400-600 CE,,Unknown,Olalde et al. 2019,0,n/a (female),122,fasta,,,,,,,
I3582,I3582,Spain,,,Spain_Visigoth_Granada,,Spain_Visigoth_Granada,,37.3244444,-4.005833333,M,"Granada, Montefrío, El Castillón",,K1b1a,..,,,400-600 CE,,Unknown,Olalde et al. 2019,0,..,115,fasta,10398G;11467G;12308G;12372A;15257A;16093C;5913A;9055A,10398;11467;12308;12372;15257;16093;5913;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-CYB;MT-CR;MT-CO1;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;LHON;Cyclic Vomiting Syndrome;Prostate Cancer / hypertension;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports,+;-,-;+
I3585,I3585,Spain,,,Spain_Visigoth_Granada,,Spain_Visigoth_Granada,,36.9572222,-4.12,M,"Granada, Ventas de Zafarraya",,H1,..,-1250.0,-1200.0,"675-876 calCE (1250±25 BP, PSUAMS-2074)",1250,Unknown,Olalde et al. 2019,0,..,400,fasta,3010A,3010,MT-RNR2,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor,Reported,+,-
I3583,I3583,Spain,,,Spain_Visigoth_Granada,,Spain_Visigoth_Granada,,37.3244444,-4.005833333,M,"Granada, Montefrío, El Castillón",,HV0f,..,,,400-600 CE,,Unknown,Olalde et al. 2019,0,..,58.2,fasta,195C,195,MT-CR,BD-associated / melanoma pts,Reported,+,+
I3584,I3584,Spain,,,Spain_Visigoth_Granada_contam,,Spain_Visigoth_Granada_contam,,36.9572222,-4.12,M,"Granada, Ventas de Zafarraya",,H,..,,,400-700 CE,,Unknown,Olalde et al. 2019,0,..,15.6,fasta,16129A,16129,MT-CR,Cyclic Vomiting Syndrome with Migraine,Reported,-,+
I12030,I12030,Spain,,,Spain_Visigoth,,Spain_Visigoth,,42.01656,2.814897,F,"Girona, Pla de l'Horta",,J1c3g,n/a (female),,,416-700 CE,,Unknown,Olalde et al. 2019,0,n/a (female),87.24,fasta,10398G;11251G;13708A;228A;295T;3010A;4216C;462T;489C,10398;11251;13708;228;295;3010;4216;462;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-RNR2;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Low VO2max response;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports,+;nr,-;nr;+
I12032,I12032,Spain,,,Spain_Visigoth,,Spain_Visigoth,,42.01656,2.814897,M,"Girona, Pla de l'Horta",,C4a1a+195,..,,,416-700 CE,,Unknown,Olalde et al. 2019,0,..,99.01,fasta,10398G;12705T;15043A;16093C;16129A;195C;3552A;489C,10398;12705;15043;16093;16129;195;3552;489,MT-ND3;MT-CO1;MT-CYB;MT-CR;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Possible protective factor for normal tension glaucoma;MDD-associated;Cyclic Vomiting Syndrome;Cyclic Vomiting Syndrome with Migraine;BD-associated / melanoma pts;Resistance to high altitude pulmonary edema (HAPE);Low VO2max response,Reported / lineage L & M marker / also hg IJK;Reported;Reported /hg C marker,+;<NA>;-,-;<NA>;+
I12033,I12033,Spain,,,Spain_Visigoth,,Spain_Visigoth,,42.01656,2.814897,M,"Girona, Pla de l'Horta",,V,..,,,416-700 CE,,Unknown,Olalde et al. 2019,0,..,174.7,fasta,,,,,,,
RISE207,RISE207_noUDG.SG,Sweden,,,Sweden_BA.SG,,Sweden_BA.SG,,55.997,14.104,M,Ängamöllan,,J1c8a1,..,-3130.0,-3076.0,"1495-1301 calBCE (3130±27 BP, OxA-29651)",3130,Unknown,Allentoft et al. 2015,0,..,..,fasta,,,,,,,
RISE175,RISE175_noUDG.SG,Sweden,,,Sweden_BA.SG,,Sweden_BA.SG,,55.397,13.6,M,Abekås I,,T1a1,..,-3025.0,-2965.0,"1396-1131 calBCE (3025±30 BP, OxA-28998)",3025,Unknown,Allentoft et al. 2015,0,..,..,fasta,,,,,,,
RISE210,RISE210_noUDG.SG,Sweden,,,Sweden_BA.SG,,Sweden_BA.SG,,55.997,14.104,F,Ängamöllan,,T2a1a,n/a (female),-3105.0,-3049.0,"1436-1286 calBCE (3105±28 BP, OxA-29654)",3105,Unknown,Allentoft et al. 2015,0,n/a (female),..,fasta,,,,,,,
RISE174,RISE174_noUDG.SG,Sweden,,,Sweden_IA.SG,,Sweden_IA.SG,,55.545,13.098,M,Oxie 7,,W1,..,-1521.0,-1445.0,"433-639 calCE (1521±38 BP, UBA-28275)",1521,Unknown,Allentoft et al. 2015,0,..,..,fasta,,,,,,,
RISE179,RISE179_noUDG.SG,Sweden,,,Sweden_LN.SG,,Sweden_LN.SG,,55.397,13.6,M,Abekås I,,K1a3,..,-3556.0,-3500.0,"2015-1774 calBCE (3556±28 BP, OxA-29193)",3556,Unknown,Allentoft et al. 2015,0,..,..,fasta,,,,,,,
RISE97,RISE97_noUDG.SG,Sweden,,,Sweden_LN.SG,,Sweden_LN.SG,,55.557,13.059,F,Fredriksberg,,K2a5,n/a (female),-3590.0,-3532.0,"2030-1830 calBCE (3590±29 BP, OxA-28986)",3590,Unknown,Allentoft et al. 2015,0,n/a (female),..,fasta,,,,,,,
RISE98,RISE98_noUDG.SG,Sweden,,,Sweden_LN.SG,,Sweden_LN.SG,,55.381,13.445,M,L Beddinge 56,,K1b1a1,..,-3736.0,-3672.0,"2278-2032 calBCE (3736±32 BP, OxA-28987)",3736,Unknown,Allentoft et al. 2015,0,..,..,fasta,,,,,,,
Bichon,Bichon_noUDG.SG,Switzerland,,,Switzerland_Bichon.SG,,Switzerland_Bichon.SG,,47.09999847,6.869999886,M,Grotte du Bichon,,U5b1h,I2a,-1855.0,-1755.0,"11850-11579 calBCE (11855±50 BP, OxA-27763)",1855,Unknown,Jones et al. 2015,0,..,..,fasta,,,,,,,
MX298,MX298,Switzerland,,,Switzerland_EBA_2,,Switzerland_EBA_2,,47.45,9.292,M,Wartau,,X2b4,..,-3988.0,-3910.0,"2622-2349 calBCE (3988±39 BP, BE-8022.1.1)",3988,Unknown,Furtwangler et al. 2020,0,..,..,fasta,,,,,,,
MX310,MX310,Switzerland,,,Switzerland_EBA_2_contam,,Switzerland_EBA_2_contam,,47.101,7.406,M,Burgäschisee,,..,..,,,2862-2581 calBCE,,Unknown,Furtwangler et al. 2020,0,..,..,fasta,,,,,,,
Aes20,Aes20,Switzerland,,,Switzerland_LN,,Switzerland_LN,,47.465413,7.601691,M,Aesch,,K2b1a,..,-4269.0,-4221.0,"2917-2876 calBCE (4269±24 BP, BE-9188.1.1)",4269,Unknown,Furtwangler et al. 2020,0,..,..,fasta,,,,,,,
MX299,MX299,Switzerland,,,Switzerland_LN_contam_o,,Switzerland_LN_contam_o,,47.262067,7.659835,M,Oberbipp Horgen,,..,..,-4225.0,-4151.0,"2910-2674 calBCE (4225±37 BP, BE-6191.1.1)",4225,Unknown,Furtwangler et al. 2020,0,..,..,fasta,,,,,,,
Bon005,Bon005_noUDG.WGC,Turkey,,,Turkey_Boncuklu_N_lc.SG,,Turkey_Boncuklu_N_lc.SG,,37.75191,32.864901,F,Boncuklu,,N1a1a1,n/a (female),,,8300-8240 calBCE (Wk-43898),,Unknown,Kilinc et al. 2016,0,n/a (female),..,fasta,,,,,,,
Bon001,Bon001_noUDG.WGC,Turkey,,,Turkey_Boncuklu_N.SG,,Turkey_Boncuklu_N.SG,,37.75191,32.864901,M,Boncuklu,,U3,..,,,8212-7952 calBCE (Ba-120539),,Unknown,Kilinc et al. 2016,0,..,..,fasta,,,,,,,
Bon002,Bon002_noUDG.WGC,Turkey,,,Turkey_Boncuklu_N.SG,,Turkey_Boncuklu_N.SG,,37.75191,32.864901,F,Boncuklu,,K1a,n/a (female),,,8279-7977 calBCE (Wk-29763),,Unknown,Kilinc et al. 2016,0,n/a (female),..,fasta,,,,,,,
Bon004,Bon004_noUDG.WGC,Turkey,,,Turkey_Boncuklu_N.SG,,Turkey_Boncuklu_N.SG,,37.75191,32.864901,M,Boncuklu,,N1a1a1,..,,,8300-7950 BCE,,Unknown,Kilinc et al. 2016,0,..,..,fasta,,,,,,,
I1584,I1584,Turkey,,,Turkey_C,,Turkey_C,,40.3,29.56,F,"Northwest Anatolia, Marmara, Barcın",,K1a17,n/a (female),-5016.0,-4954.0,"3946-3660 calBCE (5016±31 BP, OxA-32776)",5016,Unknown,Lazaridis et al. 2016,0,n/a (female),..,fasta,10398G;11467G;12308G;12372A;9055A,10398;11467;12308;12372;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+,-;+
I1584,I1584_noUDG,Turkey,,,Turkey_C,,Turkey_C,,40.3,29.56,F,"Northwest Anatolia, Marmara, Barc�n",,K1a17,n/a (female),-5016.0,-4954.0,"3946-3660 calBCE (5016±31 BP, OxA-32776)",5016,Unknown,Lazaridis et al. 2022,0,n/a (female),863.207798,fasta,10398G;11467G;12308G;12372A;9055A,10398;11467;12308;12372;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+,-;+
I1584,I2500_noUDG,Turkey,,,Turkey_C_dup.I1584_do.not.mergeI2500,,Turkey_C_dup.I1584_do.not.mergeI2500,,40.3,29.56,F,"Northwest Anatolia, Marmara, Barcın",,K1a17,n/a (female),-5016.0,-4954.0,"3946-3660 calBCE (5016±31 BP, OxA-32776)",5016,Unknown,Lazaridis et al. 2016,0,n/a (female),475,fasta,10398G;11467G;12308G;12372A;9055A,10398;11467;12308;12372;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+,-;+
I1584,I5395,Turkey,,,Turkey_C_dup.I1584_do.not.mergeI5395,,Turkey_C_dup.I1584_do.not.mergeI5395,,40.3,29.56,F,"Northwest Anatolia, Marmara, Barcın",,K1a17,n/a (female),-5016.0,-4954.0,"3946-3660 calBCE (5016±31 BP, OxA-32776)",5016,Unknown,Lazaridis et al. 2016,0,n/a (female),168,fasta,10398G;11467G;12308G;12372A;9055A,10398;11467;12308;12372;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+,-;+
I1584,I5432,Turkey,,,Turkey_C_dup.I1584_do.not.mergeI5432,,Turkey_C_dup.I1584_do.not.mergeI5432,,40.3,29.56,F,"Northwest Anatolia, Marmara, Barcın",,K1a17,n/a (female),-5016.0,-4954.0,"3946-3660 calBCE (5016±31 BP, OxA-32776)",5016,Unknown,Lazaridis et al. 2016,0,n/a (female),40,fasta,10398G;11467G;12308G;12372A;9055A,10398;11467;12308;12372;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+,-;+
I2495,I2495,Turkey,,,Turkey_EBA,,Turkey_EBA,,37.91774,30.70839,M,"Harmanören-Göndürle Höyük (Mediterranean, Isparta) ",,H,..,-3925.0,-3855.0,"2560-2295 calBCE (3925±35 BP, Poz-81111)",3925,Unknown,Lazaridis et al. 2017,0,..,430.651458,fasta,,,,,,,
I2499,I2499,Turkey,,,Turkey_EBA,,Turkey_EBA,,37.91774,30.70839,F,"Harmanören-Göndürle Höyük (Mediterranean, Isparta) ",,K1a2,n/a (female),-4040.0,-3970.0,"2836-2468 calBCE (4040±35 BP, Poz-82213)",4040,Unknown,Lazaridis et al. 2017,0,n/a (female),22.323375,fasta,10398G;11467G;12308G;12372A;9055A,10398;11467;12308;12372;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+,-;+
I2683,I2683,Turkey,,,Turkey_EBA,,Turkey_EBA,,37.91774,30.70839,F,"Harmanören-Göndürle Höyük (Mediterranean, Isparta) ",,T2b+152,n/a (female),-4015.0,-3955.0,"2621-2467 calBCE (4015±30 BP, PSUAMS-1988)",4015,Unknown,Lazaridis et al. 2017,0,n/a (female),583,fasta,11251G;15928A;4216C;4917G,11251;15928;4216;4917,MT-ND4;MT-TT;MT-ND1;MT-ND2,Reduced risk of PD;Multiple Sclerosis / idiopathic repeat miscarriage / AD protection;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;LHON / Insulin Resistance / AMD / NRTI-PN,Reported;Conflicting reports,nr;+,nr;-
I2495,I2495_noUDG,Turkey,,,Turkey_EBA_noUDG,,Turkey_EBA_noUDG,,37.91774,30.70839,M,"Harmanören-Göndürle Höyük (Mediterranean, Isparta) ",,H,..,-3925.0,-3855.0,"2560-2295 calBCE (3925±35 BP, Poz-81111)",3925,Unknown,Lazaridis et al. 2022,0,..,430.651458,fasta,,,,,,,
I2499,I2499_noUDG,Turkey,,,Turkey_EBA_noUDG,,Turkey_EBA_noUDG,,37.91774,30.70839,F,"Harmanören-Göndürle Höyük (Mediterranean, Isparta) ",,K1a2,n/a (female),-4040.0,-3970.0,"2836-2468 calBCE (4040±35 BP, Poz-82213)",4040,Unknown,Lazaridis et al. 2022,0,n/a (female),22.323375,fasta,10398G;11467G;12308G;12372A;9055A,10398;11467;12308;12372;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+,-;+
I2683,I2683_noUDG,Turkey,,,Turkey_EBA_noUDG,,Turkey_EBA_noUDG,,37.91774,30.70839,F,"Harmanören-Göndürle Höyük (Mediterranean, Isparta) ",,T2b+152,n/a (female),-4015.0,-3955.0,"2621-2467 calBCE (4015±30 BP, PSUAMS-1988)",4015,Unknown,Lazaridis et al. 2022,0,n/a (female),594.123785,fasta,11251G;15928A;4216C;4917G,11251;15928;4216;4917,MT-ND4;MT-TT;MT-ND1;MT-ND2,Reduced risk of PD;Multiple Sclerosis / idiopathic repeat miscarriage / AD protection;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;LHON / Insulin Resistance / AMD / NRTI-PN,Reported;Conflicting reports,nr;+,nr;-
kum4,kum4_noUDG.SG,Turkey,,,Turkey_Kumtepe_N_lc.SG,,Turkey_Kumtepe_N_lc.SG,,39.95,26.2,F,Kumtepe,,..,n/a (female),,,4900-4300 BCE,,Unknown,Omrak et al. 2016,0,n/a (female),..,fasta,,,,,,,
Tep006,Tep006_noUDG.WGC,Turkey,,,Turkey_TepecikCiftlik_N_father.or.son.Tep004.SG,,Turkey_TepecikCiftlik_N_father.or.son.Tep004.SG,,38.172218,34.49387,M,Tepecik Ciftlik,,N1a1a1,..,-7280.0,-7220.0,"6223-6072 calBCE (7280±30 BP, Beta-410035)",7280,Unknown,Kilinc et al. 2016,0,..,..,fasta,,,,,,,
Tep002,Tep002_noUDG.WGC,Turkey,,,Turkey_TepecikCiftlik_N.SG,,Turkey_TepecikCiftlik_N.SG,,38.172218,34.49387,F,Tepecik Ciftlik,,K1a12a,n/a (female),-7710.0,-7650.0,"6636-6467 calBCE (7710±30 BP, Beta-410031)",7710,Unknown,Kilinc et al. 2016,0,n/a (female),..,fasta,,,,,,,
Tep003,Tep003_noUDG.WGC,Turkey,,,Turkey_TepecikCiftlik_N.SG,,Turkey_TepecikCiftlik_N.SG,,38.172218,34.49387,M,Tepecik Ciftlik,,N1b1a,..,-7630.0,-7570.0,"6570-6422 calBCE (7630±30 BP, Beta-410032)",7630,Unknown,Kilinc et al. 2016,0,..,..,fasta,,,,,,,
Tep004,Tep004_noUDG.WGC,Turkey,,,Turkey_TepecikCiftlik_N.SG,,Turkey_TepecikCiftlik_N.SG,,38.172218,34.49387,F,Tepecik Ciftlik,,N1a1a1,n/a (female),-7400.0,-7340.0,"6385-6102 calBCE (7400±30 BP, Beta-410033)",7400,Unknown,Kilinc et al. 2016,0,n/a (female),..,fasta,,,,,,,
ILK002,ILK002,Ukraine,,,Ukraine_EBA_GlobularAmphora,,Ukraine_EBA_GlobularAmphora,,49.55777778,27.68861111,M,Ilatka,,..,..,-4192.0,-4148.0,"2889-2675 calBCE (4192±22 BP, MAMS-30073)",4192,Unknown,Mathieson et al. 2018,0,..,..,fasta,,,,,,,
ILK001,ILK001,Ukraine,,,Ukraine_GlobularAmphora,,Ukraine_GlobularAmphora,,49.55777778,27.68861111,M,Ilatka,,..,..,-4221.0,-4177.0,"2900-2701 calBCE (4221±22 BP, MAMS-30072)",4221,Unknown,Mathieson et al. 2018,0,..,..,fasta,,,,,,,
ILK003,ILK003,Ukraine,,,Ukraine_GlobularAmphora,,Ukraine_GlobularAmphora,,49.55777778,27.68861111,F,Ilatka,,..,n/a (female),-4225.0,-4181.0,"2901-2703 calBCE (4225±22 BP, MAMS-30074)",4225,Unknown,Mathieson et al. 2018,0,n/a (female),..,fasta,,,,,,,
I1944,S1944.E1.L3_v54.1_addback,Iran,,,Iran_GanjDareh_N,,Iran_GanjDareh_N,,34.45,48.116,F,Ganj Dareh,,R2+13500,..,,,8000-7700 BCE,,Unknown,Narasimhan et al. 2019,0,..,4.453256,fasta,4216C,4216,MT-ND1,LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Conflicting reports,+,-
I1951,S1951.E1.L3_v54.1_addback,Iran,,,Iran_GanjDareh_N,,Iran_GanjDareh_N,,34.45,48.116,F,Ganj Dareh,,HV,..,-8800.0,-8700.0,"8198-7613 calBCE (8800±50 BP, Poz-81109)",8800,Unknown,Narasimhan et al. 2019,0,..,13.102963,fasta,,,,,,,
